No definition available.
Viral agents as the cause of diseases classified to other chapters, including avohilmo
AB1_VIRAL_INOTHER_WIDE
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519870 |
1. Apply sex-specific ruleNone |
519870 |
2. Check conditionsNone |
519870 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
1017 |
4. Check minimum number of eventsNone |
1017 |
5. Include endpointsNone |
1017 |
6. Filter based on genotype QC (FinnGen only) |
969 |
Control definitions (FinnGen only)
- Control exclude
- AB1_BACT_BIR_OTHER_INF_AGENTS
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF13
Similar endpoints
↥List of similar endpoints to
Viral agents as the cause of diseases classified to other chapters, including avohilmo
based on the number of shared cases.
Similar with more cases:
- Bacterial, viral and other infectious agents, including avohilmo
- Certain infectious and parasitic diseases, including avohilmo
- Any prescribed medicine buy
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 969 | 587 | 382 |
| Unadjusted period prevalence (%) | 0.20 | 0.21 | 0.18 |
| Median age at first event (years) | 50.43 | 45.30 | 58.31 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1016
- Matched controls
- 10160
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
B97.7
ICD-10 Finland
Papillomavirus as the cause of diseases classified to other chapters
+∞
307.7
616
*
D14.0
ICD-10 Finland
Benign neoplasm: Middle ear, nasal cavity and accessory sinuses
51.3
262.3
153
35
D14.1
ICD-10 Finland
Benign neoplasm: Larynx
79.7
246.3
132
19
B97.4
ICD-10 Finland
Respiratory syncytial virus as the cause of diseases classified to other chapters
+∞
221.1
204
*
DQB10
NOMESCO Finland
Endoscopic excision of lesion of larynx
48.9
206.0
121
28
N72
ICD-10 Finland
Inflammatory disease of cervix uteri
56.6
179.5
102
20
ULA02
NOMESCO Finland
Kolposcopy
5.9
121.4
263
566
ZXC10
NOMESCO Finland
Use of laser
13.8
118.2
114
92
R87.6
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal cytological findings
5.7
113.1
253
558
LDA20
NOMESCO Finland
Biopsy of vaginal cervix
5.6
81.3
174
363
LDC03
NOMESCO Finland
Conisation of cervix uteri using diathermy or laser
7.2
77.8
123
190
DHA10
NOMESCO Finland
Biopsy of cavity of nose
20.7
71.7
55
28
B97.2
ICD-10 Finland
Coronavirus as the cause of diseases classified to other chapters
+∞
70.7
67
*
DQA10
NOMESCO Finland
Biopsy of larynx
22.4
58.0
43
20
QA1S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in head
20.4
55.7
43
22
LDA10
NOMESCO Finland
Curettage of cervix uteri
5.7
53.5
105
200
N87.0
ICD-10 Finland
Mild cervical dysplasia
7.4
52.3
79
115
LFB20
NOMESCO Finland
Destruction of lesion of vulva or perineum
23.2
52.0
38
17
Z2221
NOMESCO Finland
Medical doctor
2.8
51.4
401
1938
UDH02
NOMESCO Finland
Rhinopharyngoscopy
4.3
51.3
148
389
LDB20
NOMESCO Finland
Electrocoagulation or laser therapy of cervix uteri
14.1
49.6
46
34
ZXD10
NOMESCO Finland
Scheduled procedure
2.6
49.1
488
2646
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
3.4
48.1
200
675
J38.1
ICD-10 Finland
Polyp of vocal cord and larynx
16.6
47.1
40
25
ZXE00
NOMESCO Finland
One hour or less
2.5
42.7
496
2840
B977, D141,
ICD-10 Finland
+∞
37.7
36
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.4
35.8
336
1720
A63.0
ICD-10 Finland
Anogenital (venereal) warts
4.7
35.7
86
195
N771, B977,
ICD-10 Finland
+∞
35.6
34
*
DHB20
NOMESCO Finland
Polypectomy of internal nose
8.5
33.6
44
54
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
4.9
33.4
77
168
DM1BD
NOMESCO Finland
Extensive CT of paranasal sinuses and face area
76.9
33.1
37
5
D38.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Larynx
38.8
32.7
41
11
DHB10
NOMESCO Finland
Excision of lesion of internal nose
41.6
32.3
40
10
B97.8
ICD-10 Finland
Other viral agents as the cause of diseases classified to other chapters
+∞
31.4
30
*
R4110
NOMESCO Finland
Physiotherapy
2.3
30.7
347
1901
UDQ22
NOMESCO Finland
Microlaryngoscopy
11.4
29.4
31
28
ZXA10
NOMESCO Finland
Bilateral
2.5
29.1
228
1062
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
2.8
28.6
160
631
ZXE10
NOMESCO Finland
More than one and less than three hours
2.1
28.4
406
2425
B977, D140,
ICD-10 Finland
+∞
28.3
27
*
ZXD20
NOMESCO Finland
Day surgery
2.7
27.7
173
722
ZXA05
NOMESCO Finland
Left side
2.3
27.3
267
1368
R87.5
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal microbiological findings
6.2
27.0
47
79
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
5.3
26.9
55
108
ZXA00
NOMESCO Finland
Right side
2.2
26.2
288
1545
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
3.6
25.7
90
268
WX402
NOMESCO Finland
General anaesthesia
2.2
25.3
286
1549
B97.0
ICD-10 Finland
Adenovirus as the cause of diseases classified to other chapters
+∞
25.1
24
*
DNB30
NOMESCO Finland
Excision of lesion of ethmoidal sinus
+∞
24.1
23
*
J33.0
ICD-10 Finland
Polyp of nasal cavity
4.4
20.9
54
129
UDQ02
NOMESCO Finland
Direct laryngoscopy
8.3
19.7
26
32
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.0
19.3
247
1384
Z3231
NOMESCO Finland
Registered nurse
1.9
19.2
308
1865
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
2.7
18.6
107
425
DMB30
NOMESCO Finland
Transmaxillary excision of lesion of maxillary antrum
183.1
17.6
18
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.9
17.3
263
1556
D06BB04
ATC
podophyllotoxin; topical
2.8
16.5
85
318
J33.8
ICD-10 Finland
Other polyp of sinus
4.5
15.3
37
84
TDM10
NOMESCO Finland
Puncture of maxillary antrum
3.3
14.9
58
185
J12.1
ICD-10 Finland
Respiratory syncytial virus pneumonia
12.1
14.6
26
22
B97.1
ICD-10 Finland
Enterovirus as the cause of diseases classified to other chapters
+∞
14.6
14
*
GB3AV, ,
NOMESCO Finland
152.1
14.5
15
*
DM1DG
NOMESCO Finland
Paranasal sinuses and face area very extensive MRI examination with high intensity magnet
36.6
14.5
18
5
WX002
NOMESCO Finland
Sedation and analgesia
1.9
14.4
197
1118
J20.5
ICD-10 Finland
Acute bronchitis due to respiratory syncytial virus
13.6
14.3
24
18
ZXE20
NOMESCO Finland
More than three and less than five hours
2.1
13.4
144
750
N87.1
ICD-10 Finland
Moderate cervical dysplasia
4.0
13.3
38
98
Z3226
NOMESCO Finland
Physiotherapist
1.9
13.2
196
1142
H02AB06
ATC
prednisolone; systemic
1.6
12.9
471
3516
DMB35
NOMESCO Finland
Endoscopic excision of neoplasm or another lesion from maxillary sinus
+∞
12.5
12
*
DPA25
NOMESCO Finland
Trephine of frontal sinus through nose
6.3
12.5
21
34
LEB00
NOMESCO Finland
Biopsy of vagina
4.9
12.4
27
56
8077/2-C53.9
ICD-O-3
Squamous intraepithelial neoplasia, high grade of cervix uteri
4.3
12.3
32
77
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
12.3
450
3350
D14.4
ICD-10 Finland
Benign neoplasm: Respiratory system, unspecified
121.3
11.4
12
*
2121A
ICD-9 Finland
Benign neoplasm of respiratory and intrathoracic organs, Larynx
121.3
11.4
12
*
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
4.4
11.3
28
65
WX110
NOMESCO Finland
Infiltration anesthesia
1.7
11.1
744
6330
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.9
11.1
156
889
R50.9
ICD-10 Finland
Fever, unspecified
1.8
11.0
170
999
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.6
11.0
550
4367
N02AX02
ATC
tramadol; systemic, rectal
1.6
11.0
407
3018
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
2.0
10.9
124
658
R02
ICPC
Shortness of breath/dyspnoea
1.9
10.6
144
811
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.7
10.5
210
1328
WX400
NOMESCO Finland
Inhalation anesthesy
2.7
10.4
57
221
D06BB10
ATC
imiquimod; topical
2.5
10.2
66
277
R2110
NOMESCO Finland
Giving the first information
2.3
10.2
79
360
R01AD09
ATC
mometasone; nasal
1.5
10.1
473
3673
J01CA04
ATC
amoxicillin; systemic
1.7
10.1
841
7454
1420
FHL
Laryngomicroscopy
9.2
10.0
20
22
Z71.8
ICD-10 Finland
Other specified counselling
1.6
9.8
365
2691
J38.3
ICD-10 Finland
Other diseases of vocal cords
4.8
9.8
22
47
J46
ICD-10 Finland
Status asthmaticus
3.3
9.8
36
111
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.6
9.7
286
1997
J01AA02
ATC
doxycycline; systemic
1.6
9.7
739
6361
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
1.7
9.7
228
1506
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
4.1
9.5
26
65
127
Kela drug reimbursment
Transplant complication
3.9
9.4
27
70
ZXD05
NOMESCO Finland
Urgent procedure
1.6
9.4
303
2156
21210
ICD-8 Finland
Benign neoplasm of respiratory system, Larynx
100.9
9.4
10
*
L28
ICPC
Limited function/disability (L)
1.8
9.3
167
1022
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.0
9.3
103
541
R03AC12
ATC
salmeterol; inhalant
2.8
9.2
45
164
TPH04
NOMESCO Finland
Cathetrisation of vein
1.7
9.2
209
1366
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.6
9.2
308
2213
R03AC02
ATC
salbutamol; inhalant
1.5
8.9
561
4593
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.8
8.8
153
927
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.5
8.8
558
4567
R52.9
ICD-10 Finland
Pain, unspecified
1.9
8.8
111
609
J02AC01
ATC
fluconazole; systemic
1.5
8.7
388
2956
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.8
8.7
141
838
ZXC00
NOMESCO Finland
Use of diathermy
9.1
8.5
17
19
A28
ICPC
Limited function/disability NOS
1.8
8.5
149
906
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.9
8.4
113
633
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.7
8.3
159
990
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.6
8.3
200
1324
A02BC02
ATC
pantoprazole; systemic
1.5
8.3
639
5411
R96
ICPC
Asthma
1.9
8.1
99
538
R06.0
ICD-10 Finland
Dyspnoea
1.6
8.1
256
1808
L04AA06
ATC
mycophenolic acid; systemic
3.4
8.0
28
84
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
2.6
7.9
46
184
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.7
7.9
148
917
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.5
7.8
265
1898
WX892
NOMESCO Finland
Monitored bed care
2.1
7.8
75
374
L17
ICPC
Foot/toe symptom/complaint
1.5
7.8
297
2181
WW500
NOMESCO Finland
Blood transfusion
2.6
7.8
43
168
Z01.7
ICD-10 Finland
Laboratory examination
1.6
7.7
174
1131
ZXC95
NOMESCO Finland
Use of surgical navigator
4.4
7.7
19
44
LEB30
NOMESCO Finland
Destruction of lesion of vaginal mucosa
8.1
7.6
16
20
XX1XW
NOMESCO Finland
Extensive written report from radiologist
3.6
7.6
24
67
J12.8
ICD-10 Finland
Other viral pneumonia
6.8
7.6
18
27
L04AD02
ATC
tacrolimus; systemic
4.1
7.6
20
49
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.5
7.5
297
2195
R49.0
ICD-10 Finland
Dysphonia
3.3
7.4
27
83
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.5
7.4
257
1846
XF600
NOMESCO Finland
Bloodpressure measurement
2.1
7.4
67
327
TLC02
NOMESCO Finland
Simple extraction of IUD
2.4
7.3
48
204
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.5
7.3
362
2796
C03CA01
ATC
furosemide; systemic
1.6
7.2
221
1543
A63.8
ICD-10 Finland
Other specified predominantly sexually transmitted diseases
15.9
7.2
11
7
C32.0
ICD-10 Finland
Malignant neoplasm: Glottis
15.9
7.2
11
7
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.7
7.2
145
915
Z2446
NOMESCO Finland
Social worker
2.0
7.1
80
422
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
2.3
7.1
50
220
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.1
7.0
63
306
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
7.0
411
3268
R49.08
ICD-10 Finland
Other specified dysphonia
3.0
7.0
29
97
WX734
NOMESCO Finland
JET-ventilation
13.9
6.9
11
8
H02AB07
ATC
prednisone; oral
1.7
6.9
118
712
R01AD08
ATC
fluticasone; nasal
1.5
6.9
276
2041
R03AK07
ATC
formoterol and budesonide; inhalant
1.5
6.8
214
1501
DMB10
NOMESCO Finland
Radical maxillary antrotomy
9.4
6.8
13
14
N87.2
ICD-10 Finland
Severe cervical dysplasia, not elsewhere classified
2.8
6.8
32
115
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.4
6.8
47
205
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.9
6.7
91
512
R81
ICPC
Pneumonia
2.5
6.7
42
175
R03BA02
ATC
budesonide; inhalant
1.6
6.7
177
1195
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.1
6.7
59
285
J01FA10
ATC
azithromycin; systemic
1.4
6.6
571
4843
ZX120
NOMESCO Finland
Intravenous
1.9
6.5
89
501
DMB00
NOMESCO Finland
Endonasal trephine of maxillary antrum
6.9
6.5
15
22
R03AC13
ATC
formoterol; inhalant
2.3
6.5
48
215
J01MA02
ATC
ciprofloxacin; systemic
1.4
6.5
334
2583
NDG77
NOMESCO Finland
Other excision, reconstruction or fusion of joint of first finger
70.3
6.4
7
*
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.1
6.4
61
303
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.3
6.4
47
210
J45.9
ICD-10 Finland
Asthma, unspecified
1.6
6.4
178
1215
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.2
6.4
50
230
XF400
NOMESCO Finland
ECG with 12 standard connections
1.6
6.4
136
871
LFB00
NOMESCO Finland
Biopsy of vulva or perineum
3.0
6.3
27
92
A99
ICPC
Disease/condition unspecnature/site
1.7
6.3
107
644
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.7
6.3
130
826
R51.80
ICD-10 Finland
Headache
1.6
6.3
169
1145
C32.9
ICD-10 Finland
Malignant neoplasm: Larynx, unspecified
+∞
6.3
6
*
B97.6
ICD-10 Finland
Parvovirus as the cause of diseases classified to other chapters
+∞
6.3
6
*
N02BE01
ATC
paracetamol; systemic, rectal
1.6
6.2
862
7930
J01MA14
ATC
moxifloxacin; systemic
1.9
6.2
82
457
S29
ICPC
Skin symptom/complaint other
1.5
6.2
194
1358
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.7
6.2
112
686
Z09.8
ICD-10 Finland
Follow-up examination after other treatment for other conditions
2.4
6.2
39
163
AA1AD
NOMESCO Finland
CT of head and brain
1.5
6.2
240
1758
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.8
6.1
97
572
R05
ICPC
Cough
1.5
6.1
250
1851
J01MA12
ATC
levofloxacin; systemic
1.6
6.0
153
1022
SPAT1324
SPAT
Screening procedure
0.5
6.0
66
1181
DPA30
NOMESCO Finland
Sphenotomy
6.1
6.0
15
25
TimeCodeWAS
↥TODO / Current known limitations:
- Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
- Legend / how to read the glyphs.
- Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
- Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
- Download CSV.
- No filters and sorters.
- Limited amount of endpoints (~400) having TimeCodeWAS data.
- Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Use of laser
ZXC10 [2001311360]
ZXC10 [2001311360]
2.4e+00
3.9e+00
—
1.0e+50
1.0e+50
4.6e+00
3.8e+00
cases:1.81%
controls:0.16%
cases:3.31%
controls:0.07%
—
—
cases:1.60%
controls:0.00%
cases:0.60%
controls:0.00%
cases:4.93%
controls:0.05%
cases:7.06%
controls:0.17%
18
16
974
9907
33
7
964
9964
—
16
0
981
9971
6
0
987
9951
47
5
906
9681
56
14
737
8088
Rhinopharyngoscopy
UDH02 [2001301680]
UDH02 [2001301680]
2.0e+00
3.3e+00
—
1.0e+50
2.5e+00
3.4e+00
2.6e+00
cases:3.83%
controls:0.55%
cases:3.31%
controls:0.12%
—
—
cases:2.51%
controls:0.00%
cases:0.60%
controls:0.05%
cases:4.62%
controls:0.17%
cases:6.18%
controls:0.51%
38
55
954
9868
33
12
964
9959
—
25
0
972
9971
6
5
987
9946
44
16
909
9670
49
41
744
8061
Obstetrics / Gynecology
16 [38004461]
16 [38004461]
4.0e-01
1.1e+00
1.7e+00
6.0e+00
1.8e+00
1.3e+00
7.3e-01
cases:22.38%
controls:16.24%
cases:18.56%
controls:6.73%
cases:7.02%
controls:1.37%
cases:27.48%
controls:0.09%
cases:7.25%
controls:1.33%
cases:21.62%
controls:6.95%
cases:30.26%
controls:17.28%
222
1611
770
8312
185
671
812
9300
70
137
927
9834
274
9
723
9962
72
132
921
9819
206
673
747
9013
240
1400
553
6702
Scheduled procedure
ZXD10 [2001311387]
ZXD10 [2001311387]
9.2e-01
1.9e+00
2.6e+00
1.0e+50
2.4e+00
2.8e+00
2.0e+00
cases:12.00%
controls:5.13%
cases:9.03%
controls:1.50%
cases:2.71%
controls:0.20%
cases:4.91%
controls:0.00%
cases:1.41%
controls:0.13%
cases:12.49%
controls:0.90%
cases:18.92%
controls:3.16%
119
509
873
9414
90
150
907
9821
27
20
970
9951
49
0
948
9971
14
13
979
9938
119
87
834
9599
150
256
643
7846
Otolaryngology
4 [38004449]
4 [38004449]
9.6e-01
2.0e+00
2.6e+00
—
2.7e+00
2.3e+00
1.6e+00
cases:23.79%
controls:10.63%
cases:24.37%
controls:4.21%
cases:9.33%
controls:0.74%
—
—
cases:9.26%
controls:0.71%
cases:27.70%
controls:3.83%
cases:34.68%
controls:9.78%
236
1055
756
8868
243
420
754
9551
93
74
904
9897
—
92
71
901
9880
264
371
689
9315
275
792
518
7310
Medical doctor
Z2221 [2001311556]
Z2221 [2001311556]
9.3e-01
1.9e+00
2.5e+00
—
2.3e+00
2.1e+00
1.9e+00
cases:8.87%
controls:3.71%
cases:5.92%
controls:0.96%
cases:2.21%
controls:0.18%
—
—
cases:1.21%
controls:0.12%
cases:6.09%
controls:0.79%
cases:13.49%
controls:2.25%
88
368
904
9555
59
96
938
9875
22
18
975
9953
—
12
12
981
9939
58
77
895
9609
107
182
686
7920
Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
40982-1 [3038288]
40982-1 [3038288]
1.3e+00
1.3e+00
3.7e+00
1.0e+50
2.8e+00
1.2e+00
9.0e-01
cases:4.13%
controls:1.19%
cases:2.91%
controls:0.79%
cases:3.51%
controls:0.09%
cases:7.42%
controls:0.00%
cases:2.32%
controls:0.15%
cases:2.41%
controls:0.77%
cases:5.04%
controls:2.12%
41
118
951
9805
29
79
968
9892
35
9
962
9962
74
0
923
9971
23
15
970
9936
23
75
930
9611
40
172
753
7930
Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40987-0 [3043924]
40987-0 [3043924]
1.3e+00
1.4e+00
3.7e+00
1.0e+50
2.7e+00
1.1e+00
7.8e-01
cases:4.03%
controls:1.12%
cases:3.11%
controls:0.80%
cases:3.81%
controls:0.10%
cases:7.62%
controls:0.00%
cases:2.52%
controls:0.17%
cases:2.41%
controls:0.81%
cases:4.92%
controls:2.31%
40
111
952
9812
31
80
966
9891
38
10
959
9961
76
0
921
9971
25
17
968
9934
23
78
930
9608
39
187
754
7915
Conisation of cervix uteri using diathermy or laser
LDC03 [2001306664]
LDC03 [2001306664]
2.0e+00
3.3e+00
—
1.0e+50
—
3.4e+00
2.2e+00
cases:1.92%
controls:0.27%
cases:1.81%
controls:0.07%
—
—
cases:3.81%
controls:0.00%
—
—
cases:1.57%
controls:0.05%
cases:2.02%
controls:0.22%
19
27
973
9896
18
7
979
9964
—
38
0
959
9971
—
15
5
938
9681
16
18
777
8084
Outpatient Visit
OP [9202]
OP [9202]
4.9e-01
9.8e-01
9.8e-01
5.2e+00
1.0e+00
1.1e+00
9.4e-01
cases:79.33%
controls:70.18%
cases:71.72%
controls:48.82%
cases:23.87%
controls:10.52%
cases:45.14%
controls:0.47%
cases:23.87%
controls:9.96%
cases:73.56%
controls:48.63%
cases:89.53%
controls:76.88%
787
6964
205
2959
715
4868
282
5103
238
1049
759
8922
450
47
547
9924
237
991
756
8960
701
4710
252
4976
710
6229
83
1873
One hour or less
ZXE00 [2001311394]
ZXE00 [2001311394]
8.3e-01
1.8e+00
1.9e+00
1.0e+50
1.7e+00
2.5e+00
1.8e+00
cases:12.30%
controls:5.76%
cases:9.13%
controls:1.60%
cases:1.60%
controls:0.25%
cases:4.61%
controls:0.00%
cases:0.81%
controls:0.15%
cases:11.33%
controls:1.07%
cases:19.29%
controls:3.73%
122
572
870
9351
91
160
906
9811
16
25
981
9946
46
0
951
9971
8
15
985
9936
108
104
845
9582
153
302
640
7800
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 [3044938]
34487-9 [3044938]
1.1e+00
1.3e+00
3.4e+00
1.0e+50
2.7e+00
1.2e+00
6.8e-01
cases:5.34%
controls:1.88%
cases:4.11%
controls:1.14%
cases:4.81%
controls:0.16%
cases:9.43%
controls:0.00%
cases:3.42%
controls:0.23%
cases:3.78%
controls:1.13%
cases:6.05%
controls:3.17%
53
187
939
9736
41
114
956
9857
48
16
949
9955
94
0
903
9971
34
23
959
9928
36
109
917
9577
48
257
745
7845
Abnormal findings in specimens from female genital organs, abnormal cytological findings
R87.6 [45558487]
R87.6 [45558487]
2.0e+00
3.2e+00
—
—
—
2.8e+00
2.1e+00
cases:7.66%
controls:1.09%
cases:9.93%
controls:0.45%
—
—
—
—
—
—
cases:5.88%
controls:0.36%
cases:9.08%
controls:1.16%
76
108
916
9815
99
45
898
9926
—
—
—
56
35
897
9651
72
94
721
8008
Base excess in Arterial blood by calculation
1925-7 [3003396]
1925-7 [3003396]
8.2e-01
1.2e+00
2.6e+00
—
3.2e+00
1.4e+00
8.1e-01
cases:3.23%
controls:1.44%
cases:2.41%
controls:0.71%
cases:0.70%
controls:0.05%
—
—
cases:1.41%
controls:0.06%
cases:2.73%
controls:0.69%
cases:4.41%
controls:2.01%
32
143
960
9780
24
71
973
9900
7
5
990
9966
—
14
6
979
9945
26
67
927
9619
35
163
758
7939
Emergency Room Visit
ER [9203]
ER [9203]
3.8e-01
5.6e-01
1.5e+00
5.3e+00
1.1e+00
5.7e-01
5.6e-01
cases:40.83%
controls:32.04%
cases:17.45%
controls:10.79%
cases:5.92%
controls:1.35%
cases:9.43%
controls:0.05%
cases:4.13%
controls:1.36%
cases:16.68%
controls:10.20%
cases:39.09%
controls:26.87%
405
3179
587
6744
174
1076
823
8895
59
135
938
9836
94
5
903
9966
41
135
952
9816
159
988
794
8698
310
2177
483
5925
Biopsy of vaginal cervix
LDA20 [2001306656]
LDA20 [2001306656]
2.0e+00
3.2e+00
1.0e+50
1.0e+50
—
2.9e+00
1.9e+00
cases:4.54%
controls:0.64%
cases:4.71%
controls:0.20%
cases:2.21%
controls:0.00%
cases:3.51%
controls:0.00%
—
—
cases:3.15%
controls:0.18%
cases:3.91%
controls:0.58%
45
64
947
9859
47
20
950
9951
22
0
975
9971
35
0
962
9971
—
30
17
923
9669
31
47
762
8055
Kolposcopy
ULA02 [2001306679]
ULA02 [2001306679]
1.8e+00
3.1e+00
—
1.0e+50
—
3.1e+00
2.1e+00
cases:6.75%
controls:1.23%
cases:8.22%
controls:0.40%
—
—
cases:8.53%
controls:0.00%
—
—
cases:7.56%
controls:0.37%
cases:7.57%
controls:1.02%
67
122
925
9801
82
40
915
9931
—
85
0
912
9971
—
72
36
881
9650
60
83
733
8019
pH of Arterial blood
2744-1 [3019977]
2744-1 [3019977]
7.7e-01
1.2e+00
2.6e+00
—
3.1e+00
1.3e+00
8.0e-01
cases:3.13%
controls:1.47%
cases:2.41%
controls:0.72%
cases:0.70%
controls:0.05%
—
—
cases:1.31%
controls:0.06%
cases:2.73%
controls:0.74%
cases:4.41%
controls:2.04%
31
146
961
9777
24
72
973
9899
7
5
990
9966
—
13
6
980
9945
26
72
927
9614
35
165
758
7937
Polyp of nasal cavity
J33.0 [45562447]
J33.0 [45562447]
1.6e+00
3.7e+00
1.0e+50
1.0e+50
—
2.8e+00
1.7e+00
cases:1.31%
controls:0.27%
cases:2.41%
controls:0.06%
cases:0.80%
controls:0.00%
cases:0.50%
controls:0.00%
—
—
cases:1.15%
controls:0.07%
cases:1.64%
controls:0.31%
13
27
979
9896
24
6
973
9965
8
0
989
9971
5
0
992
9971
—
11
7
942
9679
13
25
780
8077
Curettage of cervix uteri
LDA10 [2001306655]
LDA10 [2001306655]
2.0e+00
3.4e+00
1.0e+50
1.0e+50
—
2.7e+00
1.5e+00
cases:2.22%
controls:0.31%
cases:2.31%
controls:0.08%
cases:1.30%
controls:0.00%
cases:1.81%
controls:0.00%
—
—
cases:1.36%
controls:0.09%
cases:1.51%
controls:0.33%
22
31
970
9892
23
8
974
9963
13
0
984
9971
18
0
979
9971
—
13
9
940
9677
12
27
781
8075
Carbon dioxide [Partial pressure] in Arterial blood
2019-8 [3027946]
2019-8 [3027946]
8.1e-01
1.2e+00
2.5e+00
—
2.9e+00
1.3e+00
7.4e-01
cases:3.13%
controls:1.42%
cases:2.31%
controls:0.68%
cases:0.60%
controls:0.05%
—
—
cases:1.21%
controls:0.07%
cases:2.62%
controls:0.72%
cases:4.16%
controls:2.04%
31
141
961
9782
23
68
974
9903
6
5
991
9966
—
12
7
981
9944
25
70
928
9616
33
165
760
7937
Oxygen [Partial pressure] in Arterial blood
2703-7 [3027801]
2703-7 [3027801]
8.1e-01
1.2e+00
2.5e+00
—
2.9e+00
1.3e+00
7.4e-01
cases:3.13%
controls:1.42%
cases:2.31%
controls:0.68%
cases:0.60%
controls:0.05%
—
—
cases:1.21%
controls:0.07%
cases:2.62%
controls:0.73%
cases:4.16%
controls:2.04%
31
141
961
9782
23
68
974
9903
6
5
991
9966
—
12
7
981
9944
25
71
928
9615
33
165
760
7937
Benign neoplasm: Middle ear, nasal cavity and accessory sinuses
D14.0 [45581284]
D14.0 [45581284]
3.9e+00
—
1.0e+50
1.0e+50
1.0e+50
—
5.3e+00
cases:3.02%
controls:0.06%
—
—
cases:2.81%
controls:0.00%
cases:10.03%
controls:0.00%
cases:3.02%
controls:0.00%
—
—
cases:12.86%
controls:0.07%
30
6
962
9917
—
28
0
969
9971
100
0
897
9971
30
0
963
9951
—
102
6
691
8096
Mild cervical dysplasia
N87.0 [45567868]
N87.0 [45567868]
2.5e+00
—
1.0e+50
1.0e+50
—
4.1e+00
2.6e+00
cases:1.61%
controls:0.13%
—
—
cases:0.50%
controls:0.00%
cases:1.50%
controls:0.00%
—
—
cases:3.15%
controls:0.05%
cases:3.28%
controls:0.26%
16
13
976
9910
—
5
0
992
9971
15
0
982
9971
—
30
5
923
9681
26
21
767
8081
General anesthesia, balanced
WX408 [2001310808]
WX408 [2001310808]
4.9e-01
1.3e+00
3.0e+00
1.0e+50
1.7e+00
2.4e+00
2.0e+00
cases:5.85%
controls:3.65%
cases:3.81%
controls:1.06%
cases:1.60%
controls:0.08%
cases:1.91%
controls:0.00%
cases:0.50%
controls:0.09%
cases:6.82%
controls:0.67%
cases:9.96%
controls:1.44%
58
362
934
9561
38
106
959
9865
16
8
981
9963
19
0
978
9971
5
9
988
9942
65
65
888
9621
79
117
714
7985
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
1988-5 [3020460]
2.8e-01
4.3e-01
1.3e+00
4.5e+00
1.7e+00
5.7e-01
3.5e-01
cases:38.41%
controls:32.03%
cases:27.38%
controls:19.74%
cases:12.64%
controls:3.82%
cases:18.15%
controls:0.24%
cases:18.93%
controls:3.94%
cases:29.80%
controls:19.33%
cases:44.64%
controls:36.25%
381
3178
611
6745
273
1968
724
8003
126
381
871
9590
181
24
816
9947
188
392
805
9559
284
1872
669
7814
354
2937
439
5165
Right side
ZXA00 [2001311346]
ZXA00 [2001311346]
4.4e-01
1.2e+00
2.1e+00
—
2.2e+00
2.0e+00
1.4e+00
cases:4.54%
controls:2.97%
cases:2.31%
controls:0.69%
cases:0.80%
controls:0.10%
—
—
cases:0.60%
controls:0.07%
cases:3.78%
controls:0.53%
cases:6.94%
controls:1.88%
45
295
947
9628
23
69
974
9902
8
10
989
9961
—
6
7
987
9944
36
51
917
9635
55
152
738
7950
Bacteria identified in Blood by Culture
600-7 [3023368]
600-7 [3023368]
5.9e-01
9.5e-01
2.8e+00
1.0e+50
2.5e+00
1.1e+00
7.5e-01
cases:7.96%
controls:4.59%
cases:5.02%
controls:2.00%
cases:3.61%
controls:0.22%
cases:7.32%
controls:0.00%
cases:4.33%
controls:0.36%
cases:6.30%
controls:2.26%
cases:10.34%
controls:5.18%
79
455
913
9468
50
199
947
9772
36
22
961
9949
73
0
924
9971
43
36
950
9915
60
219
893
9467
82
420
711
7682
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
14631-6 [3006140]
3.6e-01
5.1e-01
1.1e+00
3.8e+00
1.6e+00
7.7e-01
4.2e-01
cases:14.62%
controls:10.67%
cases:9.33%
controls:5.80%
cases:3.51%
controls:1.14%
cases:2.51%
controls:0.06%
cases:5.84%
controls:1.22%
cases:11.75%
controls:5.83%
cases:18.54%
controls:12.97%
145
1059
847
8864
93
578
904
9393
35
114
962
9857
25
6
972
9965
58
121
935
9830
112
565
841
9121
147
1051
646
7051
General Practice
1 [38004446]
1 [38004446]
3.8e-01
4.5e-01
1.1e+00
4.5e+00
1.6e+00
5.4e-01
9.1e-02
cases:16.43%
controls:11.80%
cases:7.02%
controls:4.59%
cases:2.21%
controls:0.71%
cases:4.21%
controls:0.05%
cases:3.02%
controls:0.64%
cases:7.24%
controls:4.37%
cases:12.86%
controls:11.87%
163
1171
829
8752
70
458
927
9513
22
71
975
9900
42
5
955
9966
30
64
963
9887
69
423
884
9263
102
962
691
7140
Other polyp of sinus
J33.8 [45591556]
J33.8 [45591556]
1.8e+00
2.8e+00
1.0e+50
—
—
2.0e+00
1.9e+00
cases:1.01%
controls:0.17%
cases:1.50%
controls:0.09%
cases:0.80%
controls:0.00%
—
—
—
—
cases:0.63%
controls:0.08%
cases:0.88%
controls:0.14%
10
17
982
9906
15
9
982
9962
8
0
989
9971
—
—
6
8
947
9678
7
11
786
8091
Day surgery
ZXD20 [2001311388]
ZXD20 [2001311388]
1.2e+00
2.7e+00
—
1.0e+50
—
2.6e+00
2.0e+00
cases:2.92%
controls:0.86%
cases:2.91%
controls:0.21%
—
—
cases:1.20%
controls:0.00%
—
—
cases:2.73%
controls:0.22%
cases:5.42%
controls:0.77%
29
85
963
9838
29
21
968
9950
—
12
0
985
9971
—
26
21
927
9665
43
62
750
8040
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
51480-2 [3031040]
3.9e-01
4.7e-01
7.7e-01
4.3e+00
1.2e+00
5.9e-01
5.0e-01
cases:23.19%
controls:16.94%
cases:11.43%
controls:7.48%
cases:2.91%
controls:1.37%
cases:4.11%
controls:0.06%
cases:3.93%
controls:1.23%
cases:13.33%
controls:7.88%
cases:25.35%
controls:17.14%
230
1681
762
8242
114
746
883
9225
29
137
968
9834
41
6
956
9965
39
122
954
9829
127
763
826
8923
201
1389
592
6713
Infectious Disease
44 [38004484]
44 [38004484]
9.0e-01
1.1e+00
2.5e+00
1.0e+50
2.6e+00
1.0e+00
5.4e-01
cases:3.83%
controls:1.59%
cases:1.91%
controls:0.64%
cases:1.60%
controls:0.14%
cases:2.01%
controls:0.00%
cases:1.51%
controls:0.11%
cases:1.78%
controls:0.65%
cases:2.90%
controls:1.72%
38
158
954
9765
19
64
978
9907
16
14
981
9957
20
0
977
9971
15
11
978
9940
17
63
936
9623
23
139
770
7963
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
751-8 [3013650]
3.0e-01
4.8e-01
8.9e-01
3.9e+00
1.4e+00
5.7e-01
5.1e-01
cases:18.35%
controls:14.27%
cases:13.94%
controls:9.09%
cases:5.12%
controls:2.18%
cases:4.41%
controls:0.09%
cases:8.36%
controls:2.16%
cases:14.38%
controls:8.67%
cases:23.83%
controls:15.81%
182
1416
810
8507
139
906
858
9065
51
217
946
9754
44
9
953
9962
83
215
910
9736
137
840
816
8846
189
1281
604
6821
Pneumonia, unspecified
J18.9 [45601123]
J18.9 [45601123]
8.2e-01
1.1e+00
3.1e+00
1.0e+50
2.1e+00
7.6e-01
4.3e-01
cases:5.85%
controls:2.66%
cases:3.01%
controls:1.05%
cases:2.51%
controls:0.11%
cases:4.11%
controls:0.00%
cases:1.61%
controls:0.19%
cases:2.73%
controls:1.29%
cases:5.30%
controls:3.52%
58
264
934
9659
30
105
967
9866
25
11
972
9960
41
0
956
9971
16
19
977
9932
26
125
927
9561
42
285
751
7817
pH of Urine
2756-5 [3015736]
2756-5 [3015736]
3.7e-01
5.4e-01
1.0e+00
3.8e+00
1.6e+00
6.2e-01
3.1e-01
cases:12.10%
controls:8.67%
cases:6.62%
controls:3.97%
cases:2.01%
controls:0.72%
cases:2.11%
controls:0.05%
cases:2.72%
controls:0.57%
cases:7.97%
controls:4.44%
cases:15.13%
controls:11.52%
120
860
872
9063
66
396
931
9575
20
72
977
9899
21
5
976
9966
27
57
966
9894
76
430
877
9256
120
933
673
7169
Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
49891-5 [3029511]
49891-5 [3029511]
1.2e+00
2.2e+00
—
1.0e+50
—
2.5e+00
2.0e+00
cases:2.52%
controls:0.80%
cases:2.31%
controls:0.25%
—
—
cases:1.50%
controls:0.00%
—
—
cases:2.94%
controls:0.25%
cases:4.54%
controls:0.65%
25
79
967
9844
23
25
974
9946
—
15
0
982
9971
—
28
24
925
9662
36
53
757
8049
Differential panel, method unspecified - Blood
69738-3 [42870588]
69738-3 [42870588]
2.2e-01
4.4e-01
1.0e+00
3.7e+00
1.7e+00
5.1e-01
4.8e-01
cases:9.48%
controls:7.73%
cases:7.32%
controls:4.82%
cases:2.71%
controls:0.97%
cases:2.01%
controls:0.05%
cases:5.24%
controls:1.01%
cases:7.56%
controls:4.70%
cases:12.99%
controls:8.43%
94
767
898
9156
73
481
924
9490
27
97
970
9874
20
5
977
9966
52
101
941
9850
72
455
881
9231
103
683
690
7419
Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
72493-0 [43055120]
72493-0 [43055120]
1.4e+00
1.8e+00
—
—
2.9e+00
1.7e+00
1.1e+00
cases:1.51%
controls:0.37%
cases:1.60%
controls:0.27%
—
—
—
—
cases:1.31%
controls:0.07%
cases:1.26%
controls:0.23%
cases:1.51%
controls:0.49%
15
37
977
9886
16
27
981
9944
—
—
13
7
980
9944
12
22
941
9664
12
40
781
8062
Sytologyspecimen from mouth of uterus
XLD00 [2001306651]
XLD00 [2001306651]
1.1e+00
2.0e+00
—
1.0e+50
—
2.6e+00
2.2e+00
cases:4.33%
controls:1.49%
cases:2.41%
controls:0.34%
—
—
cases:5.02%
controls:0.00%
—
—
cases:4.72%
controls:0.38%
cases:8.32%
controls:1.00%
43
148
949
9775
24
34
973
9937
—
50
0
947
9971
—
45
37
908
9649
66
81
727
8021
Urea [Moles/volume] in Serum or Plasma
22664-7 [3020779]
22664-7 [3020779]
7.8e-01
9.9e-01
1.9e+00
—
2.1e+00
1.1e+00
1.0e+00
cases:3.53%
controls:1.64%
cases:2.91%
controls:1.10%
cases:1.10%
controls:0.17%
—
—
cases:1.71%
controls:0.22%
cases:3.04%
controls:1.03%
cases:4.92%
controls:1.86%
35
163
957
9760
29
110
968
9861
11
17
986
9954
—
17
22
976
9929
29
100
924
9586
39
151
754
7951
Anogenital (venereal) warts
A63.0 [45585929]
A63.0 [45585929]
1.2e+00
2.5e+00
—
1.0e+50
1.0e+50
2.6e+00
1.5e+00
cases:1.41%
controls:0.41%
cases:1.50%
controls:0.13%
—
—
cases:0.90%
controls:0.00%
cases:1.11%
controls:0.00%
cases:2.20%
controls:0.17%
cases:2.02%
controls:0.46%
14
41
978
9882
15
13
982
9958
—
9
0
988
9971
11
0
982
9951
21
16
932
9670
16
37
777
8065
Monocytes/Leukocytes in Blood
26485-3 [3019069]
26485-3 [3019069]
2.0e-01
4.1e-01
1.0e+00
3.9e+00
1.6e+00
5.1e-01
4.5e-01
cases:13.71%
controls:11.54%
cases:10.23%
controls:7.06%
cases:3.61%
controls:1.33%
cases:2.31%
controls:0.05%
cases:6.85%
controls:1.53%
cases:10.81%
controls:6.76%
cases:18.54%
controls:12.63%
136
1145
856
8778
102
704
895
9267
36
133
961
9838
23
5
974
9966
68
152
925
9799
103
655
850
9031
147
1023
646
7079
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
26478-8 [3002030]
1.9e-01
4.0e-01
1.1e+00
3.9e+00
1.5e+00
5.0e-01
4.5e-01
cases:13.91%
controls:11.76%
cases:10.33%
controls:7.20%
cases:3.91%
controls:1.37%
cases:2.31%
controls:0.05%
cases:6.75%
controls:1.57%
cases:10.91%
controls:6.94%
cases:19.17%
controls:13.08%
138
1167
854
8756
103
718
894
9253
39
137
958
9834
23
5
974
9966
67
156
926
9795
104
672
849
9014
152
1060
641
7042
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
26474-7 [3019198]
2.1e-01
4.2e-01
1.0e+00
3.9e+00
1.5e+00
4.5e-01
4.1e-01
cases:15.02%
controls:12.57%
cases:11.43%
controls:7.79%
cases:4.01%
controls:1.49%
cases:2.41%
controls:0.05%
cases:6.85%
controls:1.58%
cases:11.33%
controls:7.57%
cases:20.43%
controls:14.51%
149
1247
843
8676
114
777
883
9194
40
149
957
9822
24
5
973
9966
68
157
925
9794
108
733
845
8953
162
1176
631
6926
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
26450-7 [3006504]
2.0e-01
4.1e-01
9.7e-01
3.9e+00
1.5e+00
5.2e-01
4.5e-01
cases:13.71%
controls:11.47%
cases:10.33%
controls:7.08%
cases:3.41%
controls:1.32%
cases:2.31%
controls:0.05%
cases:6.55%
controls:1.54%
cases:10.81%
controls:6.73%
cases:18.41%
controls:12.58%
136
1138
856
8785
103
706
894
9265
34
132
963
9839
23
5
974
9966
65
153
928
9798
103
652
850
9034
146
1019
647
7083
Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
48065-7 [3051714]
48065-7 [3051714]
6.5e-01
7.4e-01
2.0e+00
—
2.8e+00
9.9e-01
5.4e-01
cases:7.46%
controls:4.04%
cases:3.11%
controls:1.51%
cases:1.00%
controls:0.14%
—
—
cases:2.11%
controls:0.13%
cases:3.25%
controls:1.23%
cases:7.94%
controls:4.78%
74
401
918
9522
31
151
966
9820
10
14
987
9957
—
21
13
972
9938
31
119
922
9567
63
387
730
7715
Basophils/Leukocytes in Blood
30180-4 [3022096]
30180-4 [3022096]
1.9e-01
3.9e-01
9.6e-01
3.9e+00
1.5e+00
4.9e-01
4.6e-01
cases:13.51%
controls:11.47%
cases:10.13%
controls:7.09%
cases:3.41%
controls:1.33%
cases:2.31%
controls:0.05%
cases:6.85%
controls:1.54%
cases:10.60%
controls:6.75%
cases:18.54%
controls:12.59%
134
1138
858
8785
101
707
896
9264
34
133
963
9838
23
5
974
9966
68
153
925
9798
101
654
852
9032
147
1020
646
7082
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
6598-7 [3019800]
2.6e-01
3.9e-01
1.7e+00
4.4e+00
1.6e+00
2.8e-01
1.5e-01
cases:9.48%
controls:7.48%
cases:5.02%
controls:3.45%
cases:2.51%
controls:0.49%
cases:4.11%
controls:0.05%
cases:2.42%
controls:0.51%
cases:4.83%
controls:3.68%
cases:10.59%
controls:9.22%
94
742
898
9181
50
344
947
9627
25
49
972
9922
41
5
956
9966
24
51
969
9900
46
356
907
9330
84
747
709
7355
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
26511-6 [3018010]
2.3e-01
4.3e-01
1.1e+00
3.7e+00
1.5e+00
4.9e-01
4.6e-01
cases:14.01%
controls:11.51%
cases:10.43%
controls:7.01%
cases:3.81%
controls:1.35%
cases:1.91%
controls:0.05%
cases:6.45%
controls:1.47%
cases:10.70%
controls:6.82%
cases:18.92%
controls:12.81%
139
1142
853
8781
104
699
893
9272
38
135
959
9836
19
5
978
9966
64
146
929
9805
102
661
851
9025
150
1038
643
7064
Tissue Pathology biopsy report
66121-5 [40768804]
66121-5 [40768804]
4.5e-01
9.3e-01
2.1e+00
1.0e+50
1.9e+00
1.4e+00
8.4e-01
cases:12.70%
controls:8.50%
cases:8.22%
controls:3.40%
cases:3.21%
controls:0.39%
cases:4.81%
controls:0.00%
cases:1.81%
controls:0.27%
cases:9.34%
controls:2.58%
cases:16.02%
controls:7.59%
126
843
866
9080
82
339
915
9632
32
39
965
9932
48
0
949
9971
18
27
975
9924
89
250
864
9436
127
615
666
7487
Basophils [#/volume] in Blood
26444-0 [3006315]
26444-0 [3006315]
2.2e-01
4.4e-01
9.7e-01
3.8e+00
1.5e+00
4.5e-01
4.4e-01
cases:14.62%
controls:12.05%
cases:11.33%
controls:7.61%
cases:3.71%
controls:1.44%
cases:2.21%
controls:0.05%
cases:6.75%
controls:1.57%
cases:11.12%
controls:7.39%
cases:20.30%
controls:14.10%
145
1196
847
8727
113
759
884
9212
37
144
960
9827
22
5
975
9966
67
156
926
9795
106
716
847
8970
161
1142
632
6960
Monocytes [#/volume] in Blood
26484-6 [3001604]
26484-6 [3001604]
2.3e-01
4.3e-01
9.6e-01
3.8e+00
1.5e+00
4.5e-01
4.4e-01
cases:14.62%
controls:11.97%
cases:11.23%
controls:7.60%
cases:3.71%
controls:1.45%
cases:2.21%
controls:0.05%
cases:6.75%
controls:1.57%
cases:11.12%
controls:7.38%
cases:20.30%
controls:14.07%
145
1188
847
8735
112
758
885
9213
37
145
960
9826
22
5
975
9966
67
156
926
9795
106
715
847
8971
161
1140
632
6962
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
28540-3 [3003338]
2.1e-01
3.7e-01
9.1e-01
4.3e+00
1.3e+00
4.3e-01
3.0e-01
cases:36.39%
controls:31.63%
cases:29.59%
controls:22.43%
cases:11.03%
controls:4.74%
cases:13.54%
controls:0.22%
cases:14.90%
controls:4.71%
cases:30.43%
controls:22.21%
cases:43.38%
controls:36.19%
361
3139
631
6784
295
2236
702
7735
110
473
887
9498
135
22
862
9949
148
469
845
9482
290
2151
663
7535
344
2932
449
5170
Intravenous general anesthesia
WX404 [2001310807]
WX404 [2001310807]
5.5e-01
1.2e+00
2.0e+00
—
—
2.4e+00
2.0e+00
cases:4.23%
controls:2.48%
cases:2.61%
controls:0.83%
cases:0.70%
controls:0.10%
—
—
—
—
cases:3.67%
controls:0.36%
cases:6.43%
controls:0.94%
42
246
950
9677
26
83
971
9888
7
10
990
9961
—
—
35
35
918
9651
51
76
742
8026
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
2951-2 [3019550]
1.2e-01
2.6e-01
1.0e+00
4.4e+00
1.4e+00
2.9e-01
2.1e-01
cases:36.39%
controls:33.68%
cases:29.69%
controls:24.60%
cases:11.74%
controls:4.58%
cases:16.15%
controls:0.23%
cases:17.82%
controls:4.88%
cases:30.01%
controls:24.28%
cases:45.02%
controls:39.90%
361
3342
631
6581
296
2453
701
7518
117
457
880
9514
161
23
836
9948
177
486
816
9465
286
2352
667
7334
357
3233
436
4869
More than one and less than three hours
ZXE10 [2001311401]
ZXE10 [2001311401]
6.3e-01
9.2e-01
2.4e+00
1.0e+50
1.6e+00
1.9e+00
1.5e+00
cases:8.77%
controls:4.88%
cases:3.41%
controls:1.39%
cases:1.71%
controls:0.15%
cases:1.00%
controls:0.00%
cases:0.60%
controls:0.12%
cases:5.46%
controls:0.90%
cases:10.47%
controls:2.43%
87
484
905
9439
34
139
963
9832
17
15
980
9956
10
0
987
9971
6
12
987
9939
52
87
901
9599
83
197
710
7905
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
24357-6 [3037467]
3.5e-01
4.2e-01
7.4e-01
3.9e+00
1.1e+00
4.7e-01
4.0e-01
cases:23.69%
controls:18.00%
cases:12.04%
controls:8.27%
cases:2.91%
controls:1.40%
cases:3.21%
controls:0.07%
cases:3.73%
controls:1.27%
cases:13.12%
controls:8.59%
cases:25.09%
controls:18.27%
235
1786
757
8137
120
825
877
9146
29
140
968
9831
32
7
965
9964
37
126
956
9825
125
832
828
8854
199
1480
594
6622
Ketones [Presence] in Urine by Test strip
2514-8 [3035350]
2514-8 [3035350]
3.4e-01
5.1e-01
9.2e-01
3.8e+00
1.3e+00
4.8e-01
2.6e-01
cases:14.21%
controls:10.58%
cases:8.63%
controls:5.39%
cases:2.51%
controls:1.01%
cases:2.51%
controls:0.06%
cases:3.22%
controls:0.87%
cases:9.34%
controls:6.02%
cases:19.04%
controls:15.32%
141
1050
851
8873
86
537
911
9434
25
101
972
9870
25
6
972
9965
32
87
961
9864
89
583
864
9103
151
1241
642
6861
Bacteria identified in Isolate by Culture
43409-2 [3042936]
43409-2 [3042936]
4.4e-01
6.6e-01
2.2e+00
—
3.2e+00
1.1e+00
7.8e-01
cases:3.83%
controls:2.51%
cases:2.01%
controls:1.04%
cases:0.90%
controls:0.10%
—
—
cases:1.51%
controls:0.06%
cases:2.94%
controls:1.00%
cases:5.67%
controls:2.68%
38
249
954
9674
20
104
977
9867
9
10
988
9961
—
15
6
978
9945
28
97
925
9589
45
217
748
7885
podophyllotoxin
D06BB04 [21602086]
D06BB04 [21602086]
1.6e+00
2.6e+00
—
—
—
1.9e+00
1.3e+00
cases:2.52%
controls:0.53%
cases:2.11%
controls:0.16%
—
—
—
—
—
—
cases:0.94%
controls:0.14%
cases:1.51%
controls:0.43%
25
53
967
9870
21
16
976
9955
—
—
—
9
14
944
9672
12
35
781
8067
Functional endoscopic opening of maxillary antrum
DMB20 [2001301780]
DMB20 [2001301780]
1.5e+00
2.5e+00
—
1.0e+50
—
3.3e+00
1.3e+00
cases:1.92%
controls:0.43%
cases:1.71%
controls:0.14%
—
—
cases:0.60%
controls:0.00%
—
—
cases:1.36%
controls:0.05%
cases:1.13%
controls:0.31%
19
43
973
9880
17
14
980
9957
—
6
0
991
9971
—
13
5
940
9681
9
25
784
8077
Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
43730-1 [3043849]
43730-1 [3043849]
1.8e+00
2.0e+00
—
—
—
1.8e+00
1.6e+00
cases:1.41%
controls:0.24%
cases:1.30%
controls:0.17%
—
—
—
—
—
—
cases:1.15%
controls:0.19%
cases:1.51%
controls:0.30%
14
24
978
9899
13
17
984
9954
—
—
—
11
18
942
9668
12
24
781
8078
Eosinophils [#/volume] in Blood
26449-9 [3013115]
26449-9 [3013115]
2.6e-01
4.7e-01
9.1e-01
3.5e+00
1.6e+00
4.6e-01
4.2e-01
cases:15.93%
controls:12.78%
cases:12.14%
controls:7.93%
cases:3.71%
controls:1.52%
cases:2.21%
controls:0.07%
cases:7.35%
controls:1.65%
cases:11.54%
controls:7.61%
cases:20.68%
controls:14.60%
158
1268
834
8655
121
791
876
9180
37
152
960
9819
22
7
975
9964
73
164
920
9787
110
737
843
8949
164
1183
629
6919
salbutamol; inhalant
R03AC02 [21603256]
R03AC02 [21603256]
5.3e-01
7.2e-01
8.8e-01
3.0e+00
1.2e+00
6.0e-01
3.8e-01
cases:21.47%
controls:13.90%
cases:14.34%
controls:7.51%
cases:3.21%
controls:1.35%
cases:1.00%
controls:0.05%
cases:4.03%
controls:1.29%
cases:12.28%
controls:7.14%
cases:21.19%
controls:15.58%
213
1379
779
8544
143
749
854
9222
32
135
965
9836
10
5
987
9966
40
128
953
9823
117
692
836
8994
168
1262
625
6840
Oxygen saturation in Arterial blood
2708-6 [3016502]
2708-6 [3016502]
7.9e-01
1.4e+00
—
—
3.1e+00
1.2e+00
7.5e-01
cases:2.72%
controls:1.26%
cases:2.31%
controls:0.59%
—
—
—
—
cases:1.11%
controls:0.05%
cases:2.20%
controls:0.65%
cases:3.91%
controls:1.89%
27
125
965
9798
23
59
974
9912
—
—
11
5
982
9946
21
63
932
9623
31
153
762
7949
Glucose [Presence] in Urine by Test strip
25428-4 [3009261]
25428-4 [3009261]
3.4e-01
5.5e-01
9.2e-01
3.6e+00
1.3e+00
4.9e-01
2.9e-01
cases:14.62%
controls:10.88%
cases:9.03%
controls:5.43%
cases:2.51%
controls:1.01%
cases:2.51%
controls:0.07%
cases:3.12%
controls:0.88%
cases:9.55%
controls:6.10%
cases:19.42%
controls:15.33%
145
1080
847
8843
90
541
907
9430
25
101
972
9870
25
7
972
9964
31
88
962
9863
91
591
862
9095
154
1242
639
6860
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
2823-3 [3023103]
1.4e-01
2.3e-01
1.0e+00
4.4e+00
1.4e+00
3.0e-01
2.2e-01
cases:37.10%
controls:33.94%
cases:29.49%
controls:24.86%
cases:11.94%
controls:4.69%
cases:16.05%
controls:0.23%
cases:17.82%
controls:4.96%
cases:30.43%
controls:24.45%
cases:45.27%
controls:39.98%
368
3368
624
6555
294
2479
703
7492
119
468
878
9503
160
23
837
9948
177
494
816
9457
290
2368
663
7318
359
3239
434
4863
Internal Medicine
11 [38004456]
11 [38004456]
2.7e-01
3.1e-01
9.2e-01
4.6e+00
8.3e-01
4.7e-01
1.6e-01
cases:24.19%
controls:19.62%
cases:10.43%
controls:7.84%
cases:3.31%
controls:1.34%
cases:7.72%
controls:0.08%
cases:3.22%
controls:1.43%
cases:12.28%
controls:8.04%
cases:20.18%
controls:17.70%
240
1947
752
7976
104
782
893
9189
33
134
964
9837
77
8
920
9963
32
142
961
9809
117
779
836
8907
160
1434
633
6668
SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
94500-6 [706163]
94500-6 [706163]
2.4e-01
3.1e-01
1.4e+00
4.9e+00
8.4e-01
2.3e-01
2.7e-01
cases:15.02%
controls:12.22%
cases:10.33%
controls:7.77%
cases:5.22%
controls:1.36%
cases:6.22%
controls:0.05%
cases:2.62%
controls:1.15%
cases:9.55%
controls:7.76%
cases:23.20%
controls:18.80%
149
1213
843
8710
103
775
894
9196
52
136
945
9835
62
5
935
9966
26
114
967
9837
91
752
862
8934
184
1523
609
6579
Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]
5802-4 [3021601]
3.2e-01
5.1e-01
9.2e-01
3.7e+00
1.3e+00
5.1e-01
2.8e-01
cases:13.91%
controls:10.48%
cases:8.53%
controls:5.32%
cases:2.51%
controls:1.01%
cases:2.41%
controls:0.06%
cases:3.12%
controls:0.84%
cases:9.44%
controls:5.91%
cases:19.17%
controls:15.14%
138
1040
854
8883
85
530
912
9441
25
101
972
9870
24
6
973
9965
31
84
962
9867
90
572
863
9114
152
1227
641
6875
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
14682-9 [3020564]
1.2e-01
2.7e-01
8.9e-01
4.2e+00
1.3e+00
3.1e-01
1.7e-01
cases:40.22%
controls:37.32%
cases:34.70%
controls:28.77%
cases:13.44%
controls:5.99%
cases:16.55%
controls:0.29%
cases:19.54%
controls:6.31%
cases:35.57%
controls:28.92%
cases:48.80%
controls:44.46%
399
3703
593
6220
346
2869
651
7102
134
597
863
9374
165
29
832
9942
194
628
799
9323
339
2801
614
6885
387
3602
406
4500
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
6768-6 [3035995]
2.7e-01
2.9e-01
8.2e-01
3.5e+00
1.3e+00
5.9e-01
4.4e-01
cases:24.29%
controls:19.66%
cases:15.55%
controls:12.13%
cases:5.12%
controls:2.32%
cases:3.11%
controls:0.10%
cases:8.36%
controls:2.31%
cases:18.89%
controls:11.48%
cases:30.77%
controls:22.33%
241
1951
751
7972
155
1209
842
8762
51
231
946
9740
31
10
966
9961
83
230
910
9721
180
1112
773
8574
244
1809
549
6293
Dyspnoea
R06.0 [45558449]
R06.0 [45558449]
4.7e-01
8.3e-01
1.9e+00
1.0e+50
2.2e+00
1.2e+00
7.4e-01
cases:4.74%
controls:3.01%
cases:2.71%
controls:1.19%
cases:1.30%
controls:0.19%
cases:1.10%
controls:0.00%
cases:0.70%
controls:0.08%
cases:3.25%
controls:1.01%
cases:7.69%
controls:3.83%
47
299
945
9624
27
119
970
9852
13
19
984
9952
11
0
986
9971
7
8
986
9943
31
98
922
9588
61
310
732
7792
Supplier / Service Provider
OMOP5117446 [33004]
OMOP5117446 [33004]
-7.6e-01
-3.4e-01
5.5e-01
—
2.6e+00
2.5e+00
2.5e+00
cases:15.32%
controls:27.99%
cases:7.42%
controls:10.14%
cases:1.50%
controls:0.87%
—
—
cases:0.81%
controls:0.06%
cases:6.19%
controls:0.55%
cases:13.75%
controls:1.23%
152
2777
840
7146
74
1011
923
8960
15
87
982
9884
—
8
6
985
9945
59
53
894
9633
109
100
684
8002
Chronic maxillary sinusitis
J32.0 [45586667]
J32.0 [45586667]
1.4e+00
2.2e+00
—
1.0e+50
—
1.9e+00
1.3e+00
cases:3.13%
controls:0.76%
cases:2.61%
controls:0.30%
—
—
cases:0.50%
controls:0.00%
—
—
cases:1.26%
controls:0.20%
cases:2.90%
controls:0.78%
31
75
961
9848
26
30
971
9941
—
5
0
992
9971
—
12
19
941
9667
23
63
770
8039
sulfamethoxazole and trimethoprim
J01EE01 [21602961]
J01EE01 [21602961]
1.2e+00
1.6e+00
—
—
2.2e+00
1.9e+00
6.6e-01
cases:2.02%
controls:0.63%
cases:1.20%
controls:0.25%
—
—
—
—
cases:0.60%
controls:0.07%
cases:1.89%
controls:0.28%
cases:1.13%
controls:0.59%
20
63
972
9860
12
25
985
9946
—
—
6
7
987
9944
18
27
935
9659
9
48
784
8054
Monitoring vital functions without anesthesia
WX000 [2001310756]
WX000 [2001310756]
1.6e+00
2.4e+00
—
1.0e+50
—
2.8e+00
1.1e+00
cases:1.41%
controls:0.29%
cases:1.20%
controls:0.11%
—
—
cases:0.60%
controls:0.00%
—
—
cases:1.05%
controls:0.06%
cases:1.01%
controls:0.33%
14
29
978
9894
12
11
985
9960
—
6
0
991
9971
—
10
6
943
9680
8
27
785
8075
Hemoglobin [Mass/volume] in Arterial blood
30313-1 [3002173]
30313-1 [3002173]
6.6e-01
1.4e+00
—
—
3.1e+00
1.4e+00
8.2e-01
cases:2.12%
controls:1.11%
cases:2.31%
controls:0.55%
—
—
—
—
cases:1.11%
controls:0.05%
cases:2.10%
controls:0.51%
cases:3.91%
controls:1.75%
21
110
971
9813
23
55
974
9916
—
—
11
5
982
9946
20
49
933
9637
31
142
762
7960
Bacteria identified in Sputum by Culture
6460-0 [3023419]
6460-0 [3023419]
1.5e+00
2.8e+00
—
—
—
2.5e+00
—
cases:0.91%
controls:0.20%
cases:0.80%
controls:0.05%
—
—
—
—
—
—
cases:0.63%
controls:0.05%
—
—
9
20
983
9903
8
5
989
9966
—
—
—
6
5
947
9681
—
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
14804-9 [3022250]
14804-9 [3022250]
7.0e-01
9.5e-01
1.5e+00
—
1.9e+00
1.0e+00
7.1e-01
cases:3.73%
controls:1.88%
cases:3.01%
controls:1.18%
cases:1.10%
controls:0.24%
—
—
cases:1.91%
controls:0.29%
cases:3.15%
controls:1.18%
cases:5.04%
controls:2.54%
37
187
955
9736
30
118
967
9853
11
24
986
9947
—
19
29
974
9922
30
114
923
9572
40
206
753
7896
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
30385-9 [3002385]
2.2e-01
2.8e-01
8.4e-01
3.8e+00
1.1e+00
3.2e-01
2.9e-01
cases:30.65%
controls:26.13%
cases:25.18%
controls:20.28%
cases:9.83%
controls:4.51%
cases:11.33%
controls:0.28%
cases:13.60%
controls:4.84%
cases:26.23%
controls:20.45%
cases:40.35%
controls:33.50%
304
2593
688
7330
251
2022
746
7949
98
450
899
9521
113
28
884
9943
135
482
858
9469
250
1981
703
7705
320
2714
473
5388
INR in Blood by Coagulation assay
34714-6 [3032080]
34714-6 [3032080]
3.5e-01
4.4e-01
6.7e-01
3.6e+00
9.9e-01
6.0e-01
2.5e-01
cases:13.00%
controls:9.52%
cases:7.82%
controls:5.19%
cases:3.21%
controls:1.67%
cases:3.51%
controls:0.10%
cases:4.63%
controls:1.77%
cases:9.02%
controls:5.18%
cases:13.49%
controls:10.79%
129
945
863
8978
78
517
919
9454
32
167
965
9804
35
10
962
9961
46
176
947
9775
86
502
867
9184
107
874
686
7228
Asthma, unspecified
J45.9 [45562456]
J45.9 [45562456]
8.7e-01
1.0e+00
1.4e+00
1.0e+50
1.7e+00
9.5e-01
5.9e-01
cases:6.25%
controls:2.71%
cases:3.91%
controls:1.47%
cases:1.10%
controls:0.27%
cases:1.40%
controls:0.00%
cases:1.21%
controls:0.22%
cases:3.99%
controls:1.58%
cases:6.05%
controls:3.44%
62
269
930
9654
39
147
958
9824
11
27
986
9944
14
0
983
9971
12
22
981
9929
38
153
915
9533
48
279
745
7823
Gas panel - Capillary blood
24337-8 [3022313]
24337-8 [3022313]
6.1e-02
6.5e-01
2.6e+00
—
2.8e+00
1.1e+00
5.6e-01
cases:1.21%
controls:1.14%
cases:1.10%
controls:0.58%
cases:0.90%
controls:0.07%
—
—
cases:1.51%
controls:0.09%
cases:1.47%
controls:0.49%
cases:1.89%
controls:1.09%
12
113
980
9810
11
58
986
9913
9
7
988
9964
—
15
9
978
9942
14
47
939
9639
15
88
778
8014
Cells panel - Urine sediment
58434-2 [40761535]
58434-2 [40761535]
5.0e-01
1.1e+00
1.9e+00
1.0e+50
2.5e+00
9.3e-01
5.3e-01
cases:2.92%
controls:1.79%
cases:1.91%
controls:0.64%
cases:0.70%
controls:0.11%
cases:0.50%
controls:0.00%
cases:1.01%
controls:0.08%
cases:1.78%
controls:0.71%
cases:2.52%
controls:1.51%
29
178
963
9745
19
64
978
9907
7
11
990
9960
5
0
992
9971
10
8
983
9943
17
69
936
9617
20
122
773
7980
Platelets [#/volume] in Blood
26515-7 [3007461]
26515-7 [3007461]
1.1e-01
2.2e-01
8.3e-01
4.2e+00
1.1e+00
2.8e-01
1.3e-01
cases:44.66%
controls:41.92%
cases:37.91%
controls:33.00%
cases:15.45%
controls:7.40%
cases:18.05%
controls:0.34%
cases:20.04%
controls:7.46%
cases:39.24%
controls:32.84%
cases:52.71%
controls:49.49%
443
4160
549
5763
378
3290
619
6681
154
738
843
9233
180
34
817
9937
199
742
794
9209
374
3181
579
6505
418
4010
375
4092
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
718-7 [3000963]
1.0e-01
2.1e-01
8.3e-01
4.2e+00
1.1e+00
2.7e-01
1.2e-01
cases:44.66%
controls:42.17%
cases:38.01%
controls:33.10%
cases:15.55%
controls:7.43%
cases:18.05%
controls:0.34%
cases:20.04%
controls:7.46%
cases:39.24%
controls:32.97%
cases:52.71%
controls:49.61%
443
4185
549
5738
379
3300
618
6671
155
741
842
9230
180
34
817
9937
199
742
794
9209
374
3193
579
6493
418
4019
375
4083
MCH [Entitic mass]
28539-5 [3035941]
28539-5 [3035941]
9.6e-02
2.1e-01
8.3e-01
4.2e+00
1.1e+00
2.7e-01
1.3e-01
cases:44.46%
controls:42.09%
cases:37.91%
controls:33.02%
cases:15.45%
controls:7.40%
cases:18.05%
controls:0.34%
cases:20.04%
controls:7.45%
cases:39.14%
controls:32.86%
cases:52.71%
controls:49.54%
441
4177
551
5746
378
3292
619
6679
154
738
843
9233
180
34
817
9937
199
741
794
9210
373
3183
580
6503
418
4014
375
4088
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
26453-1 [3026361]
1.0e-01
2.2e-01
8.3e-01
4.2e+00
1.1e+00
2.7e-01
1.3e-01
cases:44.66%
controls:42.11%
cases:38.01%
controls:33.05%
cases:15.45%
controls:7.41%
cases:18.05%
controls:0.34%
cases:20.04%
controls:7.47%
cases:39.24%
controls:32.94%
cases:52.71%
controls:49.56%
443
4179
549
5744
379
3295
618
6676
154
739
843
9232
180
34
817
9937
199
743
794
9208
374
3191
579
6495
418
4015
375
4087
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
20570-8 [3009542]
9.5e-02
2.1e-01
8.2e-01
4.2e+00
1.1e+00
2.7e-01
1.3e-01
cases:44.46%
controls:42.12%
cases:37.91%
controls:33.08%
cases:15.45%
controls:7.42%
cases:18.05%
controls:0.34%
cases:20.04%
controls:7.45%
cases:39.14%
controls:32.92%
cases:52.71%
controls:49.56%
441
4180
551
5743
378
3298
619
6673
154
740
843
9231
180
34
817
9937
199
741
794
9210
373
3189
580
6497
418
4015
375
4087
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
30428-7 [3024731]
1.0e-01
2.2e-01
8.3e-01
4.2e+00
1.1e+00
2.8e-01
1.2e-01
cases:44.66%
controls:42.11%
cases:38.01%
controls:33.06%
cases:15.45%
controls:7.40%
cases:17.95%
controls:0.34%
cases:19.94%
controls:7.46%
cases:39.24%
controls:32.86%
cases:52.59%
controls:49.53%
443
4179
549
5744
379
3296
618
6675
154
738
843
9233
179
34
818
9937
198
742
795
9209
374
3183
579
6503
417
4013
376
4089
Leukocytes [#/volume] in Blood
26464-8 [3010813]
26464-8 [3010813]
9.8e-02
2.2e-01
8.2e-01
4.2e+00
1.1e+00
2.7e-01
1.3e-01
cases:44.56%
controls:42.14%
cases:38.21%
controls:33.07%
cases:15.45%
controls:7.43%
cases:18.05%
controls:0.34%
cases:20.04%
controls:7.48%
cases:39.14%
controls:32.95%
cases:52.71%
controls:49.56%
442
4182
550
5741
381
3297
616
6674
154
741
843
9230
180
34
817
9937
199
744
794
9207
373
3192
580
6494
418
4015
375
4087
Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
18500-9 [3018006]
18500-9 [3018006]
6.2e-01
1.1e+00
2.8e+00
1.0e+50
—
1.1e+00
8.0e-01
cases:7.06%
controls:3.91%
cases:2.81%
controls:0.98%
cases:1.50%
controls:0.09%
cases:1.10%
controls:0.00%
—
—
cases:2.94%
controls:1.04%
cases:6.18%
controls:2.86%
70
388
922
9535
28
98
969
9873
15
9
982
9962
11
0
986
9971
—
28
101
925
9585
49
232
744
7870
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
5894-1 [3033658]
5.9e-01
7.6e-01
1.5e+00
—
1.8e+00
9.0e-01
7.6e-01
cases:8.57%
controls:4.92%
cases:5.22%
controls:2.52%
cases:1.30%
controls:0.30%
—
—
cases:2.11%
controls:0.34%
cases:5.77%
controls:2.43%
cases:10.59%
controls:5.25%
85
488
907
9435
52
251
945
9720
13
30
984
9941
—
21
34
972
9917
55
235
898
9451
84
425
709
7677
Hematology
82 [38004501]
82 [38004501]
1.0e+00
1.2e+00
1.2e+00
1.0e+50
1.8e+00
1.2e+00
1.2e+00
cases:2.82%
controls:1.02%
cases:2.61%
controls:0.80%
cases:0.90%
controls:0.26%
cases:0.90%
controls:0.00%
cases:1.71%
controls:0.30%
cases:2.83%
controls:0.88%
cases:3.28%
controls:1.06%
28
101
964
9822
26
80
971
9891
9
26
988
9945
9
0
988
9971
17
30
976
9921
27
85
926
9601
26
86
767
8016
Carbon dioxide [Partial pressure] in Capillary blood
2020-6 [3023024]
2020-6 [3023024]
1.5e-01
7.0e-01
2.5e+00
—
2.9e+00
9.6e-01
5.5e-01
cases:1.61%
controls:1.39%
cases:1.50%
controls:0.75%
cases:1.10%
controls:0.09%
—
—
cases:2.22%
controls:0.13%
cases:1.78%
controls:0.69%
cases:2.77%
controls:1.62%
16
138
976
9785
15
75
982
9896
11
9
986
9962
—
22
13
971
9938
17
67
936
9619
22
131
771
7971
pH of Capillary blood
2745-8 [3009343]
2745-8 [3009343]
1.6e-01
7.3e-01
2.4e+00
—
2.9e+00
1.0e+00
6.1e-01
cases:1.61%
controls:1.38%
cases:1.50%
controls:0.73%
cases:1.00%
controls:0.09%
—
—
cases:2.22%
controls:0.13%
cases:1.78%
controls:0.64%
cases:2.77%
controls:1.53%
16
137
976
9786
15
73
982
9898
10
9
987
9962
—
22
13
971
9938
17
62
936
9624
22
124
771
7978
Laboratory Visit
OMOP4822461 [32036]
OMOP4822461 [32036]
5.7e-02
2.1e-01
9.0e-01
4.1e+00
1.0e+00
2.9e-01
1.0e-01
cases:48.19%
controls:46.76%
cases:47.64%
controls:42.44%
cases:27.48%
controls:13.40%
cases:29.89%
controls:0.72%
cases:29.10%
controls:12.63%
cases:50.05%
controls:42.82%
cases:57.00%
controls:54.44%
478
4640
514
5283
475
4232
522
5739
274
1336
723
8635
298
72
699
9899
289
1257
704
8694
477
4148
476
5538
452
4411
341
3691
Outpatient Hospital
22 [8756]
22 [8756]
3.4e-01
8.6e-01
1.4e+00
—
1.7e+00
1.2e+00
7.9e-01
cases:28.53%
controls:22.07%
cases:14.04%
controls:6.46%
cases:3.11%
controls:0.81%
—
—
cases:3.83%
controls:0.70%
cases:16.05%
controls:5.65%
cases:28.50%
controls:15.26%
283
2190
709
7733
140
644
857
9327
31
81
966
9890
—
38
70
955
9881
153
547
800
9139
226
1236
567
6866
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
62238-1 [40764999]
1.7e-01
2.0e-01
8.2e-01
4.0e+00
1.1e+00
3.1e-01
2.1e-01
cases:28.53%
controls:25.21%
cases:23.77%
controls:20.29%
cases:9.33%
controls:4.33%
cases:9.73%
controls:0.20%
cases:13.09%
controls:4.61%
cases:26.13%
controls:20.56%
cases:39.09%
controls:34.19%
283
2502
709
7421
237
2023
760
7948
93
432
904
9539
97
20
900
9951
130
459
863
9492
249
1991
704
7695
310
2770
483
5332
Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
72720-6 [43055554]
72720-6 [43055554]
1.7e-01
7.2e-01
2.3e+00
—
2.9e+00
1.0e+00
6.5e-01
cases:1.61%
controls:1.36%
cases:1.30%
controls:0.64%
cases:0.90%
controls:0.09%
—
—
cases:2.11%
controls:0.12%
cases:1.68%
controls:0.61%
cases:2.52%
controls:1.33%
16
135
976
9788
13
64
984
9907
9
9
988
9962
—
21
12
972
9939
16
59
937
9627
20
108
773
7994
tacrolimus; oral, parenteral
L04AD02 [21603925]
L04AD02 [21603925]
2.3e+00
2.1e+00
2.0e+00
—
—
1.8e+00
1.7e+00
cases:1.11%
controls:0.11%
cases:1.00%
controls:0.12%
cases:0.50%
controls:0.07%
—
—
—
—
cases:0.94%
controls:0.17%
cases:0.88%
controls:0.16%
11
11
981
9912
10
12
987
9959
5
7
992
9964
—
—
9
16
944
9670
7
13
786
8089
Chronic laryngitis
J37.0 [45601128]
J37.0 [45601128]
1.2e+00
2.4e+00
—
1.0e+50
—
2.1e+00
1.6e+00
cases:0.60%
controls:0.18%
cases:1.10%
controls:0.10%
—
—
cases:0.60%
controls:0.00%
—
—
cases:0.94%
controls:0.11%
cases:1.26%
controls:0.26%
6
18
986
9905
11
10
986
9961
—
6
0
991
9971
—
9
11
944
9675
10
21
783
8081
valaciclovir; oral
J05AB11 [21603137]
J05AB11 [21603137]
9.0e-01
1.0e+00
1.8e+00
—
1.5e+00
1.2e+00
1.2e+00
cases:4.33%
controls:1.81%
cases:2.01%
controls:0.71%
cases:1.00%
controls:0.17%
—
—
cases:0.70%
controls:0.15%
cases:2.52%
controls:0.74%
cases:5.30%
controls:1.73%
43
180
949
9743
20
71
977
9900
10
17
987
9954
—
7
15
986
9936
24
72
929
9614
42
140
751
7962
CBC panel - Blood by Automated count
58410-2 [40761511]
58410-2 [40761511]
1.5e-01
2.0e-01
7.2e-01
4.2e+00
1.2e+00
1.5e-01
1.6e-01
cases:39.52%
controls:35.95%
cases:25.68%
controls:22.12%
cases:8.32%
controls:4.22%
cases:10.23%
controls:0.17%
cases:12.39%
controls:4.15%
cases:24.03%
controls:21.37%
cases:41.74%
controls:38.02%
392
3567
600
6356
256
2206
741
7765
83
421
914
9550
102
17
895
9954
123
413
870
9538
229
2070
724
7616
331
3080
462
5022
Supine thorax X-ray examination
GD1QA [2001303648]
GD1QA [2001303648]
7.4e-01
5.2e-01
2.6e+00
1.0e+50
2.0e+00
7.9e-01
7.6e-01
cases:3.23%
controls:1.57%
cases:1.10%
controls:0.66%
cases:0.90%
controls:0.07%
cases:1.71%
controls:0.00%
cases:0.91%
controls:0.12%
cases:1.99%
controls:0.92%
cases:3.78%
controls:1.80%
32
156
960
9767
11
66
986
9905
9
7
988
9964
17
0
980
9971
9
12
984
9939
19
89
934
9597
30
146
763
7956
Flexible laryngoscopy
UDQ12 [2001301827]
UDQ12 [2001301827]
1.1e+00
1.7e+00
—
1.0e+50
—
1.9e+00
1.4e+00
cases:1.71%
controls:0.60%
cases:1.10%
controls:0.21%
—
—
cases:0.90%
controls:0.00%
—
—
cases:1.05%
controls:0.15%
cases:1.89%
controls:0.47%
17
60
975
9863
11
21
986
9950
—
9
0
988
9971
—
10
15
943
9671
15
38
778
8064
Thorax X-ray examination
GD1AA [2001303617]
GD1AA [2001303617]
4.2e-01
7.1e-01
1.9e+00
1.0e+50
1.4e+00
9.3e-01
7.3e-01
cases:10.58%
controls:7.23%
cases:5.72%
controls:2.90%
cases:2.71%
controls:0.43%
cases:5.32%
controls:0.00%
cases:1.61%
controls:0.40%
cases:6.82%
controls:2.82%
cases:13.24%
controls:6.87%
105
717
887
9206
57
289
940
9682
27
43
970
9928
53
0
944
9971
16
40
977
9911
65
273
888
9413
105
557
688
7545
amoxicillin and beta-lactamase inhibitor; oral, parenteral
J01CR02 [21602863]
J01CR02 [21602863]
4.8e-01
8.8e-01
1.5e+00
—
1.9e+00
8.8e-01
4.3e-01
cases:11.39%
controls:7.36%
cases:5.12%
controls:2.19%
cases:1.30%
controls:0.30%
—
—
cases:1.91%
controls:0.30%
cases:5.56%
controls:2.37%
cases:11.73%
controls:7.99%
113
730
879
9193
51
218
946
9753
13
30
984
9941
—
19
30
974
9921
53
230
900
9456
93
647
700
7455
Bacteria identified in Skin by Aerobe culture
620-5 [3007853]
620-5 [3007853]
4.7e-01
6.8e-01
1.9e+00
—
2.8e+00
1.2e+00
5.7e-01
cases:3.63%
controls:2.30%
cases:1.71%
controls:0.87%
cases:0.80%
controls:0.12%
—
—
cases:1.01%
controls:0.06%
cases:2.73%
controls:0.81%
cases:3.78%
controls:2.17%
36
228
956
9695
17
87
980
9884
8
12
989
9959
—
10
6
983
9945
26
78
927
9608
30
176
763
7926
Tacrolimus [Mass/volume] in Blood
11253-2 [3026250]
11253-2 [3026250]
2.3e+00
2.0e+00
1.7e+00
—
1.9e+00
1.6e+00
1.6e+00
cases:1.01%
controls:0.10%
cases:0.90%
controls:0.12%
cases:0.50%
controls:0.09%
—
—
cases:0.60%
controls:0.09%
cases:0.84%
controls:0.17%
cases:0.88%
controls:0.17%
10
10
982
9913
9
12
988
9959
5
9
992
9962
—
6
9
987
9942
8
16
945
9670
7
14
786
8088
Emergency use of U07.1 | COVID-19, virus identified
U07.1 [45756093]
U07.1 [45756093]
3.0e-01
7.7e-01
1.9e+00
—
2.9e+00
1.1e+00
2.3e-01
cases:2.52%
controls:1.87%
cases:2.21%
controls:1.03%
cases:1.30%
controls:0.19%
—
—
cases:1.91%
controls:0.11%
cases:2.73%
controls:0.92%
cases:5.42%
controls:4.34%
25
186
967
9737
22
103
975
9868
13
19
984
9952
—
19
11
974
9940
26
89
927
9597
43
352
750
7750
Nonallergic asthma
J45.1 [45557625]
J45.1 [45557625]
9.7e-01
1.1e+00
2.8e+00
1.0e+50
—
1.2e+00
1.1e+00
cases:2.42%
controls:0.93%
cases:1.40%
controls:0.49%
cases:0.80%
controls:0.05%
cases:0.50%
controls:0.00%
—
—
cases:1.15%
controls:0.36%
cases:2.14%
controls:0.75%
24
92
968
9831
14
49
983
9922
8
5
989
9966
5
0
992
9971
—
11
35
942
9651
17
61
776
8041
Fever, unspecified
R50.9 [45582716]
R50.9 [45582716]
8.6e-01
1.0e+00
2.7e+00
1.0e+50
—
1.3e+00
7.3e-01
cases:4.13%
controls:1.78%
cases:1.60%
controls:0.59%
cases:1.00%
controls:0.07%
cases:1.00%
controls:0.00%
—
—
cases:1.89%
controls:0.53%
cases:3.03%
controls:1.48%
41
177
951
9746
16
59
981
9912
10
7
987
9964
10
0
987
9971
—
18
51
935
9635
24
120
769
7982
olodaterol and tiotropium bromide
R03AL06 [1588644]
R03AL06 [1588644]
2.0e+00
1.7e+00
—
—
—
2.1e+00
1.6e+00
cases:0.91%
controls:0.12%
cases:0.70%
controls:0.13%
—
—
—
—
—
—
cases:0.84%
controls:0.10%
cases:1.01%
controls:0.20%
9
12
983
9911
7
13
990
9958
—
—
—
8
10
945
9676
8
16
785
8086
prednisolone; oral, parenteral
H02AB06 [21602734]
H02AB06 [21602734]
6.0e-01
9.3e-01
1.7e+00
—
1.3e+00
7.4e-01
5.3e-01
cases:16.63%
controls:9.84%
cases:10.33%
controls:4.33%
cases:4.11%
controls:0.78%
—
—
cases:2.82%
controls:0.82%
cases:8.81%
controls:4.42%
cases:15.51%
controls:9.71%
165
976
827
8947
103
432
894
9539
41
78
956
9893
—
28
82
965
9869
84
428
869
9258
123
787
670
7315
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
2075-0 [3014576]
4.3e-01
9.5e-01
1.8e+00
—
1.9e+00
1.1e+00
5.5e-01
cases:2.92%
controls:1.92%
cases:2.61%
controls:1.02%
cases:0.80%
controls:0.13%
—
—
cases:0.81%
controls:0.12%
cases:3.04%
controls:1.07%
cases:4.67%
controls:2.74%
29
191
963
9732
26
102
971
9869
8
13
989
9958
—
8
12
985
9939
29
104
924
9582
37
222
756
7880
prednisolone
A07EA01 [21600653]
A07EA01 [21600653]
5.9e-01
9.3e-01
1.7e+00
—
1.3e+00
7.4e-01
5.4e-01
cases:16.63%
controls:9.94%
cases:10.33%
controls:4.36%
cases:4.11%
controls:0.78%
—
—
cases:2.82%
controls:0.82%
cases:8.81%
controls:4.43%
cases:15.64%
controls:9.78%
165
986
827
8937
103
435
894
9536
41
78
956
9893
—
28
82
965
9869
84
429
869
9257
124
792
669
7310
Essential (primary) hypertension
I10 [45591453]
I10 [45591453]
1.3e-01
3.2e-01
6.6e-01
4.4e+00
9.1e-01
4.5e-01
1.4e-01
cases:16.03%
controls:14.33%
cases:10.03%
controls:7.48%
cases:2.71%
controls:1.42%
cases:3.81%
controls:0.05%
cases:3.12%
controls:1.29%
cases:11.86%
controls:7.88%
cases:19.29%
controls:17.25%
159
1422
833
8501
100
746
897
9225
27
142
970
9829
38
5
959
9966
31
128
962
9823
113
763
840
8923
153
1398
640
6704
Limited function/disability NOS
A28 [2002000162]
A28 [2002000162]
8.0e-01
9.9e-01
1.6e+00
1.2e+00
1.5e+00
8.3e-01
1.2e-01
cases:3.83%
controls:1.75%
cases:3.11%
controls:1.18%
cases:1.81%
controls:0.36%
cases:0.50%
controls:0.15%
cases:1.71%
controls:0.40%
cases:2.83%
controls:1.26%
cases:3.03%
controls:2.70%
38
174
954
9749
31
118
966
9853
18
36
979
9935
5
15
992
9956
17
40
976
9911
27
122
926
9564
24
219
769
7883
ciclosporin; oral, parenteral
L04AD01 [21603924]
L04AD01 [21603924]
1.1e+00
1.9e+00
—
—
—
2.1e+00
1.6e+00
cases:0.91%
controls:0.31%
cases:0.90%
controls:0.14%
—
—
—
—
—
—
cases:1.05%
controls:0.13%
cases:1.13%
controls:0.22%
9
31
983
9892
9
14
988
9957
—
—
—
10
13
943
9673
9
18
784
8084
Pulmonary Disease
29 [38004472]
29 [38004472]
5.5e-01
7.7e-01
1.3e+00
—
1.5e+00
8.0e-01
5.2e-01
cases:13.71%
controls:8.40%
cases:9.03%
controls:4.40%
cases:2.61%
controls:0.69%
—
—
cases:3.22%
controls:0.71%
cases:9.13%
controls:4.33%
cases:13.62%
controls:8.55%
136
834
856
9089
90
439
907
9532
26
69
971
9902
—
32
71
961
9880
87
419
866
9267
108
693
685
7409
Sinoscopy
UDM02 [2001301774]
UDM02 [2001301774]
1.6e+00
—
—
—
—
2.5e+00
3.0e+00
cases:0.81%
controls:0.17%
—
—
—
—
—
—
—
—
cases:0.73%
controls:0.06%
cases:1.26%
controls:0.06%
8
17
984
9906
—
—
—
—
7
6
946
9680
10
5
783
8097
Surface analgesia on skin or mucosa
WX105 [2001310765]
WX105 [2001310765]
9.7e-01
1.5e+00
—
—
—
1.6e+00
1.4e+00
cases:3.13%
controls:1.21%
cases:2.01%
controls:0.44%
—
—
—
—
—
—
cases:1.99%
controls:0.39%
cases:4.54%
controls:1.21%
31
120
961
9803
20
44
977
9927
—
—
—
19
38
934
9648
36
98
757
8004
erdosteine; oral
R05CB15 [21603394]
R05CB15 [21603394]
4.0e-01
9.2e-01
2.1e+00
—
2.4e+00
5.1e-01
5.5e-01
cases:3.53%
controls:2.39%
cases:2.31%
controls:0.93%
cases:0.80%
controls:0.10%
—
—
cases:1.91%
controls:0.17%
cases:1.68%
controls:1.01%
cases:5.67%
controls:3.36%
35
237
957
9686
23
93
974
9878
8
10
989
9961
—
19
17
974
9934
16
98
937
9588
45
272
748
7830
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
50554-5 [3029287]
4.5e-01
7.8e-01
1.2e+00
—
1.6e+00
7.6e-01
6.9e-01
cases:11.59%
controls:7.70%
cases:7.12%
controls:3.40%
cases:2.11%
controls:0.66%
—
—
cases:2.72%
controls:0.57%
cases:7.56%
controls:3.70%
cases:14.88%
controls:8.10%
115
764
877
9159
71
339
926
9632
21
66
976
9905
—
27
57
966
9894
72
358
881
9328
118
656
675
7446
General anaesthesia
WX402 [2001310806]
WX402 [2001310806]
6.1e-01
8.0e-01
2.2e+00
—
—
9.2e-01
8.7e-01
cases:3.73%
controls:2.06%
cases:2.91%
controls:1.33%
cases:1.00%
controls:0.11%
—
—
—
—
cases:2.62%
controls:1.06%
cases:7.82%
controls:3.42%
37
204
955
9719
29
133
968
9838
10
11
987
9960
—
—
25
103
928
9583
62
277
731
7825
CT of paranasal sinuses and face area
DM1AD [2001301741]
DM1AD [2001301741]
1.3e+00
3.7e+00
—
—
—
—
1.7e+00
cases:1.11%
controls:0.31%
cases:2.01%
controls:0.05%
—
—
—
—
—
—
—
—
cases:1.13%
controls:0.21%
11
31
981
9892
20
5
977
9966
—
—
—
—
9
17
784
8085
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
1742-6 [3006923]
8.8e-02
2.0e-01
6.6e-01
3.5e+00
9.1e-01
3.1e-01
1.1e-01
cases:37.70%
controls:35.65%
cases:29.49%
controls:25.43%
cases:8.53%
controls:4.58%
cases:4.81%
controls:0.15%
cases:11.38%
controls:4.89%
cases:31.69%
controls:25.39%
cases:46.28%
controls:43.56%
374
3538
618
6385
294
2536
703
7435
85
457
912
9514
48
15
949
9956
113
487
880
9464
302
2459
651
7227
367
3529
426
4573
Oxygen capacity [Volume Fraction] in Arterial blood
59275-8 [40762366]
59275-8 [40762366]
1.2e+00
1.5e+00
—
—
—
1.7e+00
9.5e-01
cases:1.92%
controls:0.58%
cases:1.50%
controls:0.33%
—
—
—
—
—
—
cases:1.47%
controls:0.27%
cases:2.40%
controls:0.94%
19
58
973
9865
15
33
982
9938
—
—
—
14
26
939
9660
19
76
774
8026
Telehealth
OMOP5556618 [722455]
OMOP5556618 [722455]
2.1e-01
4.4e-01
1.1e+00
2.1e+00
1.0e+00
3.7e-01
3.6e-01
cases:29.54%
controls:25.41%
cases:13.44%
controls:9.09%
cases:4.11%
controls:1.41%
cases:0.80%
controls:0.10%
cases:3.83%
controls:1.40%
cases:11.02%
controls:7.89%
cases:22.07%
controls:16.50%
293
2521
699
7402
134
906
863
9065
41
141
956
9830
8
10
989
9961
38
139
955
9812
105
764
848
8922
175
1337
618
6765
methylprednisolone; oral, parenteral
H02AB04 [21602732]
H02AB04 [21602732]
1.0e+00
1.3e+00
1.8e+00
—
—
1.2e+00
7.6e-01
cases:4.13%
controls:1.49%
cases:2.21%
controls:0.64%
cases:0.70%
controls:0.12%
—
—
—
—
cases:1.99%
controls:0.59%
cases:2.40%
controls:1.14%
41
148
951
9775
22
64
975
9907
7
12
990
9959
—
—
19
57
934
9629
19
92
774
8010
fluticasone furoate; nasal
R01AD12 [21605053]
R01AD12 [21605053]
5.4e-01
1.0e+00
9.1e-01
—
1.2e+00
9.1e-01
6.3e-01
cases:15.32%
controls:9.52%
cases:9.33%
controls:3.53%
cases:1.81%
controls:0.73%
—
—
cases:2.22%
controls:0.66%
cases:9.02%
controls:3.83%
cases:14.75%
controls:8.41%
152
945
840
8978
93
352
904
9619
18
73
979
9898
—
22
66
971
9885
86
371
867
9315
117
681
676
7421
fluticasone; nasal
R01AD08 [21605050]
R01AD08 [21605050]
5.4e-01
1.0e+00
9.1e-01
—
1.2e+00
9.1e-01
6.3e-01
cases:15.32%
controls:9.52%
cases:9.33%
controls:3.53%
cases:1.81%
controls:0.73%
—
—
cases:2.22%
controls:0.66%
cases:9.02%
controls:3.83%
cases:14.75%
controls:8.41%
152
945
840
8978
93
352
904
9619
18
73
979
9898
—
22
66
971
9885
86
371
867
9315
117
681
676
7421
Emergency Room and Inpatient Visit
ERIP [262]
ERIP [262]
5.3e-01
7.6e-01
1.8e+00
1.0e+50
1.6e+00
5.8e-01
2.4e-01
cases:8.47%
controls:5.17%
cases:5.82%
controls:2.82%
cases:2.31%
controls:0.40%
cases:7.42%
controls:0.00%
cases:2.72%
controls:0.57%
cases:6.19%
controls:3.57%
cases:11.60%
controls:9.32%
84
513
908
9410
58
281
939
9690
23
40
974
9931
74
0
923
9971
27
57
966
9894
59
346
894
9340
92
755
701
7347
Troponin I.cardiac [Mass/volume] in Serum or Plasma
10839-9 [3021337]
10839-9 [3021337]
6.4e-01
5.1e-01
1.3e+00
—
1.6e+00
9.9e-01
5.9e-01
cases:6.35%
controls:3.46%
cases:2.91%
controls:1.78%
cases:1.10%
controls:0.29%
—
—
cases:1.61%
controls:0.32%
cases:3.99%
controls:1.52%
cases:7.31%
controls:4.17%
63
343
929
9580
29
177
968
9794
11
29
986
9942
—
16
32
977
9919
38
147
915
9539
58
338
735
7764
Left side
ZXA05 [2001311347]
ZXA05 [2001311347]
5.9e-01
1.4e+00
—
1.0e+50
—
1.7e+00
1.6e+00
cases:5.04%
controls:2.85%
cases:2.81%
controls:0.74%
—
—
cases:1.40%
controls:0.00%
—
—
cases:2.41%
controls:0.45%
cases:7.06%
controls:1.58%
50
283
942
9640
28
74
969
9897
—
14
0
983
9971
—
23
44
930
9642
56
128
737
7974
Bacteria [Presence] in Urine
87829-8 [36304419]
87829-8 [36304419]
5.1e-01
6.3e-01
1.2e+00
—
1.3e+00
8.1e-01
6.2e-01
cases:8.87%
controls:5.51%
cases:4.81%
controls:2.62%
cases:1.40%
controls:0.42%
—
—
cases:1.71%
controls:0.45%
cases:5.67%
controls:2.60%
cases:11.22%
controls:6.36%
88
547
904
9376
48
261
949
9710
14
42
983
9929
—
17
45
976
9906
54
252
899
9434
89
515
704
7587
Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
54067-4 [3051552]
54067-4 [3051552]
8.4e-01
8.8e-01
—
—
3.2e+00
1.0e+00
8.0e-01
cases:2.62%
controls:1.15%
cases:1.10%
controls:0.46%
—
—
—
—
cases:1.41%
controls:0.06%
cases:1.47%
controls:0.53%
cases:2.40%
controls:1.09%
26
114
966
9809
11
46
986
9925
—
—
14
6
979
9945
14
51
939
9635
19
88
774
8014
IgG [Mass/volume] in Serum or Plasma
2465-3 [3005719]
2465-3 [3005719]
7.0e-01
1.2e+00
1.7e+00
—
2.0e+00
1.1e+00
5.3e-01
cases:3.02%
controls:1.53%
cases:2.41%
controls:0.75%
cases:0.70%
controls:0.13%
—
—
cases:1.21%
controls:0.16%
cases:2.10%
controls:0.70%
cases:2.52%
controls:1.49%
30
152
962
9771
24
75
973
9896
7
13
990
9958
—
12
16
981
9935
20
68
933
9618
20
121
773
7981
Inpatient Hospital
21 [8717]
21 [8717]
2.4e-01
4.9e-01
1.4e+00
—
1.7e+00
7.2e-01
4.3e-01
cases:35.18%
controls:29.96%
cases:14.84%
controls:9.66%
cases:4.81%
controls:1.23%
—
—
cases:5.34%
controls:1.03%
cases:16.89%
controls:8.97%
cases:30.01%
controls:21.83%
349
2973
643
6950
148
963
849
9008
48
123
949
9848
—
53
102
940
9849
161
869
792
8817
238
1769
555
6333
pH of Venous blood
2746-6 [3012544]
2746-6 [3012544]
3.6e-01
5.6e-01
1.8e+00
1.0e+50
2.3e+00
8.4e-01
5.4e-01
cases:2.22%
controls:1.56%
cases:1.81%
controls:1.04%
cases:0.90%
controls:0.15%
cases:0.80%
controls:0.00%
cases:1.71%
controls:0.17%
cases:2.41%
controls:1.05%
cases:4.41%
controls:2.63%
22
155
970
9768
18
104
979
9867
9
15
988
9956
8
0
989
9971
17
17
976
9934
23
102
930
9584
35
213
758
7889
Case Management Agency
251B00000X [38004193]
251B00000X [38004193]
-1.5e-02
1.9e-01
5.5e-01
3.9e+00
5.0e-01
2.3e-01
-2.6e-02
cases:61.19%
controls:61.54%
cases:59.78%
controls:55.20%
cases:35.71%
controls:24.19%
cases:41.42%
controls:1.46%
cases:34.44%
controls:24.19%
cases:63.06%
controls:57.50%
cases:69.74%
controls:70.28%
607
6107
385
3816
596
5504
401
4467
356
2412
641
7559
413
146
584
9825
342
2407
651
7544
601
5569
352
4117
553
5694
240
2408
amoxicillin; oral, parenteral
J01CA04 [21602823]
J01CA04 [21602823]
5.0e-01
5.7e-01
1.0e+00
—
2.0e+00
4.5e-01
3.6e-01
cases:32.66%
controls:22.75%
cases:11.94%
controls:7.11%
cases:2.41%
controls:0.87%
—
—
cases:4.43%
controls:0.62%
cases:10.07%
controls:6.69%
cases:27.49%
controls:20.90%
324
2257
668
7666
119
709
878
9262
24
87
973
9884
—
44
62
949
9889
96
648
857
9038
218
1693
575
6409
Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
7852-7 [3010130]
7852-7 [3010130]
1.4e+00
1.8e+00
—
—
1.0e+50
1.4e+00
1.6e+00
cases:1.81%
controls:0.43%
cases:1.00%
controls:0.16%
—
—
—
—
cases:0.60%
controls:0.00%
cases:0.52%
controls:0.12%
cases:1.64%
controls:0.33%
18
43
974
9880
10
16
987
9955
—
—
6
0
987
9951
5
12
948
9674
13
27
780
8075
Predominantly allergic asthma
J45.0 [45557624]
J45.0 [45557624]
1.1e+00
1.1e+00
—
—
1.8e+00
9.3e-01
8.3e-01
cases:3.33%
controls:1.10%
cases:1.81%
controls:0.59%
—
—
—
—
cases:0.91%
controls:0.15%
cases:1.57%
controls:0.63%
cases:2.77%
controls:1.23%
33
109
959
9814
18
59
979
9912
—
—
9
15
984
9936
15
61
938
9625
22
100
771
8002
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
30391-7 [3002582]
4.7e-01
6.7e-01
1.1e+00
—
1.3e+00
7.5e-01
6.5e-01
cases:9.98%
controls:6.51%
cases:5.72%
controls:3.02%
cases:1.60%
controls:0.56%
—
—
cases:2.01%
controls:0.56%
cases:6.61%
controls:3.22%
cases:13.75%
controls:7.70%
99
646
893
9277
57
301
940
9670
16
56
981
9915
—
20
56
973
9895
63
312
890
9374
109
624
684
7478
Moderate cervical dysplasia
N87.1 [45534145]
N87.1 [45534145]
1.4e+00
—
—
1.0e+50
—
2.6e+00
2.3e+00
cases:0.71%
controls:0.17%
—
—
—
—
cases:1.10%
controls:0.00%
—
—
cases:1.78%
controls:0.13%
cases:1.89%
controls:0.20%
7
17
985
9906
—
—
11
0
986
9971
—
17
13
936
9673
15
16
778
8086
Lactate [Moles/volume] in Serum or Plasma
2524-7 [3014111]
2524-7 [3014111]
5.0e-01
1.1e+00
—
—
2.7e+00
1.1e+00
6.8e-01
cases:2.12%
controls:1.29%
cases:1.71%
controls:0.57%
—
—
—
—
cases:1.01%
controls:0.07%
cases:1.68%
controls:0.57%
cases:3.53%
controls:1.83%
21
128
971
9795
17
57
980
9914
—
—
10
7
983
9944
16
55
937
9631
28
148
765
7954
Bilateral
ZXA10 [2001311348]
ZXA10 [2001311348]
5.2e-01
1.7e+00
2.1e+00
1.0e+50
—
1.9e+00
1.3e+00
cases:3.83%
controls:2.31%
cases:3.01%
controls:0.58%
cases:0.50%
controls:0.06%
cases:0.80%
controls:0.00%
—
—
cases:3.15%
controls:0.49%
cases:5.80%
controls:1.65%
38
229
954
9694
30
58
967
9913
5
6
992
9965
8
0
989
9971
—
30
47
923
9639
46
134
747
7968
Protein [Mass/volume] in Serum or Plasma
2885-2 [3020630]
2885-2 [3020630]
6.3e-01
1.2e+00
—
—
2.3e+00
1.3e+00
4.9e-01
cases:2.42%
controls:1.30%
cases:1.91%
controls:0.56%
—
—
—
—
cases:1.21%
controls:0.12%
cases:2.10%
controls:0.59%
cases:2.40%
controls:1.48%
24
129
968
9794
19
56
978
9915
—
—
12
12
981
9939
20
57
933
9629
19
120
774
7982
Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
31374-2 [3007080]
31374-2 [3007080]
1.2e+00
1.9e+00
—
—
1.0e+50
1.8e+00
1.3e+00
cases:1.51%
controls:0.48%
cases:1.20%
controls:0.18%
—
—
—
—
cases:0.60%
controls:0.00%
cases:0.94%
controls:0.17%
cases:1.13%
controls:0.32%
15
48
977
9875
12
18
985
9953
—
—
6
0
987
9951
9
16
944
9670
9
26
784
8076
Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
22246-3 [3017918]
22246-3 [3017918]
1.3e+00
1.9e+00
—
—
—
1.4e+00
1.5e+00
cases:1.81%
controls:0.48%
cases:1.10%
controls:0.16%
—
—
—
—
—
—
cases:0.52%
controls:0.12%
cases:1.64%
controls:0.37%
18
48
974
9875
11
16
986
9955
—
—
—
5
12
948
9674
13
30
780
8072
IgM [Mass/volume] in Serum or Plasma
2472-9 [3028026]
2472-9 [3028026]
7.7e-01
1.2e+00
2.1e+00
—
2.3e+00
1.2e+00
4.3e-01
cases:2.32%
controls:1.09%
cases:1.50%
controls:0.44%
cases:0.50%
controls:0.06%
—
—
cases:0.70%
controls:0.07%
cases:1.57%
controls:0.47%
cases:1.77%
controls:1.16%
23
108
969
9815
15
44
982
9927
5
6
992
9965
—
7
7
986
9944
15
46
938
9640
14
94
779
8008
Puncture of maxillary antrum
TDM10 [2001301819]
TDM10 [2001301819]
7.8e-01
2.5e+00
—
1.0e+50
1.0e+50
—
2.3e+00
cases:0.81%
controls:0.37%
cases:1.20%
controls:0.10%
—
—
cases:0.80%
controls:0.00%
cases:0.50%
controls:0.00%
—
—
cases:1.51%
controls:0.16%
8
37
984
9886
12
10
985
9961
—
8
0
989
9971
5
0
988
9951
—
12
13
781
8089
Abnormal findings in specimens from female genital organs, abnormal microbiological findings
R87.5 [45563329]
R87.5 [45563329]
1.6e+00
—
—
1.0e+50
—
2.3e+00
2.4e+00
cases:0.60%
controls:0.12%
—
—
—
—
cases:0.90%
controls:0.00%
—
—
cases:0.94%
controls:0.09%
cases:1.89%
controls:0.17%
6
12
986
9911
—
—
9
0
988
9971
—
9
9
944
9677
15
14
778
8088
Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
5159-9 [3007844]
5159-9 [3007844]
1.1e+00
1.9e+00
—
—
1.0e+50
1.8e+00
1.2e+00
cases:1.51%
controls:0.50%
cases:1.20%
controls:0.19%
—
—
—
—
cases:0.60%
controls:0.00%
cases:0.94%
controls:0.17%
cases:1.13%
controls:0.35%
15
50
977
9873
12
19
985
9952
—
—
6
0
987
9951
9
16
944
9670
9
28
784
8074
Gas panel - Venous blood
24339-4 [3000991]
24339-4 [3000991]
6.0e-01
8.3e-01
1.7e+00
—
2.7e+00
1.1e+00
8.8e-01
cases:2.22%
controls:1.23%
cases:1.91%
controls:0.84%
cases:0.50%
controls:0.09%
—
—
cases:1.21%
controls:0.08%
cases:2.10%
controls:0.70%
cases:4.41%
controls:1.88%
22
122
970
9801
19
84
978
9887
5
9
992
9962
—
12
8
981
9943
20
68
933
9618
35
152
758
7950
Normoblasts [#/volume] in Blood
715-3 [3021589]
715-3 [3021589]
1.7e-01
1.9e-01
6.3e-01
3.2e+00
1.0e+00
1.8e-01
4.3e-01
cases:11.59%
controls:9.93%
cases:9.13%
controls:7.68%
cases:3.21%
controls:1.74%
cases:2.21%
controls:0.09%
cases:5.34%
controls:1.96%
cases:9.55%
controls:8.10%
cases:19.42%
controls:13.55%
115
985
877
8938
91
766
906
9205
32
173
965
9798
22
9
975
9962
53
195
940
9756
91
785
862
8901
154
1098
639
7004
Bicarbonate [Moles/volume] standard in Capillary blood
19231-0 [3004490]
19231-0 [3004490]
4.2e-02
4.5e-01
2.2e+00
—
2.5e+00
9.8e-01
6.6e-01
cases:1.01%
controls:0.97%
cases:0.80%
controls:0.51%
cases:0.60%
controls:0.07%
—
—
cases:1.11%
controls:0.09%
cases:1.26%
controls:0.47%
cases:1.51%
controls:0.79%
10
96
982
9827
8
51
989
9920
6
7
991
9964
—
11
9
982
9942
12
46
941
9640
12
64
781
8038
Epithelial cells.non-squamous [#/volume] in Urine by Automated count
51485-1 [3030306]
51485-1 [3030306]
7.0e-01
8.7e-01
7.8e-01
—
1.6e+00
8.2e-01
6.6e-01
cases:4.84%
controls:2.46%
cases:3.31%
controls:1.41%
cases:0.50%
controls:0.23%
—
—
cases:1.31%
controls:0.27%
cases:3.88%
controls:1.74%
cases:7.94%
controls:4.27%
48
244
944
9679
33
141
964
9830
5
23
992
9948
—
13
27
980
9924
37
169
916
9517
63
346
730
7756
Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
7853-5 [3015635]
7853-5 [3015635]
1.4e+00
1.7e+00
—
—
—
1.4e+00
1.5e+00
cases:1.81%
controls:0.45%
cases:1.00%
controls:0.18%
—
—
—
—
—
—
cases:0.52%
controls:0.12%
cases:1.64%
controls:0.37%
18
45
974
9878
10
18
987
9953
—
—
—
5
12
948
9674
13
30
780
8072
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
LC2BE [2001306544]
LC2BE [2001306544]
1.4e-01
1.0e+00
1.9e+00
—
—
9.9e-01
7.3e-01
cases:4.84%
controls:4.23%
cases:3.41%
controls:1.28%
cases:0.70%
controls:0.11%
—
—
—
—
cases:3.25%
controls:1.24%
cases:8.58%
controls:4.32%
48
420
944
9503
34
128
963
9843
7
11
990
9960
—
—
31
120
922
9566
68
350
725
7752
Leukocytes [#/volume] in Urine
30405-5 [3018095]
30405-5 [3018095]
4.7e-01
6.3e-01
9.6e-01
—
1.3e+00
6.6e-01
5.9e-01
cases:11.19%
controls:7.32%
cases:6.62%
controls:3.63%
cases:1.81%
controls:0.70%
—
—
cases:2.11%
controls:0.61%
cases:7.56%
controls:4.06%
cases:16.27%
controls:9.76%
111
726
881
9197
66
362
931
9609
18
70
979
9901
—
21
61
972
9890
72
393
881
9293
129
791
664
7311
Polypectomy of internal nose
DHB20 [2001301689]
DHB20 [2001301689]
2.3e+00
—
1.0e+50
—
—
—
2.2e+00
cases:1.11%
controls:0.11%
—
—
cases:0.50%
controls:0.00%
—
—
—
—
—
—
cases:0.88%
controls:0.10%
11
11
981
9912
—
5
0
992
9971
—
—
—
7
8
786
8094
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
14749-6 [3013826]
3.0e-01
5.4e-01
1.5e+00
—
1.5e+00
5.4e-01
3.9e-01
cases:16.63%
controls:12.88%
cases:10.23%
controls:6.23%
cases:3.91%
controls:0.89%
—
—
cases:4.03%
controls:0.89%
cases:10.07%
controls:6.15%
cases:19.92%
controls:14.45%
165
1278
827
8645
102
621
895
9350
39
89
958
9882
—
40
89
953
9862
96
596
857
9090
158
1171
635
6931
Multiple myeloma
C90.0 [45600562]
C90.0 [45600562]
1.9e+00
2.2e+00
—
—
2.3e+00
1.6e+00
—
cases:0.60%
controls:0.09%
cases:0.80%
controls:0.09%
—
—
—
—
cases:0.60%
controls:0.06%
cases:0.52%
controls:0.10%
—
—
6
9
986
9914
8
9
989
9962
—
—
6
6
987
9945
5
10
948
9676
—
Enterovirus RNA [Presence] in Specimen by NAA with probe detection
29591-5 [3016881]
29591-5 [3016881]
1.6e+00
1.8e+00
1.0e+50
—
—
2.9e+00
—
cases:0.91%
controls:0.19%
cases:0.60%
controls:0.10%
cases:0.50%
controls:0.00%
—
—
—
—
cases:0.94%
controls:0.05%
—
—
9
19
983
9904
6
10
991
9961
5
0
992
9971
—
—
9
5
944
9681
—
Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
7993-9 [3025023]
7993-9 [3025023]
1.6e+00
1.9e+00
1.0e+50
—
—
2.9e+00
—
cases:0.91%
controls:0.19%
cases:0.60%
controls:0.09%
cases:0.50%
controls:0.00%
—
—
—
—
cases:0.94%
controls:0.05%
—
—
9
19
983
9904
6
9
991
9962
5
0
992
9971
—
—
9
5
944
9681
—
Carbon dioxide [Partial pressure] in Venous blood
2021-4 [3021447]
2021-4 [3021447]
3.8e-01
4.5e-01
1.9e+00
1.0e+50
2.5e+00
8.0e-01
5.2e-01
cases:2.22%
controls:1.53%
cases:1.60%
controls:1.03%
cases:0.90%
controls:0.13%
cases:0.90%
controls:0.00%
cases:1.81%
controls:0.15%
cases:2.31%
controls:1.05%
cases:4.29%
controls:2.59%
22
152
970
9771
16
103
981
9868
9
13
988
9958
9
0
988
9971
18
15
975
9936
22
102
931
9584
34
210
759
7892
Lactate [Moles/volume] in Blood
32693-4 [3047181]
32693-4 [3047181]
1.2e+00
1.5e+00
—
1.0e+50
2.9e+00
1.6e+00
7.5e-01
cases:1.21%
controls:0.37%
cases:1.00%
controls:0.22%
—
—
cases:0.90%
controls:0.00%
cases:0.91%
controls:0.05%
cases:0.84%
controls:0.18%
cases:1.01%
controls:0.48%
12
37
980
9886
10
22
987
9949
—
9
0
988
9971
9
5
984
9946
8
17
945
9669
8
39
785
8063
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]
1920-8 [3013721]
3.5e-01
5.1e-01
1.4e+00
—
1.7e+00
7.9e-01
4.9e-01
cases:9.78%
controls:7.11%
cases:5.22%
controls:3.21%
cases:1.10%
controls:0.27%
—
—
cases:2.01%
controls:0.37%
cases:6.72%
controls:3.15%
cases:12.86%
controls:8.26%
97
706
895
9217
52
320
945
9651
11
27
986
9944
—
20
37
973
9914
64
305
889
9381
102
669
691
7433
doxycycline; oral, parenteral
J01AA02 [21602800]
J01AA02 [21602800]
4.4e-01
6.1e-01
1.6e+00
—
1.3e+00
4.7e-01
3.8e-01
cases:24.70%
controls:17.45%
cases:8.83%
controls:4.99%
cases:2.51%
controls:0.51%
—
—
cases:1.81%
controls:0.50%
cases:6.51%
controls:4.18%
cases:18.92%
controls:13.79%
245
1732
747
8191
88
498
909
9473
25
51
972
9920
—
18
50
975
9901
62
405
891
9281
150
1117
643
6985
Protein [Presence] in Urine by Test strip
20454-5 [3014051]
20454-5 [3014051]
4.9e-01
5.9e-01
1.3e+00
—
1.3e+00
6.6e-01
2.6e-01
cases:7.36%
controls:4.64%
cases:4.41%
controls:2.49%
cases:1.40%
controls:0.40%
—
—
cases:1.51%
controls:0.41%
cases:5.35%
controls:2.83%
cases:10.34%
controls:8.15%
73
460
919
9463
44
248
953
9723
14
40
983
9931
—
15
41
978
9910
51
274
902
9412
82
660
711
7442
Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
76080-1 [46235759]
76080-1 [46235759]
3.4e-01
1.3e+00
2.8e+00
1.0e+50
—
1.5e+00
4.6e-01
cases:0.91%
controls:0.64%
cases:1.00%
controls:0.28%
cases:1.00%
controls:0.06%
cases:1.91%
controls:0.00%
—
—
cases:1.26%
controls:0.29%
cases:1.26%
controls:0.80%
9
64
983
9859
10
28
987
9943
10
6
987
9965
19
0
978
9971
—
12
28
941
9658
10
65
783
8037
Epithelial cells.squamous [#/volume] in Urine by Automated count
51486-9 [3029879]
51486-9 [3029879]
7.0e-01
1.1e+00
—
—
1.7e+00
8.5e-01
5.0e-01
cases:5.04%
controls:2.57%
cases:3.61%
controls:1.28%
—
—
—
—
cases:1.31%
controls:0.25%
cases:3.78%
controls:1.65%
cases:6.43%
controls:3.99%
50
255
942
9668
36
128
961
9843
—
—
13
25
980
9926
36
160
917
9526
51
323
742
7779
Base excess in Venous blood by calculation
1927-3 [3002032]
1927-3 [3002032]
4.0e-01
5.3e-01
1.9e+00
1.0e+50
2.4e+00
7.8e-01
5.6e-01
cases:2.22%
controls:1.50%
cases:1.71%
controls:1.01%
cases:0.90%
controls:0.14%
cases:0.90%
controls:0.00%
cases:1.81%
controls:0.17%
cases:2.20%
controls:1.02%
cases:4.29%
controls:2.49%
22
149
970
9774
17
101
980
9870
9
14
988
9957
9
0
988
9971
18
17
975
9934
21
99
932
9587
34
202
759
7900
Thorax X-ray examination outside radiological department
GD1UA [2001303652]
GD1UA [2001303652]
4.2e-01
5.3e-01
1.4e+00
1.0e+50
2.2e+00
1.3e+00
8.1e-01
cases:2.62%
controls:1.74%
cases:1.10%
controls:0.65%
cases:0.50%
controls:0.12%
cases:1.30%
controls:0.00%
cases:0.60%
controls:0.07%
cases:1.68%
controls:0.49%
cases:3.28%
controls:1.48%
26
173
966
9750
11
65
986
9906
5
12
992
9959
13
0
984
9971
6
7
987
9944
16
47
937
9639
26
120
767
7982
Emergency Medicine
93 [38004510]
93 [38004510]
2.9e-01
5.5e-01
1.8e+00
—
9.6e-01
5.9e-01
2.5e-01
cases:19.96%
controls:15.78%
cases:12.74%
controls:7.79%
cases:6.82%
controls:1.19%
—
—
cases:3.52%
controls:1.38%
cases:14.17%
controls:8.35%
cases:24.21%
controls:20.00%
198
1566
794
8357
127
777
870
9194
68
119
929
9852
—
35
137
958
9814
135
809
818
8877
192
1620
601
6482
Supraventricular tachycardia
I47.1 [45567178]
I47.1 [45567178]
—
2.2e+00
—
—
—
2.0e+00
—
—
—
cases:0.60%
controls:0.07%
—
—
—
—
—
—
cases:0.63%
controls:0.08%
—
—
—
6
7
991
9964
—
—
—
6
8
947
9678
—
Oncology Clinic/Center
261QX0200X [38004268]
261QX0200X [38004268]
3.3e-01
6.2e-01
2.1e+00
1.0e+50
2.1e+00
5.1e-01
4.9e-01
cases:5.95%
controls:4.36%
cases:2.71%
controls:1.47%
cases:0.70%
controls:0.09%
cases:0.70%
controls:0.00%
cases:0.81%
controls:0.10%
cases:1.78%
controls:1.07%
cases:5.67%
controls:3.55%
59
433
933
9490
27
147
970
9824
7
9
990
9962
7
0
990
9971
8
10
985
9941
17
104
936
9582
45
288
748
7814
Reticulocytes/Erythrocytes in Blood
4679-7 [3027945]
4679-7 [3027945]
5.2e-01
1.0e+00
1.1e+00
—
2.0e+00
1.1e+00
3.5e-01
cases:3.33%
controls:2.01%
cases:2.51%
controls:0.93%
cases:0.60%
controls:0.21%
—
—
cases:1.51%
controls:0.20%
cases:3.04%
controls:1.05%
cases:3.40%
controls:2.43%
33
199
959
9724
25
93
972
9878
6
21
991
9950
—
15
20
978
9931
29
102
924
9584
27
197
766
7905
Heart failure, unspecified
I50.9 [45576879]
I50.9 [45576879]
3.9e-01
8.4e-01
2.1e+00
1.0e+50
2.0e+00
8.2e-01
2.4e-01
cases:1.92%
controls:1.30%
cases:1.71%
controls:0.74%
cases:0.80%
controls:0.10%
cases:0.90%
controls:0.00%
cases:0.91%
controls:0.12%
cases:1.99%
controls:0.89%
cases:2.40%
controls:1.90%
19
129
973
9794
17
74
980
9897
8
10
989
9961
9
0
988
9971
9
12
984
9939
19
86
934
9600
19
154
774
7948
aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]
14979-9 [3018677]
5.5e-01
1.1e+00
1.4e+00
—
2.0e+00
9.2e-01
5.9e-01
cases:4.23%
controls:2.48%
cases:2.91%
controls:0.96%
cases:0.60%
controls:0.15%
—
—
cases:0.91%
controls:0.12%
cases:2.41%
controls:0.98%
cases:4.54%
controls:2.58%
42
246
950
9677
29
96
968
9875
6
15
991
9956
—
9
12
984
9939
23
95
930
9591
36
209
757
7893
Inhalation anesthesia
WX400 [2001310805]
WX400 [2001310805]
9.5e-01
2.3e+00
—
—
—
1.7e+00
1.7e+00
cases:1.21%
controls:0.47%
cases:1.00%
controls:0.10%
—
—
—
—
—
—
cases:0.52%
controls:0.09%
cases:1.39%
controls:0.25%
12
47
980
9876
10
10
987
9961
—
—
—
5
9
948
9677
11
20
782
8082
Human papilloma virus identified in Specimen
11481-9 [3025130]
11481-9 [3025130]
8.2e-01
1.3e+00
—
1.0e+50
—
2.5e+00
1.5e+00
cases:0.71%
controls:0.31%
cases:0.60%
controls:0.17%
—
—
cases:1.71%
controls:0.00%
—
—
cases:2.10%
controls:0.18%
cases:1.64%
controls:0.36%
7
31
985
9892
6
17
991
9954
—
17
0
980
9971
—
20
17
933
9669
13
29
780
8073
ipratropium bromide; inhalant
R03BB01 [21603293]
R03BB01 [21603293]
8.2e-01
1.8e+00
—
—
—
2.4e+00
1.6e+00
cases:0.71%
controls:0.31%
cases:0.50%
controls:0.08%
—
—
—
—
—
—
cases:1.05%
controls:0.09%
cases:1.13%
controls:0.23%
7
31
985
9892
5
8
992
9963
—
—
—
10
9
943
9677
9
19
784
8083
Status asthmaticus
J46 [45591560]
J46 [45591560]
1.7e+00
—
—
1.0e+50
—
—
2.3e+00
cases:1.11%
controls:0.21%
—
—
—
—
cases:0.50%
controls:0.00%
—
—
—
—
cases:1.39%
controls:0.14%
11
21
981
9902
—
—
5
0
992
9971
—
—
11
11
782
8091
Physiotherapist
Z3226 [2001311560]
Z3226 [2001311560]
6.8e-01
5.5e-01
—
—
—
1.6e+00
1.7e+00
cases:3.63%
controls:1.87%
cases:0.90%
controls:0.52%
—
—
—
—
—
—
cases:1.47%
controls:0.31%
cases:4.79%
controls:0.90%
36
186
956
9737
9
52
988
9919
—
—
—
14
30
939
9656
38
73
755
8029
CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
9728-7 [3025271]
9728-7 [3025271]
1.7e+00
—
—
—
—
2.2e+00
—
cases:0.81%
controls:0.14%
—
—
—
—
—
—
—
—
cases:0.84%
controls:0.09%
—
—
8
14
984
9909
—
—
—
—
8
9
945
9677
—
CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
14135-8 [3001405]
14135-8 [3001405]
1.7e+00
—
—
—
—
2.2e+00
—
cases:0.81%
controls:0.14%
—
—
—
—
—
—
—
—
cases:0.73%
controls:0.08%
—
—
8
14
984
9909
—
—
—
—
7
8
946
9678
—
Audiology
64 [38004489]
64 [38004489]
3.5e-01
1.1e+00
1.3e+00
—
9.2e-01
1.5e+00
1.2e+00
cases:3.83%
controls:2.72%
cases:3.91%
controls:1.27%
cases:0.80%
controls:0.21%
—
—
cases:0.50%
controls:0.20%
cases:5.14%
controls:1.16%
cases:8.32%
controls:2.54%
38
270
954
9653
39
127
958
9844
8
21
989
9950
—
5
20
988
9931
49
112
904
9574
66
206
727
7896
Infection following a procedure, not elsewhere classified
T81.4 [45575538]
T81.4 [45575538]
4.0e-01
1.5e+00
—
—
—
1.4e+00
1.0e+00
cases:1.71%
controls:1.16%
cases:1.00%
controls:0.22%
—
—
—
—
—
—
cases:1.05%
controls:0.27%
cases:2.40%
controls:0.88%
17
115
975
9808
10
22
987
9949
—
—
—
10
26
943
9660
19
71
774
8031
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
51483-6 [3030467]
5.5e-01
6.3e-01
9.0e-01
—
1.3e+00
7.7e-01
6.5e-01
cases:9.27%
controls:5.58%
cases:5.02%
controls:2.74%
cases:1.10%
controls:0.45%
—
—
cases:1.81%
controls:0.49%
cases:5.67%
controls:2.70%
cases:11.73%
controls:6.49%
92
554
900
9369
50
273
947
9698
11
45
986
9926
—
18
49
975
9902
54
262
899
9424
93
526
700
7576
Pharmacy visit
OMOP4822462 [581458]
OMOP4822462 [581458]
3.1e-01
8.8e-01
4.0e-01
1.5e+00
5.4e-01
6.1e-01
6.6e-01
cases:95.87%
controls:94.47%
cases:92.08%
controls:82.75%
cases:53.26%
controls:43.32%
cases:9.23%
controls:2.28%
cases:55.89%
controls:42.41%
cases:89.51%
controls:82.31%
cases:97.35%
controls:94.99%
951
9374
41
549
918
8251
79
1720
531
4319
466
5652
92
227
905
9744
555
4220
438
5731
853
7973
100
1713
772
7696
21
406
Moderate depressive episode with somatic syndrome
F32.11 [2000501981]
F32.11 [2000501981]
1.6e+00
—
—
—
—
2.3e+00
—
cases:0.91%
controls:0.19%
—
—
—
—
—
—
—
—
cases:0.63%
controls:0.06%
—
—
9
19
983
9904
—
—
—
—
6
6
947
9680
—
Other specified chronic obstructive pulmonary disease
J44.8 [45586673]
J44.8 [45586673]
1.2e+00
1.5e+00
1.4e+00
1.0e+50
1.1e+00
1.2e+00
7.2e-01
cases:3.53%
controls:1.08%
cases:2.51%
controls:0.59%
cases:0.50%
controls:0.13%
cases:0.60%
controls:0.00%
cases:0.50%
controls:0.16%
cases:2.31%
controls:0.70%
cases:3.28%
controls:1.63%
35
107
957
9816
25
59
972
9912
5
13
992
9958
6
0
991
9971
5
16
988
9935
22
68
931
9618
26
132
767
7970
Medical Oncology
90 [38004507]
90 [38004507]
2.9e-01
4.8e-01
8.6e-01
2.3e+00
9.3e-01
6.2e-01
5.1e-01
cases:3.93%
controls:2.97%
cases:3.51%
controls:2.20%
cases:1.81%
controls:0.77%
cases:0.70%
controls:0.07%
cases:1.91%
controls:0.76%
cases:4.09%
controls:2.25%
cases:5.42%
controls:3.32%
39
295
953
9628
35
219
962
9752
18
77
979
9894
7
7
990
9964
19
76
974
9875
39
218
914
9468
43
269
750
7833
Haemorrhoids
K96 [2002000623]
K96 [2002000623]
—
—
—
—
—
2.2e+00
1.6e+00
—
—
—
—
—
—
—
—
—
—
cases:0.73%
controls:0.08%
cases:1.01%
controls:0.20%
—
—
—
—
—
7
8
946
9678
8
16
785
8086
IgA [Mass/volume] in Serum or Plasma
2458-8 [3007164]
2458-8 [3007164]
3.8e-01
7.2e-01
9.7e-01
—
1.8e+00
8.2e-01
5.3e-01
cases:5.95%
controls:4.14%
cases:2.91%
controls:1.43%
cases:0.50%
controls:0.19%
—
—
cases:0.81%
controls:0.14%
cases:2.83%
controls:1.27%
cases:7.19%
controls:4.36%
59
411
933
9512
29
143
968
9828
5
19
992
9952
—
8
14
985
9937
27
123
926
9563
57
353
736
7749
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
1995-0 [3021347]
2.7e-01
5.9e-01
1.0e+00
—
1.5e+00
7.4e-01
2.7e-01
cases:11.59%
controls:9.11%
cases:8.93%
controls:5.15%
cases:2.31%
controls:0.84%
—
—
cases:4.03%
controls:0.96%
cases:9.65%
controls:4.83%
cases:14.00%
controls:11.01%
115
904
877
9019
89
514
908
9457
23
84
974
9887
—
40
96
953
9855
92
468
861
9218
111
892
682
7210
risedronic acid; oral
M05BA07 [21604155]
M05BA07 [21604155]
1.0e+00
1.9e+00
—
—
—
1.9e+00
1.6e+00
cases:0.71%
controls:0.25%
cases:0.90%
controls:0.13%
—
—
—
—
—
—
cases:0.73%
controls:0.11%
cases:0.88%
controls:0.17%
7
25
985
9898
9
13
988
9958
—
—
—
7
11
946
9675
7
14
786
8088
Epstein Barr virus Ab [Presence] in Serum
49178-7 [3048929]
49178-7 [3048929]
8.8e-01
1.7e+00
—
—
—
1.3e+00
1.2e+00
cases:1.92%
controls:0.81%
cases:1.50%
controls:0.27%
—
—
—
—
—
—
cases:0.94%
controls:0.27%
cases:1.89%
controls:0.58%
19
80
973
9843
15
27
982
9944
—
—
—
9
26
944
9660
15
47
778
8055
Sodium and Potassium panel [Moles/volume] - Serum or Plasma
34548-8 [3045783]
34548-8 [3045783]
-4.4e-01
-2.3e-01
1.7e+00
1.0e+50
2.1e+00
-4.9e-02
-3.0e-01
cases:2.32%
controls:3.56%
cases:1.20%
controls:1.50%
cases:0.90%
controls:0.17%
cases:1.20%
controls:0.00%
cases:1.31%
controls:0.16%
cases:1.26%
controls:1.32%
cases:1.77%
controls:2.36%
23
353
969
9570
12
150
985
9821
9
17
988
9954
12
0
985
9971
13
16
980
9935
12
128
941
9558
14
191
779
7911
More than three and less than five hours
ZXE20 [2001311408]
ZXE20 [2001311408]
4.6e-01
9.2e-01
—
—
—
2.2e+00
1.5e+00
cases:2.02%
controls:1.28%
cases:0.70%
controls:0.28%
—
—
—
—
—
—
cases:1.57%
controls:0.18%
cases:2.40%
controls:0.52%
20
127
972
9796
7
28
990
9943
—
—
—
15
17
938
9669
19
42
774
8060
Kidney transplant status
Z94.0 [45566477]
Z94.0 [45566477]
1.7e+00
1.7e+00
1.7e+00
—
2.0e+00
1.6e+00
1.5e+00
cases:0.71%
controls:0.13%
cases:0.80%
controls:0.15%
cases:0.60%
controls:0.11%
—
—
cases:0.60%
controls:0.08%
cases:0.73%
controls:0.15%
cases:0.63%
controls:0.14%
7
13
985
9910
8
15
989
9956
6
11
991
9960
—
6
8
987
9943
7
15
946
9671
5
11
788
8091
Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]
2601-3 [3012095]
6.1e-01
7.0e-01
1.7e+00
—
1.8e+00
1.3e+00
4.6e-01
cases:5.04%
controls:2.79%
cases:2.71%
controls:1.36%
cases:0.70%
controls:0.13%
—
—
cases:1.51%
controls:0.26%
cases:4.20%
controls:1.20%
cases:4.92%
controls:3.16%
50
277
942
9646
27
136
970
9835
7
13
990
9958
—
15
26
978
9925
40
116
913
9570
39
256
754
7846
Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
95941-1 [36031861]
95941-1 [36031861]
1.1e+00
1.3e+00
2.3e+00
1.0e+50
1.8e+00
1.0e+00
7.7e-01
cases:1.21%
controls:0.42%
cases:1.10%
controls:0.29%
cases:0.80%
controls:0.08%
cases:2.51%
controls:0.00%
cases:0.60%
controls:0.10%
cases:1.15%
controls:0.41%
cases:2.52%
controls:1.18%
12
42
980
9881
11
29
986
9942
8
8
989
9963
25
0
972
9971
6
10
987
9941
11
40
942
9646
20
96
773
8006
Methemoglobin/Hemoglobin.total in Arterial blood
2615-3 [3006217]
2615-3 [3006217]
5.9e-01
1.3e+00
—
—
—
1.5e+00
9.0e-01
cases:1.41%
controls:0.79%
cases:1.20%
controls:0.34%
—
—
—
—
—
—
cases:1.26%
controls:0.29%
cases:2.65%
controls:1.10%
14
78
978
9845
12
34
985
9937
—
—
—
12
28
941
9658
21
89
772
8013
Bicarbonate [Moles/volume] in Serum or Plasma
1963-8 [3016293]
1963-8 [3016293]
5.1e-01
9.2e-01
—
1.0e+50
2.3e+00
1.3e+00
5.8e-01
cases:1.51%
controls:0.92%
cases:1.40%
controls:0.56%
—
—
cases:0.70%
controls:0.00%
cases:0.91%
controls:0.09%
cases:1.99%
controls:0.54%
cases:2.52%
controls:1.43%
15
91
977
9832
14
56
983
9915
—
7
0
990
9971
9
9
984
9942
19
52
934
9634
20
116
773
7986
Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 [3001668]
19875-4 [3001668]
6.3e-01
1.3e+00
—
—
—
1.3e+00
1.1e+00
cases:3.13%
controls:1.69%
cases:1.91%
controls:0.52%
—
—
—
—
—
—
cases:1.68%
controls:0.49%
cases:3.15%
controls:1.10%
31
168
961
9755
19
52
978
9919
—
—
—
16
47
937
9639
25
89
768
8013
FEV1/FVC --post bronchodilation
69970-2 [42868459]
69970-2 [42868459]
6.3e-01
1.3e+00
—
—
—
1.3e+00
1.1e+00
cases:3.13%
controls:1.69%
cases:1.91%
controls:0.52%
—
—
—
—
—
—
cases:1.68%
controls:0.49%
cases:3.15%
controls:1.10%
31
168
961
9755
19
52
978
9919
—
—
—
16
47
937
9639
25
89
768
8013
FEV1 percent change
69983-5 [42868472]
69983-5 [42868472]
6.3e-01
1.3e+00
—
—
—
1.3e+00
1.1e+00
cases:3.13%
controls:1.69%
cases:1.91%
controls:0.52%
—
—
—
—
—
—
cases:1.68%
controls:0.49%
cases:3.15%
controls:1.10%
31
168
961
9755
19
52
978
9919
—
—
—
16
47
937
9639
25
89
768
8013
FEV1 --post bronchodilation
20155-8 [3023550]
20155-8 [3023550]
6.3e-01
1.3e+00
—
—
—
1.3e+00
1.1e+00
cases:3.13%
controls:1.69%
cases:1.91%
controls:0.52%
—
—
—
—
—
—
cases:1.68%
controls:0.49%
cases:3.15%
controls:1.10%
31
168
961
9755
19
52
978
9919
—
—
—
16
47
937
9639
25
89
768
8013
FVC percent change Respiratory system
69982-7 [42868471]
69982-7 [42868471]
6.3e-01
1.3e+00
—
—
—
1.3e+00
1.1e+00
cases:3.13%
controls:1.69%
cases:1.91%
controls:0.52%
—
—
—
—
—
—
cases:1.68%
controls:0.49%
cases:3.15%
controls:1.10%
31
168
961
9755
19
52
978
9919
—
—
—
16
47
937
9639
25
89
768
8013
levofloxacin; inhalant, oral, parenteral
J01MA12 [21603019]
J01MA12 [21603019]
6.7e-01
6.0e-01
—
—
2.9e+00
9.1e-01
6.4e-01
cases:3.33%
controls:1.72%
cases:1.20%
controls:0.66%
—
—
—
—
cases:1.31%
controls:0.07%
cases:1.57%
controls:0.64%
cases:3.66%
controls:1.96%
33
171
959
9752
12
66
985
9905
—
—
13
7
980
9944
15
62
938
9624
29
159
764
7943
Gas panel - Arterial blood
24336-0 [3019060]
24336-0 [3019060]
9.0e-01
1.5e+00
—
1.0e+50
—
1.2e+00
8.3e-01
cases:2.02%
controls:0.83%
cases:1.60%
controls:0.37%
—
—
cases:0.70%
controls:0.00%
—
—
cases:1.26%
controls:0.37%
cases:2.14%
controls:0.95%
20
82
972
9841
16
37
981
9934
—
7
0
990
9971
—
12
36
941
9650
17
77
776
8025
Prealbumin [Mass/volume] in Serum or Plasma
14338-8 [3013742]
14338-8 [3013742]
3.2e-01
6.5e-01
—
—
2.5e+00
1.1e+00
6.9e-01
cases:2.12%
controls:1.55%
cases:1.30%
controls:0.68%
—
—
—
—
cases:0.70%
controls:0.06%
cases:1.99%
controls:0.68%
cases:3.28%
controls:1.68%
21
154
971
9769
13
68
984
9903
—
—
7
6
986
9945
19
66
934
9620
26
136
767
7966
Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
40976-3 [3040853]
40976-3 [3040853]
1.3e+00
1.2e+00
1.0e+50
1.0e+50
—
2.2e+00
9.4e-01
cases:1.21%
controls:0.34%
cases:0.70%
controls:0.22%
cases:1.20%
controls:0.00%
cases:0.60%
controls:0.00%
—
—
cases:1.15%
controls:0.12%
cases:1.01%
controls:0.39%
12
34
980
9889
7
22
990
9949
12
0
985
9971
6
0
991
9971
—
11
12
942
9674
8
32
785
8070
Other stressful life events affecting family and household
Z63.7 [45537662]
Z63.7 [45537662]
1.8e+00
—
—
—
—
—
1.7e+00
cases:0.71%
controls:0.12%
—
—
—
—
—
—
—
—
—
—
cases:1.01%
controls:0.19%
7
12
985
9911
—
—
—
—
—
8
15
785
8087
Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
38917-1 [3042194]
38917-1 [3042194]
1.4e+00
8.7e-01
—
1.0e+50
—
2.1e+00
1.0e+00
cases:1.31%
controls:0.33%
cases:0.50%
controls:0.21%
—
—
cases:0.50%
controls:0.00%
—
—
cases:1.05%
controls:0.13%
cases:1.01%
controls:0.36%
13
33
979
9890
5
21
992
9950
—
5
0
992
9971
—
10
13
943
9673
8
29
785
8073
FEV1/FVC
19926-5 [3011505]
19926-5 [3011505]
6.0e-01
1.2e+00
—
—
-1.0e+50
1.2e+00
1.0e+00
cases:3.53%
controls:1.97%
cases:2.11%
controls:0.65%
—
—
—
—
cases:0.00%
controls:0.06%
cases:1.78%
controls:0.55%
cases:3.40%
controls:1.23%
35
195
957
9728
21
65
976
9906
—
—
0
6
993
9945
17
53
936
9633
27
100
766
8002
FEV1
20150-9 [3024653]
20150-9 [3024653]
6.0e-01
1.2e+00
—
—
-1.0e+50
1.2e+00
1.0e+00
cases:3.53%
controls:1.97%
cases:2.11%
controls:0.65%
—
—
—
—
cases:0.00%
controls:0.06%
cases:1.78%
controls:0.55%
cases:3.40%
controls:1.23%
35
195
957
9728
21
65
976
9906
—
—
0
6
993
9945
17
53
936
9633
27
100
766
8002
Forced vital capacity [Volume] Respiratory system
19870-5 [3020158]
19870-5 [3020158]
6.0e-01
1.2e+00
—
—
-1.0e+50
1.2e+00
1.0e+00
cases:3.53%
controls:1.97%
cases:2.11%
controls:0.65%
—
—
—
—
cases:0.00%
controls:0.06%
cases:1.78%
controls:0.55%
cases:3.40%
controls:1.23%
35
195
957
9728
21
65
976
9906
—
—
0
6
993
9945
17
53
936
9633
27
100
766
8002
Leukocyte esterase [Presence] in Urine by Automated test strip
60026-2 [40763086]
60026-2 [40763086]
2.5e-01
4.9e-01
1.0e+00
—
1.3e+00
5.4e-01
2.9e-01
cases:11.39%
controls:9.13%
cases:6.62%
controls:4.18%
cases:2.01%
controls:0.71%
—
—
cases:2.22%
controls:0.60%
cases:7.24%
controls:4.37%
cases:14.00%
controls:10.85%
113
906
879
9017
66
417
931
9554
20
71
977
9900
—
22
60
971
9891
69
423
884
9263
111
879
682
7223
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
1798-8 [3016771]
3.7e-01
1.2e-01
1.3e+00
—
1.4e+00
6.9e-01
2.0e-01
cases:8.47%
controls:6.03%
cases:2.91%
controls:2.60%
cases:1.20%
controls:0.34%
—
—
cases:1.21%
controls:0.31%
cases:4.93%
controls:2.53%
cases:8.58%
controls:7.15%
84
598
908
9325
29
259
968
9712
12
34
985
9937
—
12
31
981
9920
47
245
906
9441
68
579
725
7523
Bicarbonate [Moles/volume] in Arterial blood
1960-4 [3008152]
1960-4 [3008152]
6.5e-01
1.2e+00
—
1.0e+50
—
1.2e+00
8.8e-01
cases:1.61%
controls:0.85%
cases:1.50%
controls:0.44%
—
—
cases:1.20%
controls:0.00%
—
—
cases:1.36%
controls:0.41%
cases:2.52%
controls:1.06%
16
84
976
9839
15
44
982
9927
—
12
0
985
9971
—
13
40
940
9646
20
86
773
8016
Urinary tract ultrasound examination
KH1AE [2001306329]
KH1AE [2001306329]
1.3e-01
—
-1.0e+50
—
—
1.9e+00
1.4e+00
cases:0.60%
controls:0.53%
—
—
cases:0.00%
controls:0.06%
—
—
—
—
cases:0.73%
controls:0.11%
cases:1.64%
controls:0.41%
6
53
986
9870
—
0
6
997
9965
—
—
7
11
946
9675
13
33
780
8069
Shortness of breath/dyspnoea
R02 [2002000883]
R02 [2002000883]
9.7e-01
1.5e+00
2.1e+00
—
—
5.1e-01
7.7e-01
cases:3.53%
controls:1.37%
cases:1.91%
controls:0.42%
cases:0.50%
controls:0.06%
—
—
—
—
cases:0.84%
controls:0.51%
cases:3.53%
controls:1.67%
35
136
957
9787
19
42
978
9929
5
6
992
9965
—
—
8
49
945
9637
28
135
765
7967
cefalexin; oral
J01DB01 [21602870]
J01DB01 [21602870]
3.2e-01
6.1e-01
7.6e-01
—
1.5e+00
4.5e-01
3.6e-01
cases:36.29%
controls:29.33%
cases:15.05%
controls:8.81%
cases:2.41%
controls:1.14%
—
—
cases:3.52%
controls:0.80%
cases:13.43%
controls:9.02%
cases:34.05%
controls:26.46%
360
2910
632
7013
150
878
847
9093
24
114
973
9857
—
35
80
958
9871
128
874
825
8812
270
2144
523
5958
Sleep apnoea
G47.3 [45562094]
G47.3 [45562094]
3.4e-01
5.9e-01
1.1e+00
—
1.0e+00
5.9e-01
4.2e-01
cases:5.75%
controls:4.17%
cases:4.71%
controls:2.67%
cases:1.50%
controls:0.53%
—
—
cases:1.51%
controls:0.56%
cases:5.25%
controls:2.97%
cases:7.82%
controls:5.27%
57
414
935
9509
47
266
950
9705
15
53
982
9918
—
15
56
978
9895
50
288
903
9398
62
427
731
7675
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
1751-7 [3024561]
2.5e-01
7.2e-01
7.6e-01
—
1.3e+00
7.5e-01
5.0e-01
cases:11.39%
controls:9.13%
cases:9.63%
controls:4.92%
cases:1.50%
controls:0.71%
—
—
cases:3.22%
controls:0.94%
cases:10.49%
controls:5.24%
cases:16.02%
controls:10.34%
113
906
879
9017
96
491
901
9480
15
71
982
9900
—
32
94
961
9857
100
508
853
9178
127
838
666
7264
Home Visit
OMOP4822459 [581476]
OMOP4822459 [581476]
4.6e-01
6.1e-01
1.1e+00
1.1e+00
1.0e+00
3.8e-01
2.2e-01
cases:8.77%
controls:5.71%
cases:5.42%
controls:3.02%
cases:3.01%
controls:1.03%
cases:1.20%
controls:0.42%
cases:3.02%
controls:1.09%
cases:5.35%
controls:3.71%
cases:9.46%
controls:7.75%
87
567
905
9356
54
301
943
9670
30
103
967
9868
12
42
985
9929
30
108
963
9843
51
359
902
9327
75
628
718
7474
Natriuretic peptide B [Mass/volume] in Serum or Plasma
30934-4 [3011960]
30934-4 [3011960]
8.9e-01
7.8e-01
—
1.0e+50
2.3e+00
8.7e-01
7.1e-01
cases:3.63%
controls:1.52%
cases:1.50%
controls:0.69%
—
—
cases:1.20%
controls:0.00%
cases:0.81%
controls:0.08%
cases:1.47%
controls:0.62%
cases:2.14%
controls:1.06%
36
151
956
9772
15
69
982
9902
—
12
0
985
9971
8
8
985
9943
14
60
939
9626
17
86
776
8016
Hemoglobin [Presence] in Urine by Test strip
5794-3 [3011397]
5794-3 [3011397]
5.3e-01
5.0e-01
9.5e-01
—
1.6e+00
5.9e-01
4.5e-01
cases:7.56%
controls:4.60%
cases:4.11%
controls:2.53%
cases:1.10%
controls:0.43%
—
—
cases:1.81%
controls:0.36%
cases:5.25%
controls:2.98%
cases:10.97%
controls:7.27%
75
456
917
9467
41
252
956
9719
11
43
986
9928
—
18
36
975
9915
50
289
903
9397
87
589
706
7513
Acute upper respiratory infection, unspecified
J06.9 [45562437]
J06.9 [45562437]
3.6e-01
4.0e-01
1.7e+00
—
1.1e+00
3.3e-01
2.9e-01
cases:11.90%
controls:8.61%
cases:5.82%
controls:3.98%
cases:2.81%
controls:0.52%
—
—
cases:1.51%
controls:0.50%
cases:6.30%
controls:4.60%
cases:17.65%
controls:13.79%
118
854
874
9069
58
397
939
9574
28
52
969
9919
—
15
50
978
9901
60
446
893
9240
140
1117
653
6985
Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
33762-6 [3029187]
33762-6 [3029187]
1.9e-01
6.2e-01
9.5e-01
—
1.9e+00
6.1e-01
3.7e-01
cases:5.75%
controls:4.78%
cases:4.81%
controls:2.64%
cases:0.80%
controls:0.31%
—
—
cases:3.32%
controls:0.50%
cases:4.93%
controls:2.74%
cases:9.84%
controls:7.04%
57
474
935
9449
48
263
949
9708
8
31
989
9940
—
33
50
960
9901
47
265
906
9421
78
570
715
7532
mycophenolic acid; oral, parenteral
L04AA06 [21603896]
L04AA06 [21603896]
1.3e+00
1.7e+00
1.6e+00
—
—
1.3e+00
1.5e+00
cases:1.01%
controls:0.27%
cases:1.00%
controls:0.19%
cases:0.50%
controls:0.10%
—
—
—
—
cases:0.84%
controls:0.23%
cases:1.13%
controls:0.26%
10
27
982
9896
10
19
987
9952
5
10
992
9961
—
—
8
22
945
9664
9
21
784
8081
Urate [Moles/volume] in Serum or Plasma
14933-6 [3026493]
14933-6 [3026493]
3.0e-01
6.4e-01
3.3e-01
—
1.4e+00
6.2e-01
4.6e-01
cases:7.16%
controls:5.39%
cases:4.11%
controls:2.22%
cases:0.50%
controls:0.36%
—
—
cases:1.21%
controls:0.31%
cases:3.99%
controls:2.19%
cases:8.45%
controls:5.49%
71
535
921
9388
41
221
956
9750
5
36
992
9935
—
12
31
981
9920
38
212
915
9474
67
445
726
7657
Procalcitonin [Mass/volume] in Serum or Plasma
33959-8 [3046279]
33959-8 [3046279]
1.3e+00
1.8e+00
—
—
—
1.4e+00
4.3e-01
cases:1.41%
controls:0.40%
cases:1.20%
controls:0.20%
—
—
—
—
—
—
cases:0.94%
controls:0.23%
cases:1.13%
controls:0.74%
14
40
978
9883
12
20
985
9951
—
—
—
9
22
944
9664
9
60
784
8042
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
77397-8 [46236098]
3.6e-01
4.3e-01
1.1e+00
—
1.7e+00
7.7e-01
5.3e-01
cases:6.05%
controls:4.29%
cases:3.31%
controls:2.18%
cases:0.70%
controls:0.23%
—
—
cases:1.31%
controls:0.23%
cases:3.88%
controls:1.83%
cases:7.44%
controls:4.52%
60
426
932
9497
33
217
964
9754
7
23
990
9948
—
13
23
980
9928
37
177
916
9509
59
366
734
7736
Telephone prescription or other care instructions
WZB00 [2001310884]
WZB00 [2001310884]
2.2e-01
4.5e-01
—
1.0e+50
3.0e+00
7.1e-01
4.7e-01
cases:6.15%
controls:5.02%
cases:1.91%
controls:1.22%
—
—
cases:2.11%
controls:0.00%
cases:1.81%
controls:0.09%
cases:2.62%
controls:1.30%
cases:5.67%
controls:3.63%
61
498
931
9425
19
122
978
9849
—
21
0
976
9971
18
9
975
9942
25
126
928
9560
45
294
748
7808
Physiotherapy
R4110 [2001310233]
R4110 [2001310233]
7.0e-01
4.6e-01
1.2e+00
1.0e+50
1.2e+00
1.1e+00
1.2e+00
cases:8.06%
controls:4.17%
cases:2.81%
controls:1.79%
cases:0.60%
controls:0.18%
cases:0.60%
controls:0.00%
cases:0.60%
controls:0.19%
cases:4.09%
controls:1.36%
cases:9.96%
controls:3.31%
80
414
912
9509
28
178
969
9793
6
18
991
9953
6
0
991
9971
6
19
987
9932
39
132
914
9554
79
268
714
7834
pantoprazole; oral, parenteral
A02BC02 [21600097]
A02BC02 [21600097]
3.1e-01
3.7e-01
6.3e-01
—
6.7e-01
5.4e-01
4.7e-01
cases:20.67%
controls:16.05%
cases:12.34%
controls:8.86%
cases:3.71%
controls:2.01%
—
—
cases:3.63%
controls:1.89%
cases:14.27%
controls:8.84%
cases:25.09%
controls:17.38%
205
1593
787
8330
123
883
874
9088
37
200
960
9771
—
36
188
957
9763
136
856
817
8830
199
1408
594
6694
Inpatient Visit
IP [9201]
IP [9201]
4.3e-01
4.1e-01
1.4e+00
—
1.9e+00
6.3e-01
3.9e-01
cases:8.17%
controls:5.49%
cases:4.11%
controls:2.78%
cases:1.00%
controls:0.26%
—
—
cases:1.51%
controls:0.22%
cases:4.62%
controls:2.52%
cases:10.21%
controls:7.17%
81
545
911
9378
41
277
956
9694
10
26
987
9945
—
15
22
978
9929
44
244
909
9442
81
581
712
7521
Other and unspecified abdominal pain
R10.4 [45568113]
R10.4 [45568113]
4.1e-01
2.7e-01
—
—
1.6e+00
7.4e-01
6.2e-01
cases:8.06%
controls:5.49%
cases:2.41%
controls:1.85%
—
—
—
—
cases:0.81%
controls:0.16%
cases:3.99%
controls:1.94%
cases:10.21%
controls:5.75%
80
545
912
9378
24
184
973
9787
—
—
8
16
985
9935
38
188
915
9498
81
466
712
7636
Short blood count panel - Blood
55429-5 [40758558]
55429-5 [40758558]
2.8e-01
2.4e-01
1.0e+00
—
1.2e+00
7.6e-01
3.5e-01
cases:8.27%
controls:6.38%
cases:4.21%
controls:3.33%
cases:1.81%
controls:0.64%
—
—
cases:2.11%
controls:0.66%
cases:6.40%
controls:3.11%
cases:9.33%
controls:6.79%
82
633
910
9290
42
332
955
9639
18
64
979
9907
—
21
66
972
9885
61
301
892
9385
74
550
719
7552
Reticulocytes [#/volume] in Blood
14196-0 [3023520]
14196-0 [3023520]
5.8e-01
8.8e-01
1.0e+00
—
1.9e+00
1.1e+00
3.2e-01
cases:2.32%
controls:1.31%
cases:1.50%
controls:0.63%
cases:0.50%
controls:0.18%
—
—
cases:0.91%
controls:0.14%
cases:1.99%
controls:0.67%
cases:2.52%
controls:1.85%
23
130
969
9793
15
63
982
9908
5
18
992
9953
—
9
14
984
9937
19
65
934
9621
20
150
773
7952
ciclesonide; nasal
R01AD13 [43534836]
R01AD13 [43534836]
6.2e-01
1.0e+00
9.2e-01
—
1.5e+00
9.6e-01
9.5e-01
cases:2.42%
controls:1.32%
cases:2.21%
controls:0.79%
cases:0.50%
controls:0.20%
—
—
cases:0.81%
controls:0.18%
cases:1.99%
controls:0.77%
cases:3.03%
controls:1.20%
24
131
968
9792
22
79
975
9892
5
20
992
9951
—
8
18
985
9933
19
75
934
9611
24
97
769
8005
ciclesonide; inhalant
R03BA08 [21603291]
R03BA08 [21603291]
6.2e-01
1.0e+00
9.2e-01
—
1.5e+00
9.6e-01
9.5e-01
cases:2.42%
controls:1.32%
cases:2.21%
controls:0.79%
cases:0.50%
controls:0.20%
—
—
cases:0.81%
controls:0.18%
cases:1.99%
controls:0.77%
cases:3.03%
controls:1.20%
24
131
968
9792
22
79
975
9892
5
20
992
9951
—
8
18
985
9933
19
75
934
9611
24
97
769
8005
Thrombin time
3243-3 [3036489]
3243-3 [3036489]
1.0e+00
4.2e-01
—
—
—
1.9e+00
9.5e-01
cases:1.81%
controls:0.67%
cases:0.50%
controls:0.33%
—
—
—
—
—
—
cases:1.26%
controls:0.19%
cases:1.64%
controls:0.64%
18
66
974
9857
5
33
992
9938
—
—
—
12
18
941
9668
13
52
780
8050
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
34531-4 [3044640]
3.0e-01
3.7e-01
1.2e+00
1.0e+50
1.7e+00
7.4e-01
4.9e-01
cases:8.57%
controls:6.50%
cases:4.01%
controls:2.82%
cases:0.90%
controls:0.27%
cases:0.50%
controls:0.00%
cases:1.61%
controls:0.30%
cases:5.04%
controls:2.46%
cases:9.46%
controls:6.01%
85
645
907
9278
40
281
957
9690
9
27
988
9944
5
0
992
9971
16
30
977
9921
48
238
905
9448
75
487
718
7615
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
19072-8 [3016431]
3.4e-01
5.6e-01
7.4e-01
—
1.3e+00
6.6e-01
2.4e-01
cases:13.71%
controls:10.19%
cases:9.93%
controls:5.92%
cases:2.01%
controls:0.96%
—
—
cases:4.23%
controls:1.14%
cases:10.60%
controls:5.78%
cases:16.14%
controls:13.11%
136
1011
856
8912
99
590
898
9381
20
96
977
9875
—
42
113
951
9838
101
560
852
9126
128
1062
665
7040
Biopsy of skin and subcutaneous tissue
TQX10 [2001310152]
TQX10 [2001310152]
7.1e-01
4.2e-01
—
—
—
1.7e+00
1.2e+00
cases:1.81%
controls:0.90%
cases:0.50%
controls:0.33%
—
—
—
—
—
—
cases:1.15%
controls:0.21%
cases:2.27%
controls:0.73%
18
89
974
9834
5
33
992
9938
—
—
—
11
20
942
9666
18
59
775
8043
Complement C4 [Mass/volume] in Serum or Plasma
4498-2 [3017766]
4498-2 [3017766]
1.1e-01
7.6e-01
—
—
—
1.8e+00
1.1e+00
cases:0.71%
controls:0.63%
cases:0.70%
controls:0.33%
—
—
—
—
—
—
cases:0.94%
controls:0.17%
cases:1.64%
controls:0.54%
7
63
985
9860
7
33
990
9938
—
—
—
9
16
944
9670
13
44
780
8058
Complement C3 [Mass/volume] in Serum or Plasma
4485-9 [3000620]
4485-9 [3000620]
6.0e-02
7.6e-01
—
—
—
1.8e+00
1.1e+00
cases:0.71%
controls:0.67%
cases:0.70%
controls:0.33%
—
—
—
—
—
—
cases:0.94%
controls:0.17%
cases:1.64%
controls:0.54%
7
66
985
9857
7
33
990
9938
—
—
—
9
16
944
9670
13
44
780
8058
Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
27811-9 [3000515]
27811-9 [3000515]
1.2e+00
4.5e-01
—
—
—
1.6e+00
8.2e-01
cases:1.92%
controls:0.57%
cases:0.50%
controls:0.32%
—
—
—
—
—
—
cases:1.26%
controls:0.25%
cases:1.39%
controls:0.62%
19
57
973
9866
5
32
992
9939
—
—
—
12
24
941
9662
11
50
782
8052
Simple examination of mouth
SAA01 [2001310274]
SAA01 [2001310274]
1.7e-01
2.9e-01
5.0e-01
2.5e+00
1.7e-01
3.6e-01
1.1e-01
cases:26.21%
controls:23.01%
cases:13.14%
controls:10.16%
cases:2.01%
controls:1.22%
cases:0.70%
controls:0.06%
cases:1.31%
controls:1.11%
cases:13.64%
controls:9.90%
cases:26.86%
controls:24.78%
260
2283
732
7640
131
1013
866
8958
20
122
977
9849
7
6
990
9965
13
110
980
9841
130
959
823
8727
213
2008
580
6094
Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
3209-4 [3019250]
3209-4 [3019250]
1.1e+00
5.5e-01
—
—
—
1.7e+00
1.0e+00
cases:1.51%
controls:0.49%
cases:0.50%
controls:0.29%
—
—
—
—
—
—
cases:1.26%
controls:0.24%
cases:1.51%
controls:0.56%
15
49
977
9874
5
29
992
9942
—
—
—
12
23
941
9663
12
45
781
8057
Band form neutrophils/Leukocytes in Blood
26508-2 [3004809]
26508-2 [3004809]
1.1e+00
1.3e+00
—
—
2.8e+00
1.3e+00
6.9e-01
cases:0.71%
controls:0.24%
cases:0.50%
controls:0.14%
—
—
—
—
cases:0.81%
controls:0.05%
cases:0.63%
controls:0.17%
cases:0.76%
controls:0.38%
7
24
985
9899
5
14
992
9957
—
—
8
5
985
9946
6
16
947
9670
6
31
787
8071
Hepatitis B virus core Ab [Presence] in Serum
16933-4 [3021879]
16933-4 [3021879]
7.2e-01
5.5e-01
—
—
2.1e+00
1.1e+00
9.5e-01
cases:3.43%
controls:1.70%
cases:1.10%
controls:0.64%
—
—
—
—
cases:0.50%
controls:0.06%
cases:1.36%
controls:0.45%
cases:3.53%
controls:1.39%
34
169
958
9754
11
64
986
9907
—
—
5
6
988
9945
13
44
940
9642
28
113
765
7989
Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32730-4 [3043723]
32730-4 [3043723]
6.4e-01
1.4e+00
—
—
—
1.4e+00
4.4e-01
cases:1.31%
controls:0.70%
cases:1.00%
controls:0.25%
—
—
—
—
—
—
cases:1.05%
controls:0.27%
cases:1.01%
controls:0.65%
13
69
979
9854
10
25
987
9946
—
—
—
10
26
943
9660
8
53
785
8049
Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32731-2 [3043747]
32731-2 [3043747]
6.3e-01
1.4e+00
—
—
—
1.4e+00
4.4e-01
cases:1.31%
controls:0.71%
cases:1.00%
controls:0.25%
—
—
—
—
—
—
cases:1.05%
controls:0.27%
cases:1.01%
controls:0.65%
13
70
979
9853
10
25
987
9946
—
—
—
10
26
943
9660
8
53
785
8049
Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2868-8 [3005229]
2868-8 [3005229]
6.3e-01
1.4e+00
—
—
—
1.4e+00
4.4e-01
cases:1.31%
controls:0.71%
cases:1.00%
controls:0.25%
—
—
—
—
—
—
cases:1.05%
controls:0.27%
cases:1.01%
controls:0.65%
13
70
979
9853
10
25
987
9946
—
—
—
10
26
943
9660
8
53
785
8049
Sedation and analgesia
WX002 [2001310758]
WX002 [2001310758]
5.5e-01
7.0e-01
—
—
—
1.2e+00
1.0e+00
cases:4.64%
controls:2.72%
cases:1.40%
controls:0.70%
—
—
—
—
—
—
cases:1.57%
controls:0.47%
cases:4.67%
controls:1.76%
46
270
946
9653
14
70
983
9901
—
—
—
15
46
938
9640
37
143
756
7959
Teaching
WZC30 [2001310891]
WZC30 [2001310891]
5.9e-01
2.5e-01
1.8e+00
—
—
9.8e-01
6.7e-01
cases:3.02%
controls:1.70%
cases:1.30%
controls:1.02%
cases:0.70%
controls:0.12%
—
—
—
—
cases:2.10%
controls:0.79%
cases:3.91%
controls:2.05%
30
169
962
9754
13
102
984
9869
7
12
990
9959
—
—
20
77
933
9609
31
166
762
7936
Fractional oxyhemoglobin in Arterial blood
2714-4 [3014007]
2714-4 [3014007]
6.3e-01
1.3e+00
—
—
—
1.4e+00
8.2e-01
cases:1.41%
controls:0.76%
cases:1.20%
controls:0.33%
—
—
—
—
—
—
cases:1.26%
controls:0.31%
cases:2.52%
controls:1.12%
14
75
978
9848
12
33
985
9938
—
—
—
12
30
941
9656
20
91
773
8011
Bicarbonate [Moles/volume] standard in Arterial blood
19230-2 [3014218]
19230-2 [3014218]
1.1e+00
1.1e+00
—
—
—
1.6e+00
5.6e-01
cases:1.71%
controls:0.57%
cases:0.90%
controls:0.31%
—
—
—
—
—
—
cases:1.47%
controls:0.31%
cases:1.77%
controls:1.01%
17
57
975
9866
9
31
988
9940
—
—
—
14
30
939
9656
14
82
779
8020
Child and Adolescent Psychiatry
OMOP4821986 [45756756]
OMOP4821986 [45756756]
9.4e-01
1.3e+00
-1.0e+50
—
—
1.3e+00
1.3e+00
cases:1.61%
controls:0.63%
cases:1.00%
controls:0.28%
cases:0.00%
controls:0.08%
—
—
—
—
cases:1.15%
controls:0.31%
cases:1.39%
controls:0.37%
16
63
976
9860
10
28
987
9943
0
8
997
9963
—
—
11
30
942
9656
11
30
782
8072
Oxygen saturation in Capillary blood
2709-4 [3021901]
2709-4 [3021901]
6.6e-01
—
—
—
2.6e+00
—
6.3e-02
cases:0.60%
controls:0.31%
—
—
—
—
—
—
cases:0.70%
controls:0.05%
—
—
cases:0.63%
controls:0.59%
6
31
986
9892
—
—
—
7
5
986
9946
—
5
48
788
8054
Office Visit
OMOP4822458 [581477]
OMOP4822458 [581477]
2.0e-01
2.9e-01
9.2e-01
1.0e+50
1.8e+00
8.1e-01
3.7e-01
cases:9.78%
controls:8.16%
cases:3.31%
controls:2.50%
cases:0.90%
controls:0.36%
cases:0.50%
controls:0.00%
cases:1.81%
controls:0.30%
cases:4.83%
controls:2.21%
cases:8.83%
controls:6.27%
97
810
895
9113
33
249
964
9722
9
36
988
9935
5
0
992
9971
18
30
975
9921
46
214
907
9472
70
508
723
7594
furosemide; oral, parenteral
C03CA01 [21601518]
C03CA01 [21601518]
5.1e-01
6.6e-01
7.1e-01
—
7.8e-01
6.6e-01
3.3e-01
cases:7.66%
controls:4.76%
cases:7.32%
controls:3.92%
cases:2.51%
controls:1.24%
—
—
cases:2.82%
controls:1.31%
cases:7.56%
controls:4.07%
cases:7.69%
controls:5.65%
76
472
916
9451
73
391
924
9580
25
124
972
9847
—
28
130
965
9821
72
394
881
9292
61
458
732
7644
Cystatin C [Mass/volume] in Serum or Plasma
33863-2 [3030366]
33863-2 [3030366]
1.0e+00
8.2e-01
—
—
—
1.5e+00
1.1e+00
cases:1.31%
controls:0.47%
cases:0.90%
controls:0.40%
—
—
—
—
—
—
cases:1.57%
controls:0.36%
cases:2.27%
controls:0.78%
13
47
979
9876
9
40
988
9931
—
—
—
15
35
938
9651
18
63
775
8039
Bicarbonate [Moles/volume] in Venous blood
14627-4 [3027273]
14627-4 [3027273]
2.3e-01
—
—
1.0e+50
2.6e+00
5.1e-01
5.6e-01
cases:0.91%
controls:0.73%
—
—
—
—
cases:0.50%
controls:0.00%
cases:0.91%
controls:0.07%
cases:0.73%
controls:0.44%
cases:2.02%
controls:1.16%
9
72
983
9851
—
—
5
0
992
9971
9
7
984
9944
7
43
946
9643
16
94
777
8008
Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
62424-7 [40765161]
62424-7 [40765161]
9.9e-01
1.5e+00
1.0e+50
1.0e+50
—
2.6e+00
—
cases:0.81%
controls:0.30%
cases:0.70%
controls:0.16%
cases:0.70%
controls:0.00%
cases:0.80%
controls:0.00%
—
—
cases:1.05%
controls:0.08%
—
—
8
30
984
9893
7
16
990
9955
7
0
990
9971
8
0
989
9971
—
10
8
943
9678
—
montelukast; oral
R03DC03 [21603356]
R03DC03 [21603356]
8.1e-01
9.0e-01
3.3e-01
—
1.1e+00
8.3e-01
5.2e-01
cases:5.65%
controls:2.60%
cases:3.91%
controls:1.62%
cases:0.60%
controls:0.43%
—
—
cases:1.01%
controls:0.33%
cases:3.67%
controls:1.64%
cases:4.54%
controls:2.75%
56
258
936
9665
39
162
958
9809
6
43
991
9928
—
10
33
983
9918
35
159
918
9527
36
223
757
7879
Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]
14879-1 [3003458]
4.6e-01
6.3e-01
1.3e+00
—
1.5e+00
9.9e-01
3.6e-01
cases:3.93%
controls:2.52%
cases:2.91%
controls:1.56%
cases:0.90%
controls:0.25%
—
—
cases:1.51%
controls:0.33%
cases:4.09%
controls:1.56%
cases:4.04%
controls:2.84%
39
250
953
9673
29
156
968
9815
9
25
988
9946
—
15
33
978
9918
39
151
914
9535
32
230
761
7872
Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
546-2 [3024135]
546-2 [3024135]
2.6e-01
7.4e-01
1.8e+00
—
—
2.2e-01
5.0e-01
cases:6.45%
controls:5.04%
cases:3.11%
controls:1.51%
cases:0.70%
controls:0.12%
—
—
—
—
cases:1.78%
controls:1.44%
cases:6.94%
controls:4.32%
64
500
928
9423
31
151
966
9820
7
12
990
9959
—
—
17
139
936
9547
55
350
738
7752
Immunohistochemistry procedure
117617002 [4035726]
117617002 [4035726]
6.6e-01
5.2e-02
2.5e+00
—
—
1.1e+00
7.5e-01
cases:2.52%
controls:1.32%
cases:0.60%
controls:0.57%
cases:0.60%
controls:0.05%
—
—
—
—
cases:0.84%
controls:0.29%
cases:2.40%
controls:1.15%
25
131
967
9792
6
57
991
9914
6
5
991
9966
—
—
8
28
945
9658
19
93
774
8009
Dysphonia
R49.0 [45558473]
R49.0 [45558473]
—
2.5e+00
—
—
—
—
—
—
—
cases:0.60%
controls:0.05%
—
—
—
—
—
—
—
—
—
—
—
6
5
991
9966
—
—
—
—
—
paracetamol; oral, parenteral, rectal
N02BE01 [21604344]
N02BE01 [21604344]
2.0e-01
4.7e-01
6.5e-01
—
5.8e-01
3.5e-01
4.2e-01
cases:36.79%
controls:32.36%
cases:24.17%
controls:16.61%
cases:6.02%
controls:3.25%
—
—
cases:5.64%
controls:3.25%
cases:23.29%
controls:17.58%
cases:45.02%
controls:34.90%
365
3211
627
6712
241
1656
756
8315
60
324
937
9647
—
56
323
937
9628
222
1703
731
7983
357
2828
436
5274
HLA Ab [Presence] in Serum
44534-6 [3042733]
44534-6 [3042733]
2.5e+00
—
—
—
—
—
—
cases:0.71%
controls:0.06%
—
—
—
—
—
—
—
—
—
—
—
—
7
6
985
9917
—
—
—
—
—
—
Extraction of multiple teeth
EBA15 [2001301927]
EBA15 [2001301927]
4.5e-01
2.5e+00
—
—
—
1.9e+00
—
cases:0.50%
controls:0.32%
cases:0.70%
controls:0.06%
—
—
—
—
—
—
cases:0.63%
controls:0.09%
—
—
5
32
987
9891
7
6
990
9965
—
—
—
6
9
947
9677
—
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
4537-7 [3013707]
1.8e-01
4.1e-01
6.3e-01
—
1.2e+00
4.9e-01
4.1e-01
cases:22.38%
controls:19.41%
cases:14.34%
controls:10.00%
cases:2.61%
controls:1.40%
—
—
cases:3.73%
controls:1.21%
cases:13.33%
controls:8.62%
cases:28.37%
controls:20.82%
222
1926
770
7997
143
997
854
8974
26
140
971
9831
—
37
120
956
9831
127
835
826
8851
225
1687
568
6415
Hemoglobin [Mass/volume] in Venous blood
30350-3 [3004119]
30350-3 [3004119]
5.3e-01
6.3e-01
—
1.0e+50
2.4e+00
5.1e-01
5.8e-01
cases:1.41%
controls:0.84%
cases:0.90%
controls:0.48%
—
—
cases:0.70%
controls:0.00%
cases:0.81%
controls:0.07%
cases:0.94%
controls:0.57%
cases:2.65%
controls:1.51%
14
83
978
9840
9
48
988
9923
—
7
0
990
9971
8
7
985
9944
9
55
944
9631
21
122
772
7980
Other change in the oral mucosa
K13.78 [2000502893]
K13.78 [2000502893]
—
2.4e+00
—
—
—
—
—
—
—
cases:0.80%
controls:0.07%
—
—
—
—
—
—
—
—
—
—
—
8
7
989
9964
—
—
—
—
—
Fungus identified in Specimen by Culture
580-1 [3000494]
580-1 [3000494]
5.2e-01
1.2e+00
—
—
—
1.3e+00
5.6e-01
cases:3.73%
controls:2.25%
cases:2.31%
controls:0.74%
—
—
—
—
—
—
cases:2.20%
controls:0.62%
cases:4.29%
controls:2.51%
37
223
955
9700
23
74
974
9897
—
—
—
21
60
932
9626
34
203
759
7899
Oxygen [Partial pressure] in Venous blood
2705-2 [3024354]
2705-2 [3024354]
5.1e-01
5.4e-01
1.7e+00
1.0e+50
2.4e+00
8.0e-01
4.9e-01
cases:2.02%
controls:1.22%
cases:1.40%
controls:0.82%
cases:0.60%
controls:0.11%
cases:0.90%
controls:0.00%
cases:1.21%
controls:0.11%
cases:1.89%
controls:0.86%
cases:3.66%
controls:2.28%
20
121
972
9802
14
82
983
9889
6
11
991
9960
9
0
988
9971
12
11
981
9940
18
83
935
9603
29
185
764
7917
salmeterol and fluticasone
R03AK06 [21603280]
R03AK06 [21603280]
7.9e-01
7.7e-01
9.6e-01
—
6.8e-01
8.3e-01
5.7e-01
cases:4.84%
controls:2.26%
cases:3.41%
controls:1.61%
cases:1.30%
controls:0.50%
—
—
cases:1.11%
controls:0.56%
cases:3.36%
controls:1.49%
cases:4.41%
controls:2.55%
48
224
944
9699
34
161
963
9810
13
50
984
9921
—
11
56
982
9895
32
144
921
9542
35
207
758
7895
codeine and paracetamol
N02AJ06 [1123647]
N02AJ06 [1123647]
3.3e-01
3.7e-01
9.4e-01
—
7.8e-01
6.5e-01
4.4e-01
cases:17.44%
controls:13.22%
cases:6.92%
controls:4.87%
cases:2.21%
controls:0.87%
—
—
cases:1.61%
controls:0.74%
cases:8.39%
controls:4.58%
cases:18.28%
controls:12.63%
173
1312
819
8611
69
486
928
9485
22
87
975
9884
—
16
74
977
9877
80
444
873
9242
145
1023
648
7079
Abnormal cervix smear
X86 [2002001371]
X86 [2002001371]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.63%
controls:0.06%
—
—
—
—
—
—
5
5
788
8097
HLA typing for celiac disease panel - Blood or Tissue
45023-9 [3045683]
45023-9 [3045683]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.63%
controls:0.06%
—
—
—
—
—
—
5
5
788
8097
Follow-up examination after surgery for other conditions
Z09.0 [45576131]
Z09.0 [45576131]
2.2e-01
1.7e+00
—
—
—
2.3e+00
9.7e-01
cases:0.60%
controls:0.48%
cases:0.50%
controls:0.09%
—
—
—
—
—
—
cases:1.15%
controls:0.11%
cases:1.39%
controls:0.53%
6
48
986
9875
5
9
992
9962
—
—
—
11
11
942
9675
11
43
782
8059
High resolution CT examination of lungs
GD1DD [2001303632]
GD1DD [2001303632]
—
1.3e+00
—
—
—
2.3e+00
9.1e-01
—
—
cases:0.60%
controls:0.17%
—
—
—
—
—
—
cases:0.84%
controls:0.08%
cases:1.01%
controls:0.41%
—
6
17
991
9954
—
—
—
8
8
945
9678
8
33
785
8069
Severe cervical dysplasia, not elsewhere classified
N87.2 [45567869]
N87.2 [45567869]
1.2e+00
—
—
1.0e+50
—
2.3e+00
1.2e+00
cases:0.71%
controls:0.22%
—
—
—
—
cases:0.80%
controls:0.00%
—
—
cases:0.84%
controls:0.08%
cases:0.63%
controls:0.19%
7
22
985
9901
—
—
8
0
989
9971
—
8
8
945
9678
5
15
788
8087
Yersinia sp identified in Specimen by Organism specific culture
701-3 [3025468]
701-3 [3025468]
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
cases:0.63%
controls:0.06%
—
—
—
—
—
—
—
6
6
947
9680
—
Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
82198-3 [21493466]
82198-3 [21493466]
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
cases:0.63%
controls:0.06%
—
—
—
—
—
—
—
6
6
947
9680
—
Vibrio sp identified in Specimen by Organism specific culture
6581-3 [3005988]
6581-3 [3005988]
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
cases:0.63%
controls:0.06%
—
—
—
—
—
—
—
6
6
947
9680
—
LabWAS
↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
249
1024
2.90
42.30
2.4
1.9
—
—
—
0
0
237
977
2.86
39.86
2.4
1.9
—
—
—
0
0
292
1391
2.54
36.46
2.8
1.9
—
—
—
0
0
302
1511
2.42
33.50
3.7
3.0
1.06
0.98
e6/l
0.16
158
787
286
1403
2.45
33.09
3.8
3.1
3.72
2.48
e6/l
0.67
143
681
411
2443
2.15
29.37
4.3
3.3
0.40
0.37
e6/l
0.10
289
1777
459
2846
2.12
29.35
4.5
3.4
24.07
78.39
e6/l
1.57
340
2170
178
846
2.34
21.21
3.1
2.4
32.01
34.28
u/l
0.47
148
713
683
5255
1.91
20.30
13.1
9.9
4.12
4.06
e9/l
0.26
571
4593
275
1587
2.00
19.82
4.0
3.7
412.45
361.31
ng/l
0.12
198
1140
520
3766
1.78
17.82
8.0
5.4
36.05
36.23
g/l
0.31
494
3566
330
2107
1.84
17.11
2.2
1.9
1.17
1.13
mg/l
0.10
274
1632
110
472
2.49
16.28
2.2
1.7
—
—
—
0
0
190
1034
2.03
15.77
5.0
3.4
6.46
7.38
umol/l
0.47
167
916
716
5818
1.78
15.31
6.2
4.5
1318.00
1416.18
e6/l
—
10
87
174
942
2.02
14.58
6.7
4.6
251.92
248.86
u/l
0.10
166
900
67
239
2.93
14.21
3.2
3.3
1.00
2.16
index
1.46
37
129
87
359
2.56
13.95
2.5
1.6
—
—
—
0
0
556
4284
1.66
13.76
12.7
7.9
1.21
1.21
mmol/l
0.59
517
3745
864
7582
1.93
12.63
28.2
18.3
13.62
13.50
%
1.84
857
7508
501
3813
1.62
12.61
12.3
7.4
1.21
1.21
mmol/l
0.80
481
3546
781
6658
1.75
12.44
12.0
8.1
79.92
79.00
u/l
0.22
757
6330
165
924
1.94
12.44
12.3
9.5
0.46
0.87
mmol/l
0.70
143
762
747
6297
1.70
12.33
3.9
3.4
—
—
—
0
0
160
893
1.94
12.17
5.7
5.1
0.88
1.76
mmol/l
2.11
145
753
165
935
1.91
11.98
12.3
9.4
5.07
5.09
kpa
0.13
158
903
59
216
2.84
11.95
12.1
7.2
200.00
395.21
iu/ml
0.66
15
28
165
936
1.91
11.94
12.3
9.4
11.92
12.34
kpa
0.50
158
906
151
834
1.95
11.82
12.7
10.0
95.18
95.70
%
0.41
145
813
292
1965
1.68
11.82
3.4
2.8
4.56
6.57
e6/l
1.55
258
1798
128
670
2.04
11.66
4.0
2.9
65.62
66.85
g/l
0.97
121
627
575
4590
1.58
11.37
9.9
6.7
11.83
11.56
umol/l
0.18
557
4386
426
3174
1.59
11.33
5.0
3.5
28.80
31.82
u/l
1.47
415
3018
65
261
2.59
11.03
3.0
1.7
—
—
—
0
0
522
4105
1.56
10.79
13.4
11.3
0.00
0.00
e9/l
0.33
389
3365
105
528
2.10
10.63
14.9
11.7
0.59
0.65
%
0.93
105
523
33
91
3.71
10.59
3.7
1.8
—
—
—
0
0
78
349
2.34
10.50
1.4
1.4
—
—
—
0
0
764
6583
1.65
10.47
6.0
4.3
12.08
10.87
mm/h
1.33
736
6189
229
1490
1.69
10.35
3.1
2.6
12.42
13.49
umol/l
1.42
220
1395
66
280
2.45
10.00
3.6
2.4
0.56
0.95
g/l
0.63
60
250
54
209
2.67
9.87
2.1
1.6
143.52
137.28
au/ml
0.15
25
69
474
3697
1.53
9.86
2.2
2.1
95.73
96.67
pmol/l
0.19
265
2000
622
5149
1.54
9.75
8.4
5.4
6.54
6.58
mmol/l
0.18
595
4835
61
253
2.50
9.70
2.8
1.6
—
—
—
0
0
56
223
2.60
9.68
3.6
2.3
0.00
0.00
g/l
-0.00
51
210
310
2224
1.57
9.30
2.9
2.4
—
—
—
0
0
58
240
2.50
9.28
3.6
2.2
0.00
0.00
g/l
-0.00
51
211
63
271
2.41
9.28
3.2
2.9
—
—
—
0
0
34
105
3.32
9.23
3.6
1.7
—
—
—
0
0
221
1473
1.64
8.98
7.3
4.1
0.82
0.82
mmol/l
0.17
216
1409
44
162
2.79
8.87
3.3
1.8
—
—
—
0
0
240
1640
1.61
8.79
3.1
2.8
2.45
2.44
mmol/l
0.38
211
1483
58
247
2.43
8.74
3.7
2.3
0.01
0.02
g/l
0.20
52
225
209
1383
1.64
8.71
3.1
2.6
2.36
2.35
g/l
0.03
194
1287
58
250
2.40
8.52
1.6
1.3
—
—
—
0
0
721
6252
1.53
8.39
4.1
3.4
44.74
44.49
u/l
0.03
691
5958
44
169
2.68
8.20
1.3
1.3
—
—
—
0
0
44
169
2.68
8.20
1.3
1.3
—
—
—
0
0
193
1274
1.64
8.08
3.2
2.6
21.23
22.97
%
0.95
187
1199
235
1630
1.57
8.00
2.1
1.5
—
—
—
0
0
55
239
2.38
7.95
1.8
1.4
219.89
256.04
u/ml
0.54
41
134
941
8761
2.00
7.89
27.7
17.0
139.49
139.65
mmol/l
1.29
934
8607
43
167
2.64
7.85
1.2
1.2
1.88
4.88
u/ml
1.15
17
58
183
1201
1.64
7.83
10.3
7.2
1.07
1.06
mmol/l
0.13
173
1130
898
8246
1.77
7.79
21.1
13.8
85.76
85.47
ml/min/173m2
0.13
826
7591
942
8780
2.00
7.77
27.9
17.1
3.95
3.96
mmol/l
0.55
932
8602
943
8797
2.00
7.69
26.0
14.8
25.36
22.59
mg/l
1.77
823
7179
573
4797
1.45
7.55
4.6
3.7
0.00
0.00
estimate
0.50
97
992
976
9233
2.45
7.54
28.6
18.6
77.16
74.45
umol/l
1.19
971
9148
973
9199
2.36
7.41
16.4
11.6
25.96
26.23
u/l
0.16
965
8992
18
42
4.34
7.23
3.7
2.9
230.80
89352.60
u/ml
—
5
5
578
4872
1.43
7.18
4.7
3.8
0.00
0.34
estimate
0.54
95
944
34
124
2.80
7.02
1.9
1.6
—
—
—
0
0
54
247
2.25
6.97
4.9
4.0
33.15
50.29
mg/l
0.80
45
214
54
247
2.25
6.97
4.9
4.0
61.62
69.70
mg/l
0.09
45
215
74
386
1.99
6.81
4.1
3.2
1.02
1.02
ratio
0.62
64
363
26
83
3.19
6.75
2.5
3.9
11.36
13.98
index
0.86
14
59
140
890
1.66
6.74
2.3
2.0
—
—
—
0
0
103
601
1.79
6.73
2.0
1.7
—
—
—
0
0
120
736
1.71
6.60
2.0
2.0
—
—
—
0
0
378
2985
1.42
6.58
5.0
3.5
2.36
2.36
mmol/l
0.01
357
2751
571
4847
1.41
6.54
4.6
3.8
0.00
4.77
estimate
1.07
96
1003
33
125
2.70
6.37
2.0
1.7
—
—
—
0
0
124
777
1.68
6.30
4.2
2.9
9.47
10.59
g/l
2.26
114
724
49
225
2.24
6.29
2.0
1.4
—
—
—
0
0
49
226
2.23
6.22
5.0
3.6
62.20
2.41
ratio
0.47
21
130
307
2361
1.43
6.10
2.5
2.3
2.63
2.78
mg/l
0.63
271
2061
205
1458
1.51
6.08
2.7
2.2
—
—
—
0
0
190
1330
1.53
6.08
2.4
2.1
—
—
—
0
0
283
2152
1.44
5.96
1.7
1.5
2.42
2.32
g/l
0.15
159
1350
18
49
3.72
5.94
2.3
1.6
—
—
—
0
0
18
49
3.72
5.94
2.3
1.6
—
—
—
0
0
41
179
2.34
5.92
2.0
1.4
—
—
—
0
0
886
8236
1.59
5.75
5.4
5.4
1.77
1.86
mu/l
1.85
852
7742
96
576
1.74
5.72
4.2
3.1
225.77
179.36
ng/l
0.34
85
524
67
360
1.92
5.69
1.7
2.1
1.47
1.47
g/l
0.01
59
321
486
4078
1.37
5.64
2.9
2.6
75.05
75.47
nmol/l
0.12
457
3750
65
349
1.92
5.54
1.6
1.8
—
—
—
0
0
996
9611
2.84
5.53
35.0
22.6
250.87
254.71
e9/l
1.05
988
9449
39
172
2.32
5.52
1.2
1.3
1.89
5.09
u/ml
1.60
18
75
298
2316
1.41
5.49
4.0
3.3
1516.68
1089.96
ng/l
1.20
266
1959
544
4659
1.36
5.48
3.9
3.2
163.68
107.06
ug/l
1.45
520
4411
996
9615
2.82
5.45
34.9
22.6
4.46
4.52
e12/l
3.62
985
9429
52
260
2.05
5.42
1.3
1.2
—
—
—
0
0
16
43
3.76
5.38
1.9
1.3
—
—
—
0
0
16
43
3.76
5.38
1.9
1.3
—
—
—
0
0
498
4219
1.35
5.32
3.6
2.8
—
—
estimate
—
0
0
61
327
1.92
5.24
2.6
1.9
1.51
2.21
ug/l
0.26
53
293
292
2277
1.40
5.23
4.6
2.8
348.43
336.75
umol/l
1.08
263
2038
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
50
250
2.05
5.22
2.9
3.1
0.30
0.38
iu/ml
0.89
24
123
184
1321
1.48
5.17
2.7
2.6
125.43
103.28
ug/g
0.57
161
1061
33
140
2.40
5.11
1.9
1.4
—
—
—
0
0
127
848
1.57
5.00
3.2
2.7
0.21
0.22
g/l
0.09
121
805
36
161
2.28
4.96
1.1
1.1
—
—
—
0
0
324
2594
1.37
4.89
2.8
2.2
207.02
211.03
u/l
0.04
313
2472
75
442
1.75
4.78
1.9
1.4
—
—
—
0
0
308
2455
1.37
4.76
1.7
1.7
22.00
20.33
nmol/l
1.16
285
2116
22
79
2.82
4.73
3.2
2.3
648.29
591.60
e6/l
0.16
17
62
59
1016
0.55
4.70
4.0
4.5
30.43
31.64
%
0.40
46
702
50
261
1.96
4.66
1.3
1.2
—
—
—
0
0
22
80
2.79
4.63
3.5
2.4
187.76
215.59
e6/l
0.39
17
66
270
2123
1.37
4.51
1.9
1.7
—
—
—
0
0
173
1261
1.45
4.47
1.7
1.7
1016.28
1186.78
nmol/l
1.88
143
976
40
199
2.05
4.28
2.0
1.6
—
—
—
0
0
11
21
5.28
4.15
13.5
3.7
5.49
4.59
kpa
1.42
11
21
11
21
5.28
4.15
13.5
3.7
9.74
10.74
kpa
0.39
11
21
37
181
2.08
4.14
1.8
1.4
—
—
—
0
0
37
181
2.08
4.14
1.7
1.4
—
—
—
0
0
22
86
2.59
4.07
3.0
1.5
—
—
—
0
0
22
86
2.59
4.07
3.0
1.5
—
—
—
0
0
22
86
2.59
4.07
3.0
1.5
—
—
—
0
0
859
8060
1.43
4.03
6.2
5.9
38.30
38.67
mmol/mol
0.62
822
7645
57
328
1.78
3.98
13.3
7.6
1.52
1.37
mg/l
0.64
57
301
20
76
2.66
3.91
2.9
2.6
—
—
—
0
0
14
37
3.82
3.90
2.0
1.2
—
—
—
0
0
14
37
3.82
3.90
2.0
1.2
—
—
—
0
0
39
200
1.99
3.87
6.3
3.5
45.65
33.71
umol/l
1.34
34
185
35
177
2.01
3.62
1.9
1.5
—
—
—
0
0
57
339
1.72
3.58
1.8
1.6
9.88
8.66
u/ml
0.21
26
82
908
8646
1.47
3.56
5.5
5.4
2.71
2.75
mmol/l
0.59
868
8148
96
651
1.52
3.56
6.8
4.8
92.95
80.79
ng/l
0.77
87
587
96
654
1.52
3.48
2.5
2.4
11.69
16.77
au/ml
1.12
17
73
20
81
2.50
3.48
2.3
1.7
—
—
—
0
0
105
730
1.49
3.46
3.0
2.5
0.17
0.41
e6/l
1.64
97
695
430
3717
1.27
3.46
18.2
12.5
1.25
1.20
inr
0.96
368
3095
11
27
4.11
3.40
2.4
1.0
—
—
—
0
0
49
290
1.72
3.16
3.0
1.7
—
—
—
0
0
19
79
2.43
3.15
4.7
2.4
—
—
—
0
0
12
35
3.46
3.11
4.7
1.6
—
—
—
0
0
12
35
3.46
3.11
4.7
1.6
—
—
—
0
0
12
35
3.46
3.11
4.7
1.6
—
—
—
0
0
157
1198
1.37
3.11
1.9
1.8
1.52
1.45
%
0.57
136
1074
15
356
0.41
3.09
1.4
1.5
—
—
—
0
0
11
30
3.70
3.09
1.8
2.8
0.60
0.61
mmol/l
0.05
11
30
866
8224
1.36
3.02
4.9
4.8
5.82
5.85
mmol/l
0.28
824
7653
52
318
1.67
2.99
3.8
1.8
—
—
—
0
0
5
5
10.04
2.98
3.2
2.0
—
—
—
0
0
5
5
10.04
2.98
1.0
1.0
—
—
—
0
0
53
327
1.65
2.95
1.5
1.3
—
—
—
0
0
75
505
1.52
2.91
1.5
1.4
—
—
—
0
0
106
766
1.43
2.89
1.5
1.3
156.79
233.47
u/ml
0.52
96
711
9
22
4.12
2.88
1.2
1.2
—
—
—
0
0
223
1812
1.30
2.86
1.4
1.3
40.77
27.52
iu/ml
0.40
66
540
13
47
2.79
2.82
4.4
1.5
—
—
—
0
0
13
47
2.79
2.82
4.4
1.5
—
—
—
0
0
13
47
2.79
2.82
4.4
1.5
—
—
—
0
0
13
47
2.79
2.82
4.4
1.5
—
—
—
0
0
208
1678
1.30
2.81
1.3
1.3
6.22
9.59
u/ml
0.63
58
669
25
124
2.04
2.78
9.7
3.4
1.20
1.08
%
0.13
25
116
90
636
1.46
2.77
2.6
2.4
11.10
7.92
ug/l
0.52
83
567
93
663
1.44
2.73
3.4
2.5
61.41
69.11
ml/min/173m2
0.88
41
293
85
597
1.46
2.70
11.9
5.4
2.17
1.61
mmol/l
0.57
58
430
6
10
6.03
2.70
2.5
2.3
—
—
—
0
0
60
891
0.65
2.66
9.9
6.6
—
—
—
0
0
50
315
1.62
2.60
1.5
1.5
0.05
0.10
iu/ml
0.46
11
49
892
8554
1.35
2.54
4.9
4.9
4.65
4.66
mmol/l
0.12
859
8092
57
373
1.56
2.54
1.2
1.2
0.18
1.30
u/ml
—
5
24
17
75
2.29
2.52
1.6
2.8
1105.00
945.81
mg
0.12
17
75
43
263
1.66
2.51
1.6
1.3
—
—
—
0
0
19
89
2.16
2.46
4.9
3.8
—
—
—
0
0
103
764
1.39
2.45
4.0
4.6
19.22
16.84
ug/l
0.05
79
624
40
244
1.67
2.37
2.4
1.6
—
—
—
0
0
54
355
1.55
2.37
7.1
6.1
1.74
1.57
%
0.62
49
337
5
8
6.27
2.37
3.2
1.4
52.80
38.00
umol/l
—
5
8
104
778
1.38
2.35
2.2
2.4
12.36
12.86
nmol/l
0.24
93
709
16
71
2.27
2.35
1.2
1.4
—
—
—
0
0
11
39
2.84
2.34
1.3
1.1
—
—
—
0
0
82
590
1.42
2.33
1.3
1.3
29.63
41.70
au/ml
—
7
45
14
59
2.39
2.30
1.9
4.2
1.43
0.80
index
0.56
14
59
18
85
2.14
2.29
1.8
1.3
2067.09
2207.67
e6/l
0.05
11
54
848
8103
1.28
2.27
4.1
4.1
1.32
1.28
mmol/l
0.78
811
7561
886
8525
1.31
2.16
4.7
4.8
1.45
1.46
mmol/l
0.33
852
8013
16
74
2.18
2.15
1.8
1.4
11032.11
29491.37
e6/l
—
9
40
88
654
1.38
2.09
1.4
1.5
24.76
22.92
iu/l
0.21
67
553
13
57
2.30
1.98
2.0
2.4
2.07
1.86
umol/l
0.32
13
50
46
306
1.53
1.96
3.6
3.7
170.23
1479.03
u/ml
1.34
38
266
64
457
1.43
1.93
2.1
1.6
0.37
0.33
mg/l
0.14
26
208
749
7102
1.21
1.91
4.4
4.4
14.53
14.59
pmol/l
0.33
710
6615
9
34
2.66
1.86
1.1
1.0
26.03
49.29
iu/ml
—
9
34
9
34
2.66
1.86
2.3
1.5
—
—
—
0
0
315
2776
1.20
1.86
3.4
2.7
61.49
89.37
u/l
0.48
304
2607
15
73
2.07
1.81
1.0
1.0
—
—
—
0
0
88
672
1.34
1.79
1.7
1.5
—
—
—
0
0
13
60
2.18
1.78
1.2
1.1
—
—
—
0
0
20
109
1.85
1.78
1.4
1.3
—
—
—
0
0
58
416
1.42
1.73
5.3
4.0
54.14
50.07
%
0.61
58
407
27
163
1.67
1.72
1.5
1.5
—
—
—
0
0
8
30
2.68
1.72
4.9
2.0
37.75
41.34
g/l
—
8
30
5
13
3.86
1.71
5.0
4.5
—
—
—
0
0
5
13
3.86
1.71
2.2
1.5
—
—
—
0
0
41
275
1.51
1.71
1.5
1.4
302.26
292.93
ug/g
0.11
28
153
18
96
1.89
1.71
1.2
1.1
13.74
6.28
iu/ml
—
8
19
51
358
1.45
1.71
1.6
1.4
—
—
—
0
0
119
957
1.28
1.68
2.6
2.2
364.42
368.72
nmol/l
0.09
113
901
12
55
2.20
1.68
1.0
1.4
—
25.71
—
0
7
34
220
1.56
1.67
1.2
1.6
9.80
12.57
e6/l
0.14
25
166
10
41
2.45
1.64
6.4
3.4
1.10
1.39
%
—
10
41
51
363
1.43
1.60
1.6
1.4
0.97
0.95
ratio
0.11
29
235
51
363
1.43
1.60
1.6
1.4
1.00
1.15
ratio
0.84
29
235
51
363
1.43
1.60
1.6
1.4
1.11
1.13
ratio
0.05
29
235
13
63
2.08
1.60
1.5
1.2
—
—
—
0
0
63
467
1.37
1.57
1.5
1.6
259.77
287.03
mu/l
0.44
54
427
17
92
1.86
1.56
1.2
1.2
—
—
—
0
0
55
399
1.40
1.56
1.4
1.3
247.23
240.63
miu/ml
0.04
23
186
12
57
2.12
1.55
1.0
1.4
—
538.00
—
0
5
13
64
2.04
1.54
1.2
1.2
0.51
0.56
ratio
—
8
34
34
226
1.52
1.50
1.2
1.7
447.48
660.47
e6/l
0.13
25
177
14
73
1.93
1.44
1.5
2.3
21.96
35.67
mg/l
—
8
54
22
133
1.67
1.43
1.1
1.3
—
—
—
0
0
7
29
2.42
1.39
1.1
1.1
86.29
93.93
%
—
7
29
13
67
1.95
1.38
1.7
1.4
72.46
75.30
umol/l
0.25
13
67
32
215
1.50
1.37
1.5
1.2
—
—
—
0
0
273
2435
1.17
1.36
1.3
1.4
0.72
1.51
u/ml
2.51
52
663
54
403
1.36
1.33
2.0
1.8
2.24
7.01
iu/ml
—
9
90
327
2966
1.15
1.30
3.8
3.5
7.30
7.93
mmol/l
1.27
291
2542
52
389
1.35
1.27
1.7
1.5
56.08
60.05
ug/l
0.24
41
328
16
92
1.75
1.25
1.0
1.1
—
—
—
0
0
8
36
2.23
1.24
1.0
1.0
—
—
—
0
0
12
63
1.92
1.23
1.6
1.4
—
—
—
0
0
18
109
1.66
1.19
2.2
1.3
—
—
—
0
0
10
50
2.01
1.16
1.9
1.3
—
—
—
0
0
10
50
2.01
1.16
1.0
1.1
98.23
166.51
iu/ml
—
10
50
37
266
1.41
1.16
7.0
3.7
1.39
1.37
mmol/l
0.04
37
259
5
20
2.51
1.15
1.0
1.4
—
—
—
0
0
297
2698
1.14
1.14
4.1
4.2
8.65
9.10
mg/mmol
0.07
190
1720
17
103
1.66
1.13
2.2
1.4
—
—
—
0
0
17
103
1.66
1.13
2.2
1.4
—
—
—
0
0
34
243
1.41
1.11
1.1
1.1
2.57
2.14
u/ml
0.12
20
136
17
104
1.65
1.10
2.2
1.4
—
—
—
0
0
214
1906
1.16
1.09
4.5
4.3
22.92
21.47
%
0.72
99
849
30
212
1.43
1.05
1.2
1.1
18.17
15.10
au/ml
—
7
62
31
221
1.42
1.03
2.4
2.1
130.70
129.45
g/l
0.08
23
180
236
2134
1.14
0.97
4.7
3.7
1.02
1.02
kg/l
1.13
166
1432
24
165
1.47
0.97
1.0
1.1
2.56
4.03
eliau/ml
—
9
74
391
3646
1.12
0.97
4.4
3.6
1.24
0.04
estimate
0.50
84
837
7
36
1.95
0.97
1.7
2.9
178.43
198.08
u/l
—
7
36
17
108
1.58
0.97
2.2
1.3
—
—
—
0
0
0
31
0.00
0.96
0.0
1.4
—
8.17
—
0
31
163
1437
1.16
0.96
3.0
3.1
0.78
0.76
ug/l
0.13
112
874
17
109
1.57
0.94
2.2
1.3
—
—
—
0
0
131
1138
1.17
0.93
2.0
1.9
3.52
3.50
ratio
0.07
101
885
9
52
1.74
0.92
3.4
3.1
850.00
771.29
u/ml
—
9
52
48
381
1.27
0.84
1.5
1.5
8.26
9.24
u/l
0.29
31
301
99
849
1.18
0.84
1.7
1.7
3.34
3.49
mmol/l
0.65
68
599
9
53
1.70
0.75
1.0
1.1
1646.56
1431.74
miu/ml
—
9
53
24
175
1.38
0.75
1.5
1.2
—
—
—
0
0
32
413
0.77
0.74
1.1
1.1
1.53
1.54
g/l
0.12
32
413
95
825
1.17
0.71
3.6
3.1
—
—
—
0
0
5
26
1.93
0.70
1.0
1.3
—
—
—
0
0
12
77
1.57
0.68
1.3
1.7
—
—
—
0
0
10
61
1.65
0.68
1.0
1.0
0.86
1.09
u/l
—
5
29
158
1743
0.89
0.68
1.8
1.7
454.78
33780584.49
pmol/l
1.93
138
1492
14
94
1.50
0.67
1.0
1.1
—
—
—
0
0
13
86
1.52
0.66
1.1
1.2
—
—
—
0
0
14
96
1.46
0.61
1.6
1.3
—
—
—
0
0
13
88
1.48
0.60
1.1
1.2
—
—
—
0
0
13
88
1.48
0.60
1.1
1.2
—
—
—
0
0
0
22
0.00
0.59
0.0
1.0
—
83.73
—
0
22
255
2385
1.09
0.58
5.4
5.2
4.68
2.30
ug/l
0.68
230
2166
31
248
1.26
0.55
1.7
1.9
191.90
208.77
pmol/l
0.41
31
237
15
107
1.41
0.55
1.0
1.1
—
—
—
0
0
31
250
1.25
0.53
1.1
1.1
2.82
4.37
u/ml
0.35
17
147
30
241
1.25
0.53
1.1
1.1
0.69
1.27
u/ml
0.51
14
119
6
40
1.50
0.51
1.8
2.2
—
152.60
—
0
5
16
118
1.36
0.50
2.6
1.2
—
—
—
0
0
21
162
1.30
0.50
1.0
1.1
—
—
—
0
0
12
84
1.43
0.49
1.1
1.2
—
—
—
0
0
18
234
0.77
0.48
1.8
1.6
67.54
54.50
ug/l
0.46
18
234
13
93
1.40
0.48
1.1
1.2
—
—
—
0
0
22
278
0.79
0.48
1.7
1.8
—
—
—
0
0
12
85
1.42
0.47
11.4
3.0
51.75
54.50
%
0.21
12
79
33
274
1.21
0.45
2.2
2.0
1.96
4.12
iu/l
2.93
16
105
7
51
1.38
0.44
2.4
1.6
—
—
—
0
0
12
87
1.38
0.42
1.3
1.0
—
—
—
0
0
13
173
0.75
0.42
5.3
3.4
9.94
8.32
pmol/l
0.24
13
173
5
32
1.57
0.42
1.8
1.5
0.42
0.44
e9/l
—
5
32
34
286
1.20
0.42
1.1
1.1
0.14
3.00
u/ml
4.06
17
170
18
228
0.79
0.41
1.5
1.6
11711.20
11884.07
e6/l
—
10
166
5
33
1.52
0.41
5.2
4.5
—
—
—
0
0
0
15
0.00
0.41
0.0
1.4
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
0.09
—
0
8
0
17
0.00
0.40
0.0
1.1
—
0.04
—
0
9
282
2689
1.07
0.40
3.6
3.1
0.67
0.05
estimate
0.50
81
812
68
607
1.13
0.40
2.6
3.5
4.51
4.60
pmol/l
0.46
62
541
33
279
1.19
0.39
1.0
1.1
1.12
6.67
eliau/ml
—
5
38
59
525
1.13
0.37
3.0
2.2
4900.39
6000.42
u/l
0.11
18
217
9
71
1.27
0.36
4.1
1.5
—
—
—
0
0
22
180
1.23
0.36
1.1
1.1
0.10
0.26
u/ml
—
7
70
21
171
1.23
0.36
1.8
1.7
—
—
—
0
0
6
42
1.43
0.35
1.5
1.5
—
—
—
0
0
23
190
1.22
0.35
2.0
2.4
70.13
104.94
ug/min
0.25
16
117
14
110
1.28
0.32
1.4
1.1
6.82
15.50
u/ml
—
5
47
63
571
1.11
0.31
1.0
1.0
—
—
—
0
0
73
667
1.10
0.31
1.7
1.6
872.99
961.85
mu/l
0.44
56
557
7
53
1.32
0.31
1.0
1.1
—
—
—
0
0
7
56
1.25
0.29
1.3
1.4
180.21
159.93
pmol/l
—
7
56
8
65
1.23
0.27
1.5
1.3
18.13
31.15
nmol/l
—
8
52
13
104
1.25
0.26
1.1
1.2
—
—
—
0
0
10
77
1.30
0.26
1.6
1.2
—
—
—
0
0
16
132
1.22
0.25
1.6
1.6
15.04
24.82
ng/l
1.70
16
132
9
76
1.19
0.24
1.7
1.2
—
—
—
0
0
11
87
1.27
0.24
4.9
3.1
3.47
4.97
nmol/l
0.34
11
87
5
42
1.19
0.21
1.4
1.1
39.32
41.45
u/ml
—
5
42
5
42
1.19
0.21
1.2
1.3
485.60
507.92
u/l
—
5
36
0
10
0.00
0.21
0.0
8.7
—
10.36
—
0
10
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
28
314
0.89
0.21
1.4
1.6
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
0.15
—
0
13
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
2.31
—
0
7
6
49
1.23
0.20
1.5
1.3
—
—
—
0
0
24
212
1.14
0.19
1.2
1.4
0.25
0.41
nmol/l
1.04
18
176
7
58
1.21
0.18
1.6
1.3
—
—
—
0
0
18
157
1.15
0.17
1.1
1.2
—
—
—
0
0
7
63
1.11
0.17
2.4
2.2
29.86
27.38
umol/l
—
7
58
17
148
1.15
0.17
1.2
1.1
—
1.28
—
0
10
380
3730
1.03
0.16
2.0
1.9
1.45
1.36
mmol/l
1.12
341
3217
6
78
0.77
0.15
1.0
1.5
—
—
—
0
0
23
207
1.11
0.15
1.1
1.1
6.67
5.76
u/ml
—
10
108
42
449
0.93
0.14
1.5
1.4
—
—
—
0
0
18
161
1.12
0.13
1.2
1.3
—
—
—
0
0
12
104
1.16
0.12
2.4
2.1
30.50
32.63
pg
1.25
12
104
322
3175
1.02
0.10
4.5
3.6
47.10
56.33
ng/l
0.14
206
2076
5
45
1.11
0.10
2.6
1.8
1.20
5.83
u/field
—
5
34
5
48
1.04
0.09
1.6
1.3
—
—
—
0
0
26
243
1.07
0.08
1.2
1.3
—
—
—
0
0
16
175
0.91
0.08
2.2
3.8
21.46
25.55
mg/l
—
9
121
258
2617
0.98
0.08
4.8
3.9
0.00
0.01
estimate
1.34
89
944
5
60
0.83
0.08
1.0
1.1
—
—
—
0
0
6
73
0.82
0.07
1.7
1.2
—
43.20
—
0
5
9
85
1.06
0.07
1.4
1.1
—
61.88
—
0
8
17
158
1.08
0.06
1.1
1.2
—
182.00
—
0
10
22
232
0.95
0.05
1.5
1.4
74.82
156.14
pmol/l
0.84
22
226
11
120
0.92
0.05
1.1
1.1
—
—
—
0
0
37
359
1.03
0.03
1.8
1.8
—
—
—
0
0
17
161
1.06
0.03
5.4
3.2
6.27
7.56
mmol/l
2.83
17
155
10
92
1.09
0.03
1.3
1.2
1.30
1.46
nmol/l
—
10
82
21
201
1.05
0.03
4.6
3.1
1.48
1.54
mmol/l
0.23
21
194
40
407
0.98
0.01
1.6
1.8
9.64
3.73
mg/l
0.67
28
298
63
632
1.00
0.00
5.9
3.8
1.22
1.23
mmol/l
0.65
56
552
75
755
0.99
0.00
1.2
1.3
129.24
130.37
u/ml
0.01
19
299
0
6
0.00
0.00
0.0
2.7
—
3.77
—
0
6
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
7
70
1.00
0.00
1.9
1.5
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
3.00
—
0
6
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
6
61
0.98
-0.00
1.3
1.4
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
10.79
—
0
9
0
5
0.00
-0.00
0.0
5.8
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
53
0.94
-0.00
2.0
1.8
122.20
106.08
ng/l
—
5
53
0
8
0.00
-0.00
0.0
1.5
—
—
—
0
0
7
77
0.91
-0.00
1.1
1.1
81.29
109.81
pmol/l
—
7
77
0
8
0.00
-0.00
0.0
1.0
—
1.35
—
0
8
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: AB1_VIRAL_INOTHER_WIDE – Viral agents as the cause of diseases classified to other chapters, including avohilmo
GWS hits: 1
This endpoint is excluded (different definition than used in FinnGen).